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Animal models are traditionally used to study organ development and homeostasis in 
vivo. The development of three dimensional multicellular stem cell based culture models, 
which are self-organizing and resemble the structure and function of an organ, enabled 
the study of these processes in vitro. The Clevers laboratory was the first to establish such 
an self-organizing epithelial structure for the mouse small intestine, called organoids 
(Sato et al., 2009). The term organoid already existed at that time in tumor biology and for 
structures or tissues that resemble an organ in vitro (Lancaster and Huch, 2019), but since 
2009 this term is mainly used for self-organizing in vitro cultures. The Clevers lab was not 
the first to develop an self-organizing stem cell based culture in vitro (Eiraku et al., 2008; 
Li et al., 1987; Shannon et al., 1987), but the first to do so from adult stem cells.
An organoid culture is established by extracting adult stem cells from primary tissue. 
These adult stem cells are subsequently embedded in an extracellular matrix (i.e 
Matrigel or Basement Membrane Extract (BME)) supplemented with a culture medium 
containing essential niche growth factors (Sato et al., 2009). Alternatively, induced 
pluripotent stem cells (iPSCs) can be used as input material for in vitro differentiation 
protocols towards epithelial lineages (Spence et al., 2011). When provided with the 
appropriate growth factor cocktail to promote stem cell maintenance and expansion, 
the culture grows out to form an organoid consisting of an heterogenous cell 
population, which accurately mimics the cellular composition of the corresponding 
organ. Organoids have the capacity to self-renew, and can be used to study processes 
such as organogenesis, tumorigenesis, tissue regeneration, drug sensitivity (Drost et 
al., 2015; Gregorieff et al., 2015; Serra et al., 2019; Spence et al., 2011; Van De Wetering et 
al., 2015). The first epithelial organoids were established for the mouse small intestine 
(Sato et al., 2009), rapidly followed by several other mouse and human organoids 
such as colon, liver, retina, and brain (Huch et al., 2013, 2015; Lancaster et al., 2013; 
Nakano et al., 2012; Sato et al., 2011a). Below I will review recent literature regarding 
three organoid models, which I studied in detail during my PhD studies: mouse 
small intestinal organoids, human colon organoids and human liver organoids. 
Furthermore, I will review common signalling pathways, which are involved in 
adult stem cell maintenance and differentiation and I will summarize multi-omics 
technologies that I applied during my PhD to study organoid cultures.
ORGANOID MODELS
Mouse small intestinal organoids
The intestinal epithelium consists of the crypts of Lieberkühn, which make up the 
intestinal stem cell niche, and villi harboring various differentiated cells (Clevers, 
549219-L-bw-Voorthuijsen
Processed on: 6-10-2020 PDF page: 10
CHAPTER 1
10
2013; Gregorieff and Clevers, 2005). The crypt-villus structure of the epithelium serves 
to enlarge the surface area in the gut to ensure optimal nutrient uptake from the 
intestinal lumen (Date and Sato, 2015; Spit et al., 2018). Intestinal stem cells are located 
in the crypt bottom and they express several adult stem cell markers such as Lgr5 
(Barker et al., 2007) and Ascl2 (van der Flier et al., 2009). The Lgr5 positive stem cells 
are flanked by Paneth cells, which are differentiated cells that nurture the stem cells. 
Furthermore, Paneth cells produce antibacterial peptides to protect the intestinal 
lumen against pathogens. The adult stem cells have self-renewal capacity and give 
rise to fast dividing transient amplifying (TA) cells. These cells migrate upwards 
along the crypt-villus axis and give rise to differentiated absorptive cells (enterocytes) 
secretory cells (tuft-, goblet-, enteroendocrine- and M-cells). Enterocytes are the most 
abundant differentiated cell type in the intestine and they are involved in absorption 
and digestion of nutrients from the lumen. Tuft- and M-cells are both involved in 
immunity, tuft cells can recognize pathogenic antigens and M-cells can present 
antigens to immune cells. Goblet cells produce mucin to form a protective mucus layer 
on the luminal side of the epithelium. Enteroendocrine cells are hormone producing 
cells (Clevers, 2013; Date and Sato, 2015; Spit et al., 2018). 
Small intestinal organoids adopt an epithelial structure that is phenotypically and 
functionally reminiscent of the in vivo situation in the intestine of an adult mouse. 
Most importantly, all major intestinal cell types are correctly positioned along the 
crypt-villus axis and are continuously generated from the proliferative stem cell/
progenitor pool by differentiation. An organoid culture can be obtained by embedding 
isolated mouse intestinal stem cells, or crude crypt material, in extracellular matrix 
supplemented with niche factors. Matrigel or BME is commonly used as extracellular 
matrix which is extracted from Engelbreth-Holm-Swarm tumors of mice and mimics 
the in vivo basal membrane (Kleinman et al., 1986; Lancaster and Knoblich, 2014; 
Li et al., 1987; Yin et al., 2016). Intestinal stem cells are dependent on active Wnt 
signaling for maintenance (Pinto et al., 2003). In vivo, Wnt is secreted by subepithelial 
mesenchymal cells and the Paneth cells (Kabiri et al., 2014; Sato et al., 2011b). In vitro, 
R-spondin1 is added to the culture medium as a niche factor to prevent degradation 
of Wnt receptors such as the Frizzled receptor (de Lau et al., 2014), which results in 
maintenance of active Wnt signaling and stem cell renewal (Yan et al., 2017a). Noggin, 
a BMP antagonist, which inhibits differentiation and induces crypt numbers (Haramis 
et al., 2004; Qi et al., 2017), is another essential niche factor for small intestinal 
organoids. Noggin withdrawal from the culture medium results in loss of organoid 
formation after 2-3 passages (Sato et al., 2009). Finally, EGF is added to facilitate crypt 
growth and long-term culture (Sato et al., 2009; Wong et al., 2012). Collectively, these 
niche factors facilitate long-term organoid culture maintenance. The mouse small 
intestinal organoid culture medium is commonly referred to as ENR (E = EGF, N = 
Noggin, R = R-spondin1).  
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1The plasticity of the intestinal epithelium studied using organoids
The intestinal epithelium self-renews every five days (Blanpain et al., 2007). Adult 
stem cells in the crypts continuously divide and differentiate into various specialized 
cell types and these cells rapidly die and shed off into the intestinal lumen when the 
tip of the villus is reached. Interestingly, the intestinal epithelium displays remarkable 
cellular plasticity. Models employing irradiation and induction of cytotoxic damage 
with drugs have demonstrated rapid replenishment of crypt units, suggesting that 
plasticity and cellular dedifferentiation of non-proliferative cells contributes to the 
regeneration process (Dekaney et al., 2009). Mouse small intestinal organoids are 
a suitable model system to study the cellular plasticity of the intestinal epithelium. 
Small molecule driven perturbations can be used to enrich for specific cell types (Yin 
et al., 2014) (Figure 1), while dedifferentiation and repopulation of the stem cell niche 
can be investigated after selectively killing Lgr5 positive stem cells (Tian et al., 2011).
A mouse small intestinal organoid culture can be enriched for stem cells by adding 
the GSK3β inhibitor CHIR99021 (Bain et al., 2007) and the HDAC class I/IIa inhibitor 
valproic acid (VPA) (Chuang et al., 2009; Gurvich et al., 2004). Wnt signaling is 
constitutively activated by GSK3β inhibition, while VPA is thought to activate notch 
signaling. By adding these two drugs (called CV medium), organoid cultures become 
highly enriched for stem cells in less than a week and display a higher colony formation 
capacity (Yin et al., 2014). Enrichment of enterocytes can be achieved by adding the 
Wnt inhibitor IWP-2, in combination with VPA (Yin et al., 2014), or by withdrawal of 
R-spondin1 from the medium (Lindeboom et al., 2018). IWP-2 inhibits Wnt signaling 
by blocking Wnt secretion via inhibition of porcupine (Chen et al., 2009; Takada et 
al., 2006), which results in differentiation of the stem cells. In combination with VPA, 
differentiation is driven towards enterocytes, suggesting that VPA blocks secretory 
cell differentiation (Yin et al., 2014). Goblet cells can be enriched by addition of IWP-2, 
and the γ-secretase inhibitor DAPT (Aguayo-Ortiz et al., 2019), which results in Notch 
inhibition (Miele et al., 2006). Paneth cell enrichment can be achieved by addition 
of DAPT and CHIR99201  (Yin et al., 2014). Expansion of the hormone-producing 
enterodendocrine cells (EECs) can be achieved by adding DAPT, IWP-2, and PD0325901 
to the culture medium. This last drug is a MEK inhibitor (Ciuffreda et al., 2009), which 
in combination with Notch and Wnt inhibition leads to an upregulation of EEC maker 
genes, including several hormones (Basak et al., 2017). Replacement of Noggin for 
BMP4 in the above described culture medium for EECs, leads to an enrichment of 
EEC subtypes that reside at the villus domain of the crypt-villus-axis in vivo (Beumer 
et al., 2018). Quiescent stem cells, or so called +4 cells, are non-dividing cells that are 
located above the crypt and can replace the stem cell niche upon damage (Buczacki et 
al., 2013). These cells are dependent of active Wnt signaling like intestinal stem cells, 
but are independent of active EGF signaling. Therefore these cells can be enriched 
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in organoid cultures by the addition of an EGFR inhibitor like Gefitinib (Basak et al., 
2017).  Tuft cells also become enriched upon EGFR inhibition (Basak et al., 2017). An 
further increase of tuft cell numbers in small intestinal organoids can be achieved by 
addition of IL-13, which induces tuft cell expansion (Howitt et al., 2016) and / or IL-4 
(Gerbe et al., 2016; von Moltke et al., 2016). Organoid cultures can also be enriched for 
M-cells by supplementing the culture medium with RankL (de Lau et al., 2012). Cellular 
enrichment strategies in organoid cultures can be used to study rare cell types such as 
M-cells (Haber et al., 2017) and tuft cells, and can be used to decipher the molecular 
mechanisms that drive cell fate decisions and differentiation in the intestine (Beumer 
et al., 2018; Gehart et al., 2019; Lindeboom et al., 2018).
As mentioned before, the intestinal epithelium is characterized by a remarkable 
cellular dedifferentiation capacity to regenerate the stem cell niche upon stem cell loss 
or damage (Metcalfe et al., 2014; Tian et al., 2011) or Paneth cell loss (van Es et al., 2019). 
In recent years it was shown that almost all intestinal cell types are able to repopulate 
the stem cell niche including Paneth cells (Yu et al., 2018), secretory progenitors (van 
Es et al., 2012; Jadhav et al., 2017; Yan et al., 2017b), and enterocytes (Tetteh et al., 2016). 
It is believed that Yap signaling is involved in regeneration of the colonic epithelium 
in vivo and in vitro (Yui et al., 2018). However, whereas some studies have reported 
that Yap promotes crypt regeneration (Cai et al., 2010; Gregorieff et al., 2015; Serra 
et al., 2019), others found that Yap suppresses crypt regeneration (Barry et al., 2013). 
Recently, it was reported that a new intestinal cell type, so-called revival stem cells, can 
regenerate the intestine upon damage in a Yap dependent manner in vivo (Ayyaz et al., 
2019), which supports a role for Yap in crypt regeneration. 
Given the fact that most intestinal cell types are able to dedifferentiate upon a loss 
of adult stem cells in the crypts, it is tempting to speculate that a general signaling 
machinery, such as Yap signaling, drives the dedifferentiation process. Remarkably, 
however, a recent study reported that instead of Yap signaling, the transcription 
factor Ascl2 acts as a major driver of dedifferentiation and regeneration (Murata et 
al., 2020). This suggests that further research is needed to decipher whether Ascl2 
and Yap signaling act in a common dedifferentiation pathway or whether multiple 
mechanisms can drive the regeneration potential of the intestinal epithelium in a cell-
type dependent or independent manner  
In summary, in recent years mouse small intestinal organoids have proven to 
be a powerful in vitro culture system, which can be used to identify drivers of 
differentiation, dedifferentiation, and regeneration in the mouse small intestinal 
epithelium.  
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FIGURE 1 | Overview of small intestinal cell types and enrichment strategies
(A) Schematic overview of small intestinal cell types and their localization along the crypt-villus axis.
(B) Enrichment strategies of ENR cultured organoids towards different cell type enriched organoid 
cultures by the addition or withdrawal of the indicated molecules.
 
Human colon organoids
The colonic epithelium is located at the distal part of the gastrointestinal tract and 
is characterized by a folded crypt structure and a lack of villi (Gregorieff and Clevers, 
2005; Spit et al., 2018). Following the establishment of mouse small intestinal organoid 
cultures (Sato et al., 2009), culture conditions for long term in vitro expansion of 
human colonic epithelium were established (Jung et al., 2011; Sato et al., 2011a). In 
addition to the essential niche factors EGF, Noggin, and R-spondin1, more compounds 
are needed to obtain and maintain human colon organoid cultures. The medium is 
supplemented with Wnt3A to sustain Wnt activation, since Wnt production of colon 
organoids is not sufficient for the maintenance of colon stem cells (Sato et al., 2011a). 
Wnt activation results in proliferating progenitor cells and inhibition of differentiation 
(van de Wetering et al., 2002). The sirtuin inhibitor nicotinamide stimulates long term 
culture maintenance (Sato et al., 2011a). In addition to Wnt3A and nicotinamide, two 
small molecule inhibitors, the Alk4/5/7 inhibitor A83-01 (Tojo et al., 2005), and the p38 
inhibitor SB202190 (Fabian et al., 2005) improve the plating efficiency of the organoid 
cultures. These molecules were identified to improve long term organoid culture in a 
compound screen (Sato et al., 2011a). Using the above described WENR + nicotinamide 
+ A83-01 + SB202190 culture medium, adult stem cell renewal and prolonged colon 
organoid culture can be achieved. However, these cultures typically lack differentiated 
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cells such as those observed in mouse small intestinal organoid cultures because 
the niche factors, which are essential to maintain the cultures, strongly inhibit 
differentiation (Sato et al., 2011a).  Other molecules, like gastrin (Sato et al., 2011a) and 
prostaglandin E2 (Jung et al., 2011), are also reported to improve human colon organoid 
cultures, but are not widely used. To overcome the differentiation block caused by 
the p38 inhibition, IGF-1 and FGF-2 can be added instead of SB202190, resulting in the 
presence of secretory cells in human intestinal organoid cultures (Fujii et al., 2018). 
Furthermore, differentiation towards enteroendocrine cells in human intestinal 
organoids can be achieved in by Notch and MEK inhibition (Beumer et al., 2018). 
CRISPR-Cas9 technology can be applied to sequentially introduce common colorectal 
cancer driver mutations in human colon organoids to investigate the onset and 
development of colon cancer in a controlled manner (Drost et al., 2015; Matano et al., 
2015). Furthermore, human colon cancer organoid biobanks have been generated with 
biopsy material from colorectal cancer patients. Organoids from these biobanks can be 
used for personalized cancer drug screenings and to study the molecular mechanisms 
of colorectal cancer progression (Fujii et al., 2016; Van De Wetering et al., 2015). In 
summary, human colon organoid technology holds great promise as a powerful tool in 
cancer biology and personalized medicine. 
Human liver organoids
The human liver contains two major cell types, hepatocytes and bile-duct epithelial 
cells (BECs, also known as cholangiocytes) (Miyajima et al., 2014; Prior et al., 2019). 
Cells in the liver are typically not highly proliferative, in contrast to cells from the 
intestinal epithelium (Magami et al., 2002). However, liver tissue is known for its great 
regenerative potential after cytotoxic damage (Miyajima et al., 2014).
The first reported liver organoids were generated from Lgr5 positive mouse adult liver 
cells (Huch et al., 2013), followed by the first human liver organoid culture system 
(Huch et al., 2015). The mouse liver organoids mostly resemble a biliary cell fate, but 
can be differentiated towards the hepatocyte lineage by inhibiting TGF-β and notch 
signaling (Huch et al., 2013). These liver organoids can be cultured for over a year in 
medium containing EGF, R-spondin1, FGF10, HGF, and nicotinamide (called ERFHn 
or expansion medium) (Huch et al., 2013). Interestingly, Lgr5 positive liver cells, from 
which organoids can be established, could only be detected and collected from liver 
tissue after induction of cytotoxic damage (Huch et al., 2013). In human liver organoids 
cultures, Forskolin (FSK) is added to the ERFHn medium to induce Lgr5 expression, 
in order to establish and maintain organoid cultures obtained from biopsies. 
Furthermore, inhibition of TGF-β by A83-01 improves colony forming efficiencies and 
culture maintenance. Human liver organoids can be cultured for more than 6 months 
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1in this culture medium (ERFHn + A + FSK) and predominantly show a ductal cell fate 
(Huch et al., 2015). Differentiation of these organoids towards hepatocytes can be 
achieved by supplementing the culture medium with BMP7 for several days followed 
by a change to a culture medium containing EGF, HGF, FGF19, A83-01, DAPT, BMP7, and 
dexamethasone for about two weeks (Huch et al., 2015). Both the murine and human 
organoids cultures described above are cholangiocyte-derived organoids, which can 
be differentiated towards a hepatocyte-like cell fate. However, these differentiated 
cultures are not long lived. More recently, culture conditions for longer term mouse 
and human hepatocyte organoids were established (Hu et al., 2018a; Peng et al., 2018). 
These culture systems facilitate culturing  proliferative hepatocytes and can therefore 
be of great value to investigate the molecular mechanisms of liver homeostasis and 
regeneration. 
Human liver organoids can also be manipulated using CRISPR-Cas9 technology 
and this has been exploited to model two major types of primary liver cancer, 
cholangiocarcinoma (Artegiani et al., 2019) and hepatocellular carcinoma (Nuciforo 
et al., 2018). Since the mutational landscape of liver cancer is very heterogeneous 
between patients, liver organoids can also be used for personalized cancer drug 
screenings (Broutier et al., 2017; Li et al., 2019).
SIGNALING PATHWAYS INVOLVED IN ADULT STEM CELL 
MAINTENANCE AND DIFFERENTIATION
As outlined above, the maintenance and differentiation of adult stem cells is 
dependent on niche factors that are regulated by signaling pathways. Adult stem cells 
in different tissues are dependent for their growth on various signaling pathways, 
whereas cancer stem cells typically become independent on these pathways for their 
growth and maintenance. Below, the main signaling pathways involved in adult stem 
cell maintenance in the intestine and colon are summarized (Date and Sato, 2015; Spit 
et al., 2018). Furthermore, the mechanism of action of various small molecules used 
throughout this thesis to manipulate signaling pathways to drive cell fate transitions 
in organoids is summarized.
Wnt signaling
Canonical Wnt signaling is essential for maintenance of the stem cell niche. Gene 
expression induced by activation of this pathway result in stem cell associated gene 
expression and proliferation. Intestinal Paneth cells and subepithelial fibroblasts 
produce Wnt ligands, which bind Firzzled (FZD) receptors and Lrp5/6, both 
present at the stem cell membrane. Upon binding of the Wnt ligand to FZD and Lrp 
5/6, Dishevelled (Dvl) is recruited to the cytoplasmic domain of FZD and Lrp 5/6. 
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Subsequently, Dvl sequesters Axin, one of the subunits of the β-catenin destruction 
complex (Axin, APC, GSK3β, and CK1). GSK3β and CK1 phosphorylate β-catenin upon 
binding to the destruction complex in the cytoplasm, after which β-catenin is marked 
for degradation. Re-localization of Axin, and its binding partners, causes inactivation 
of the β-catenin destruction complex, thus allowing nuclear translocation of 
β-catenin. Nuclear β-catenin interacts with transcription factors of the TCF family, 
resulting in Wnt induced gene expression. One of the major driver mutations resulting 
in malignant transformation in the colon epithelium is APC loss, which leads to an 
inactive β-catenin destruction complex, constitutive Wnt signaling and associated 
gene expression. Other activating molecules of the Wnt signaling pathways, which 
are described in this thesis, are the Wnt ligand Wnt3a, and the Lgr ligand R-spondin1. 
When R-spondin1 is bound to Lgrs, it most likely recruits Rnf43 and Znrf3, two proteins 
involved in degradation of the Wnt receptors FZD and Lrp6. Sequestering of these 
proteins results in stabilization of the Wnt receptors on the cellular membrane and 
amplification of the Wnt signal. Another activating molecule described in this thesis is 
CHIR99201, a GSK3β inhibitor, which causes inactivation of the β-catenin destruction 
complex. Finally, IWP2, which is a porcupine inhibitor, blocks Wnt ligand secretion 
and thus inhibits Wnt signaling. This molecule can be used to induce differentiation 
of intestinal stem cells.
Notch signaling
Notch signaling is influenced by direct cell-cell contact and regulates cell fate 
decisions. Membrane bound ligands such as Delta-like proteins (DLLs) are mainly 
expressed by secretory cells, like Paneth cells (Dll1 and 4). These ligands interact 
with Notch receptors on the neighboring cell, such as adult stem cells (Notch 1 and 
2). Upon ligand-receptor interaction, the Notch intracellular domain (NICD) is cleaved 
off by γ-secretase and gets translocated to the nucleus where it interacts with the 
transcription factor CSL to induce Notch-driven gene expression, which is essential 
for stem cell maintenance. Notch signaling regulates cell fate decisions through one of 
its direct target genes, the transcription factor Hes1. Hes1 represses expression of the 
secretory lineage inducing transcription factor Atoh1. To drive differentiation towards 
the secretory lineage in intestinal organoids, the molecule DAPT can be used. DAPT is 
an γ-secretase inhibitor, which prevents nuclear translocation of NICD.
EGFR signaling
Epidermal growth factor receptor (EGFR) signaling is essential for self-renewal and 
maintenance of the intestinal epithelium. The extracellular ligand epidermal growth 
factor (EGF) is secreted by Paneth cells and subepithelial fibroblasts, and interacts with 
the EGFR. Binding of EGF causes EGFR dimerization followed by phosphorylation of 
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1the intracellular domain of the receptor. This phosphorylation event causes activation 
of several downstream pathways, such as PI3K/Akt and MAP kinase signaling. One 
of the main cancer driver mutations in the human colon is KRASG12D, which results in 
constitutively active KRAS and therefore EGF independent activation of MAP kinase 
signaling. The p38 MAPK inhibitor SB202190 can modulate EGFR signaling in the 
colon by stabilizing EGFR, which results in upregulation of phosphorylated ERK in 
the presence of EGF (Fujii et al., 2016). A negative regulator of the EGFR pathway in the 
intestinal epithelium is Lrig1, which is expressed in the intestinal epithelium to degrade 
EGFR, thereby controlling EGFR signaling dependent proliferation and crypt expansion. 
TGF-β / BMP signaling (SMAD)
Bone morphogenetic protein (BMP) signaling induces differentiation of intestinal 
cells and inhibits stem cell maintenance. BMPs are part of the TGF-β protein family 
that regulates gene expression via a SMAD dependent cascade. BMPs interact with BMP 
receptors (BMPRs), which phosphorylate their intracellular domain and the receptor 
bound SMAD 1/5/8 upon BMP binding. These phosphorylated SMADs bind SMAD4, 
which results in their translocation to the nucleus and induction of gene expression. 
In this thesis we use Noggin as a BMP inhibitor to inhibit terminal differentiation. 
Another molecule used in this thesis is the Alk4/5/7 inhibitor A83-01. SMAD4 can 
also be translocated to the nucleus by binding to phosphorylated SMAD 2/3, which 
occurs upon TGF-β binding to the TGF-β receptor Alk5. Most likely, A83-01 blocks Alk5 
dependent phosphorylation of SMAD 2/3 and therefore inhibit SMAD4 induced gene 
expression (Tojo et al., 2005). Loss of SMAD4 dependent gene expression is also a 
major cancer driver mutation in the colon epithelium, which inhibits differentiation 
and promotes maintenance of cancer stem cells. 
MULTI-OMICS TECHNOLOGIES ADAPTED FOR ORGANOID 
TECHNOLOGY
Ever since their development, numerous technologies including advanced imaging 
and gene expression profiling have been used to investigate organoid cultures in 
detail. Early on, gene expression in organoids was mainly assessed using microarrays 
(Barker et al., 2010; Huch et al., 2013; Sato et al., 2009, 2011b), however the organoid 
field gradually adapted bulk RNA-sequencing (Boj et al., 2015; Forster et al., 2014; 
Gao et al., 2014) and single cell RNA-sequencing to study gene expression (Basak et 
al., 2017; Grün et al., 2015). Bulk RNA-sequencing in organoids is a powerful tool to 
study transcriptome-wide differential gene expression in organoids upon exposure 
to certain drugs or in cell-type enriched organoids. The advent of single cell RNA-
sequencing also facilitated the discovery and characterization of rare cell populations 
in epithelial organoid structures.
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Integration of various omics technologies, such as RNA-, ChIP- and ATAC-sequencing, 
can be applied in organoids to investigate multiple layers of gene expression regulation. 
ATAC- and ChIP-sequencing can be used to investigate the epigenetic landscape in 
organoids (Adams et al., 2019; Artegiani et al., 2019; Lindeboom et al., 2018). With 
ATAC sequencing, it is possible to assess the accessible chromatin landscape, which 
can be used to identify transcription factor binding motifs (Buenrostro et al., 2013). 
More recently, single cell ATAC-sequencing (Buenrostro et al., 2015) was developed and 
was used in an iPSC-based cerebral organoid study (Kanton et al., 2019). Inactive- and 
active epigenetic modification and transcription factor binding can be studied using 
ChIP-sequencing. By profiling, for example, the inactive chromatin mark H3K27me3, 
it is possible to deduce possible Polycomb Repressive Complex (PRC) regulated 
regions (Artegiani et al., 2019; Lindeboom et al., 2018; Oittinen et al., 2017). Regular 
ChIP-sequencing protocols require relatively large amounts of input material, which 
can be a bottleneck in organoid studies. Recently, ChIPmentation was developed 
(Schmidl et al., 2015), a ChIP-based technology that is suitable for low input samples 
and results in higher recovery rates. Therefore, ChIPmentation is a suitable technique 
to study histone marks and transcription factor binding in organoid studies (Artegiani 
et al., 2019; Lindeboom et al., 2018). Another promising genome-wide epigenetic 
modification and transcription factor profiling technique is CUT&RUN (Skene and 
Henikoff, 2017) which is also applicable for low input samples and should therefore 
also be very suitable for organoid-based studies. 
Mass spectrometry-based proteomics technology can be used to study global protein 
expression in organoids, for example to quantify proteome dynamics in (disease 
model) organoids (Artegiani et al., 2019; Boj et al., 2015; Cristobal et al., 2017; Dakic 
et al., 2017; Gonneaud et al., 2016; Jones et al., 2019; Williams et al., 2016). Post-
translational regulation of gene expression can be studied when combining absolute 
transcriptome and proteome data. A so-far untouched area in organoid-based studies 
is affinity purification coupled to mass spectrometry (AP-MS), which can be used to 
study protein complex compositions during differentiation and disease progression. 
Most organoids are grown in Matrigel, a protein-based gel (Hughes et al., 2010), 
which, if not efficiently removed during organoid harvesting, can contaminate mass 
spectrometry-based measurements and can compromise proteome quantification 
accuracy. In the future, the development of synthetic gels as a substitute for Matrigel 
will be beneficial for proteomics-based organoid studies.  
Recently, methods enabling multi-omics analyses in single cells were developed, 
which can be used to study multiple layers of molecular information from single cells 
in an heterogenous population of cells. The following multi-omics measurements in 
single cells have been described (for review see (Chappell et al., 2018; Hu et al., 2018b)): 
the genome and transcriptome (Dey et al., 2015; Macaulay et al., 2015), the methylome, 
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1transcriptome, and / or genome (for example CNV, or DNA accessibility) (Angermueller 
et al., 2016; Cheow et al., 2016; Clark et al., 2018; Hou et al., 2016), the transcriptome 
and DNA accessibility (Cao et al., 2018; Liu et al., 2019), the transcriptome and targeted 
(phospho-)proteome (Gerlach et al., 2019; Peterson et al., 2017; Stoeckius et al., 2017), 
and protein–DNA contacts and the transcriptome (Rooijers et al., 2019). In the future, 
these single cell multi-omics methods will be very useful to decipher gene expression 
regulation in heterogeneous organoid studies, also in the context of epithelial 
organoid co-cultures with immune cells (Bar-Ephraim et al., 2019; Biton et al., 2018; 
Dijkstra et al., 2018; Lindemans et al., 2015; Nozaki et al., 2016; Tsai et al., 2018). 
THESIS OUTLINE
The work presented in this thesis describes molecular mechanisms driving 
differentiation and cancer progression in mouse and human epithelial organoid 
systems. 
In chapter 2, we describe an integrative multi-omics analysis of mouse small 
intestinal organoid differentiation towards enterocytes using an integrative multi-
omics approach. We optimized several bulk omics techniques and applied them 
simultaneously on perturbed small intestinal organoid cultures. We profiled the 
transcriptome (RNA-sequencing), epigenome (ATAC-sequencing and ChIPmentation), 
proteome (mass spectrometry), and the metabolome (metabolomics in collaboration 
with the Burgering lab) of stem cell enriched, normal, and enterocyte enriched 
small intestinal organoid cultures. Integration of these different datasets resulted 
in the discovery of Hnf4g as a major driver of enterocyte differentiation. Functional 
validation in vivo (in collaboration with the Ribeiro lab) and in vitro, revealed a 
downregulation of enterocyte related gene expression and an increase of secretory 
cells upon Hnf4g loss. 
In chapter 3 we report a tool to label intestinal stem cells and colorectal cancer 
stem cells. The reporter, named stem cell ASCL2 reporter (STAR), was discovered and 
designed by the Snippert lab. STAR consists of a minimal enhancer/promoter element, 
which reports transcriptional activity of the stem cell marker ASCL2. We characterized 
the proteins that bind the minimal enhancer/promoter and ASCL2 interacting proteins 
using affinity purification coupled to mass spectrometry (AP-MS). Furthermore, we 
determined the transcriptome of STAR+ (stem cells) and STAR- (differentiated cells) 
in human colon organoids, human colorectal cancer tumor progression organoids 
(TPOs), and human colorectal cancer patient derived organoids. These analyses 
revealed an upregulation of intestinal stem cell associated genes across all samples in 
STAR+ cells. In the future, we anticipate that the STAR reporter will be a useful tool for 
adult stem cell biology in the intestine and in the context of colorectal cancer. 
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In chapter 4, we studied malignant transformation upon a loss of the tumor suppressor 
and  deubiquitinating enzyme BAP1 in the context of cholangiocarcinoma. The Clevers 
lab generated CRISPR engineered BAP1 knockout human liver organoids, in which 
they observed defects in cell polarity and epithelial organization. We performed whole 
proteome measurements using mass spectrometry and observed, in agreement with 
the phenotype, a downregulation of proteins associated with cell adhesion, migration, 
and cytoskeleton organization. Furthermore, we assessed the chromatin landscape 
using ATAC-sequencing, and observed major changes in chromatin accessibility upon 
BAP1 loss, also in regions of junctional and cytoskeletal genes, in accordance with 
transcriptional downregulation of these genes. Surprisingly, we observed a genome-
wide increase of chromatin accessibility upon BAP1 loss despite a global increase of the 
repressive chromatin mark H2AK119Ub. Using ChIPmentation, we observed increased 
chromatin accessibility upon BAP1 loss at regions, which harbor repressive chromatin 
marks, such as H3K27me3, in wild-type organoids. Based on these results we speculate 
that fine-tuning the amount of H2AK119Ub by BAP1 is required for optimal Polycomb-
driven chromatin compaction of chromatin, which requires further investigations. In 
any case, this study emphasizes the value of using CRISPR-engineered organoids for 
disease modeling. 
In chapter 5 we describe a study in which we investigate a role for retinol metabolism 
during enterocyte differentiation and colorectal cancer progression. This study was 
inspired by results obtained in chapter 2, where we observed an upregulation of 
the retinol metabolism during differentiation towards enterocytes. By using retinol 
metabolism-perturbing drugs in small intestinal organoid cultures, we uncover a 
possible role for RXR in regulating enterocyte differentiation. We further investigated 
the effects of RXR inhibition in human colorectal cancer organoids, which resulted 
in a downregulation of enterocyte related genes in colorectal cancer organoids. In 
the near future, further characterization of involved RXR dimerization partner(s) will 
contribute to elucidating the role of retinol metabolism and RXR during colorectal 
cancer progression, and possibly identify ligand(s), which may induce differentiation 
of colorectal cancer stem cells.
Chapter 6 summarizes and discusses the main findings reported in this thesis. This 
chapter focuses on the applications of multi-omics technologies used throughout the 
thesis, the challenges and possibilities of genetic engineering in organoid models, and 
the future perspectives of applying proteomics-based technologies in the organoid 
field. 
549219-L-bw-Voorthuijsen












Adams, E.J., Karthaus, W.R., Hoover, E., Liu, D., Gruet, A., Zhang, Z., Cho, H., DiLoreto, 
R., Chhangawala, S., Liu, Y., et al. (2019). FOXA1 mutations alter pioneering activity, 
differentiation and prostate cancer phenotypes. Nature 571, 408–412.
Aguayo-Ortiz, R., Guzmán-Ocampo, D.C., and Dominguez, L. (2019). Toward the 
Characterization of DAPT Interactions with γ-Secretase. ChemMedChem 14, 1005–1010.
Angermueller, C., Clark, S.J., Lee, H.J., Macaulay, I.C., Teng, M.J., Hu, T.X., Krueger, F., 
Smallwood, S.A., Ponting, C.P., Voet, T., et al. (2016). Parallel single-cell sequencing links 
transcriptional and epigenetic heterogeneity. Nat. Methods 13, 229–232.
Artegiani, B., van Voorthuijsen, L., Lindeboom, R.G.H., Seinstra, D., Heo, I., Tapia, P., López-
Iglesias, C., Postrach, D., Dayton, T., Oka, R., et al. (2019). Probing the Tumor Suppressor 
Function of BAP1 in CRISPR-Engineered Human Liver Organoids. Cell Stem Cell 24, 
927–943.
Ayyaz, A., Kumar, S., Sangiorgi, B., Ghoshal, B., Gosio, J., Ouladan, S., Fink, M., Barutcu, S., 
Trcka, D., Shen, J., et al. (2019). Single-cell transcriptomes of the regenerating intestine 
reveal a revival stem cell. Nature 569, 121–125.
Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C.J., Mclauchlan, H., Klevernic, I., Arthur, 
J.S.C., Alessi, D.R., and Cohen, P. (2007). The selectivity of protein kinase inhibitors: a 
further update. Biochem. J. 408, 297–315.
Bar-Ephraim, Y.E., Kretzschmar, K., and Clevers, H. (2019). Organoids in immunological 
research. Nat. Rev. Immunol. 1–15.
Barker, N., van Es, J.H., Kuipers, J., Kujala, P., van den Born, M., Cozijnsen, M., Haegebarth, 
A., Korving, J., Begthel, H., Peters, P.J., et al. (2007). Identification of stem cells in small 
intestine and colon by marker gene Lgr5. Nature 449, 1003–1007.
Barker, N., Huch, M., Kujala, P., van de Wetering, M., Snippert, H.J., van Es, J.H., Sato, T., 
Stange, D.E., Begthel, H., van den Born, M., et al. (2010). Lgr5+ve Stem Cells Drive Self-
Renewal in the Stomach and Build Long-Lived Gastric Units In Vitro. Cell Stem Cell 6, 
25–36.
Barry, E.R., Morikawa, T., Butler, B.L., Shrestha, K., de la Rosa, R., Yan, K.S., Fuchs, C.S., 
Magness, S.T., Smits, R., Ogino, S., et al. (2013). Restriction of intestinal stem cell 
expansion and the regenerative response by YAP. Nature 493, 106–110.
Basak, O., Beumer, J., Wiebrands, K., Seno, H., van Oudenaarden, A., and Clevers, H. (2017). 
Induced Quiescence of Lgr5+ Stem Cells in Intestinal Organoids Enables Differentiation 
of Hormone-Producing Enteroendocrine Cells. Cell Stem Cell 20, 177–190.
Beumer, J., Artegiani, B., Post, Y., Reimann, F., Gribble, F., Nguyen, T.N., Zeng, H., Van den 
Born, M., Van Es, J.H., and Clevers, H. (2018). Enteroendocrine cells switch hormone 
expression along the crypt-to-villus BMP signalling gradient. Nat. Cell Biol. 20, 909–916.
Biton, M., Haber, A.L., Rogel, N., Burgin, G., Beyaz, S., Schnell, A., Ashenberg, O., Su, C.-W., 
Smillie, C., Shekhar, K., et al. (2018). T Helper Cell Cytokines Modulate Intestinal Stem 
Cell Renewal and Differentiation. Cell 175, 1307–1320.
549219-L-bw-Voorthuijsen
Processed on: 6-10-2020 PDF page: 22
CHAPTER 1
22
Blanpain, C., Horsley, V., and Fuchs, E. (2007). Epithelial Stem Cells: Turning over New 
Leaves. Cell 128, 445–458.
Boj, S.F., Hwang, C.-I., Baker, L.A., Chio, I.I.C., Engle, D.D., Corbo, V., Jager, M., Ponz-Sarvise, 
M., Tiriac, H., Spector, M.S., et al. (2015). Organoid Models of Human and Mouse Ductal 
Pancreatic Cancer. Cell 160, 324–338.
Broutier, L., Mastrogiovanni, G., Verstegen, M.M., Francies, H.E., Gavarró, L.M., Bradshaw, 
C.R., Allen, G.E., Arnes-Benito, R., Sidorova, O., Gaspersz, M.P., et al. (2017). Human 
primary liver cancer–derived organoid cultures for disease modeling and drug 
screening. Nat. Med. 23, 1424–1435.
Buczacki, S.J.A., Zecchini, H.I., Nicholson, A.M., Russell, R., Vermeulen, L., Kemp, R., and 
Winton, D.J. (2013). Intestinal label-retaining cells are secretory precursors expressing 
Lgr5. Nature 495, 65–69.
Buenrostro, J.D., Giresi, P.G., Zaba, L.C., Chang, H.Y., and Greenleaf, W.J. (2013). 
Transposition of native chromatin for fast and sensitive epigenomic profiling of 
open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 10, 
1213–1218.
Buenrostro, J.D., Wu, B., Litzenburger, U.M., Ruff, D., Gonzales, M.L., Snyder, M.P., Chang, 
H.Y., and Greenleaf, W.J. (2015). Single-cell chromatin accessibility reveals principles of 
regulatory variation. Nature 523, 486–490.
Cai, J., Zhang, N., Zheng, Y., de Wilde, R.F., Maitra, A., and Pan, D. (2010). The Hippo 
signaling pathway restricts the oncogenic potential of an intestinal regeneration 
program. Genes Dev. 24, 2383–2388.
Cao, J., Cusanovich, D.A., Ramani, V., Aghamirzaie, D., Pliner, H.A., Hill, A.J., Daza, R.M., 
McFaline-Figueroa, J.L., Packer, J.S., Christiansen, L., et al. (2018). Joint profiling of 
chromatin accessibility and gene expression in thousands of single cells. Science  
(80-. ). 361, 1380–1385.
Chappell, L., Russell, A.J.C., and Voet, T. (2018). Single-Cell (Multi)omics Technologies. 
Annu. Rev. Genom. Hum. Genet 19, 15–41.
Chen, B., Dodge, M.E., Tang, W., Lu, J., Ma, Z., Fan, C.-W., Wei, S., Hao, W., Kilgore, J., 
Williams, N.S., et al. (2009). Small molecule–mediated disruption of Wnt-dependent 
signaling in tissue regeneration and cancer. Nat. Chem. Biol. 5, 100–107.
Cheow, L.F., Courtois, E.T., Tan, Y., Viswanathan, R., Xing, Q., Tan, R.Z., Tan, D.S.W., Robson, 
P., Loh, Y.-H., Quake, S.R., et al. (2016). Single-cell multimodal profiling reveals cellular 
epigenetic heterogeneity. Nat. Methods 13, 833–836.
Chuang, D.-M., Leng, Y., Marinova, Z., Kim, H.-J., and Chiu, C.-T. (2009). Multiple roles of 
HDAC inhibition in neurodegenerative conditions. Trends Neurosci. 32, 591–601.
Ciuffreda, L., Del Bufalo, D., Desideri, M., Di Sanza, C., Stoppacciaro, A., Ricciardi, M.R., 
Chiaretti, S., Tavolaro, S., Benassi, B., Bellacosa, A., et al. (2009). Growth-Inhibitory and 
Antiangiogenic Activity of the MEK Inhibitor PD0325901 in Malignant Melanoma with 
or without BRAF Mutations. Neoplasia 11, 720–731.
549219-L-bw-Voorthuijsen











1Clark, S.J., Argelaguet, R., Kapourani, C.-A., Stubbs, T.M., Lee, H.J., Alda-Catalinas, C., 
Krueger, F., Sanguinetti, G., Kelsey, G., Marioni, J.C., et al. (2018). scNMT-seq enables 
joint profiling of chromatin accessibility DNA methylation and transcription in single 
cells. Nat. Commun. 9, 781.
Clevers, H. (2013). The Intestinal Crypt, A Prototype Stem Cell Compartment. Cell 154, 
274–284.
Cristobal, A., van den Toorn, H.W.P., van de Wetering, M., Clevers, H., Heck, A.J.R., and 
Mohammed, S. (2017). Personalized Proteome Profiles of Healthy and Tumor Human 
Colon Organoids Reveal Both Individual Diversity and Basic Features of Colorectal 
Cancer. Cell Rep. 18, 263–274.
Dakic, V., Minardi Nascimento, J., Costa Sartore, R., Maciel, R. de M., de Araujo, D.B., 
Ribeiro, S., Martins-de-Souza, D., and Rehen, S.K. (2017). Short term changes in the 
proteome of human cerebral organoids induced by 5-MeO-DMT. Sci. Rep. 7, 12863.
Date, S., and Sato, T. (2015). Mini-Gut Organoids: Reconstitution of the Stem Cell Niche. 
Annu. Rev. Cell Dev. Biol. 31, 269–289.
Dekaney, C.M., Gulati, A.S., Garrison, A.P., Helmrath, M.A., and Henning, S.J. (2009). 
Regeneration of intestinal stem/progenitor cells following doxorubicin treatment of 
mice. Am. J. Physiol. Liver Physiol. 297, G461–G470.
Dey, S.S., Kester, L., Spanjaard, B., Bienko, M., and van Oudenaarden, A. (2015). Integrated 
genome and transcriptome sequencing of the same cell. Nat. Biotechnol. 33, 285–289.
Dijkstra, K.K., Cattaneo, C.M., Weeber, F., Chalabi, M., van de Haar, J., Fanchi, L.F., Slagter, 
M., van der Velden, D.L., Kaing, S., Kelderman, S., et al. (2018). Generation of Tumor-
Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids. 
Cell 174, 1586–1598.
Drost, J., Van Jaarsveld, R.H., Ponsioen, B., Zimberlin, C., Van Boxtel, R., Buijs, A., Sachs, N., 
Overmeer, R.M., Offerhaus, G.J., Begthel, H., et al. (2015). Sequential cancer mutations in 
cultured human intestinal stem cells. Nature 521, 43–47.
Eiraku, M., Watanabe, K., Matsuo-Takasaki, M., Kawada, M., Yonemura, S., Matsumura, 
M., Wataya, T., Nishiyama, A., Muguruma, K., and Sasai, Y. (2008). Self-Organized 
Formation of Polarized Cortical Tissues from ESCs and Its Active Manipulation by 
Extrinsic Signals. Cell Stem Cell 3, 519–532.
van Es, J.H., Sato, T., van de Wetering, M., Lyubimova, A., Yee Nee, A.N., Gregorieff, A., 
Sasaki, N., Zeinstra, L., van den Born, M., Korving, J., et al. (2012). Dll1+ secretory 
progenitor cells revert to stem cells upon crypt damage. Nat. Cell Biol. 14, 1099–1104.
van Es, J.H., Wiebrands, K., López-Iglesias, C., van de Wetering, M., Zeinstra, L., van 
den Born, M., Korving, J., Sasaki, N., Peters, P.J., van Oudenaarden, A., et al. (2019). 
Enteroendocrine and tuft cells support Lgr5 stem cells on Paneth cell depletion. Proc. 
Natl. Acad. Sci. 116, 26599–26605.
Fabian, M.A., Biggs, W.H., Treiber, D.K., Atteridge, C.E., Azimioara, M.D., Benedetti, M.G., 
Carter, T.A., Ciceri, P., Edeen, P.T., Floyd, M., et al. (2005). A small molecule–kinase 
interaction map for clinical kinase inhibitors. Nat. Biotechnol. 23, 329–336.
549219-L-bw-Voorthuijsen
Processed on: 6-10-2020 PDF page: 24
CHAPTER 1
24
van der Flier, L.G., van Gijn, M.E., Hatzis, P., Kujala, P., Haegebarth, A., Stange, D.E., Begthel, 
H., van den Born, M., Guryev, V., Oving, I., et al. (2009). Transcription Factor Achaete 
Scute-Like 2 Controls Intestinal Stem Cell Fate. Cell 136, 903–912.
Forster, R., Chiba, K., Schaeffer, L., Regalado, S.G., Lai, C.S., Gao, Q., Kiani, S., Farin, H.F., 
Clevers, H., Cost, G.J., et al. (2014). Human Intestinal Tissue with Adult Stem Cell 
Properties Derived from Pluripotent Stem Cells. Stem Cell Reports 2, 838–852.
Fujii, M., Shimokawa, M., Date, S., Takano, A., Matano, M., Nanki, K., Ohta, Y., Toshimitsu, 
K., Nakazato, Y., Kawasaki, K., et al. (2016). A Colorectal Tumor Organoid Library 
Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis. 
Cell Stem Cell 18, 827–838.
Fujii, M., Matano, M., Toshimitsu, K., Takano, A., Mikami, Y., Nishikori, S., Sugimoto, S., 
and Sato, T. (2018). Human Intestinal Organoids Maintain Self-Renewal Capacity and 
Cellular Diversity in Niche-Inspired Culture Condition. Cell Stem Cell 23, 787–793.
Gao, D., Vela, I., Sboner, A., Iaquinta, P.J., Karthaus, W.R., Gopalan, A., Dowling, C., Wanjala, 
J.N., Undvall, E.A., Arora, V.K., et al. (2014). Organoid Cultures Derived from Patients 
with Advanced Prostate Cancer. Cell 159, 176–187.
Gehart, H., van Es, J.H., Hamer, K., Beumer, J., Kretzschmar, K., Dekkers, J.F., Rios, A., and 
Clevers, H. (2019). Identification of Enteroendocrine Regulators by Real-Time Single-
Cell Differentiation Mapping. Cell 176, 1158–1173.
Gerbe, F., Sidot, E., Smyth, D.J., Ohmoto, M., Matsumoto, I., Dardalhon, V., Cesses, P., 
Garnier, L., Pouzolles, M., Brulin, B., et al. (2016). Intestinal epithelial tuft cells initiate 
type 2 mucosal immunity to helminth parasites. Nature 529, 226–230.
Gerlach, J.P., van Buggenum, J.A.G., Tanis, S.E.J., Hogeweg, M., Heuts, B.M.H., Muraro, 
M.J., Elze, L., Rivello, F., Rakszewska, A., van Oudenaarden, A., et al. (2019). Combined 
quantification of intracellular (phospho-)proteins and transcriptomics from fixed 
single cells. Sci. Rep. 9, 1469.
Gonneaud, A., Jones, C., Turgeon, N., Lévesque, D., Asselin, C., Boudreau, F., and Boisvert, 
F.-M. (2016). A SILAC-Based Method for Quantitative Proteomic Analysis of Intestinal 
Organoids. Sci. Rep. 6, 38195.
Gregorieff, A., and Clevers, H. (2005). Wnt signaling in the intestinal epithelium: from 
endoderm to cancer. Genes Dev. 19, 877–890.
Gregorieff, A., Liu, Y., Inanlou, M.R., Khomchuk, Y., and Wrana, J.L. (2015). Yap-dependent 
reprogramming of Lgr5+ stem cells drives intestinal regeneration and cancer. Nature 
526, 715–718.
Grün, D., Lyubimova, A., Kester, L., Wiebrands, K., Basak, O., Sasaki, N., Clevers, H., and van 
Oudenaarden, A. (2015). Single-cell messenger RNA sequencing reveals rare intestinal 
cell types. Nature 525, 251–255.
Gurvich, N., Tsygankova, O.M., Meinkoth, J.L., and Klein, P.S. (2004). Histone Deacetylase Is 
a Target of Valproic Acid-Mediated Cellular Differentiation. Cancer Res. 64, 1079–1086.
549219-L-bw-Voorthuijsen











1Haber, A.L., Biton, M., Rogel, N., Herbst,  rebecca H., Shekhar, K., Smillie, C., Burgin, G., 
Delorey, T.M., Howitt, M.R., Katz, Y., et al. (2017). A single-cell survey of the small 
intestinal epithelium. Nature 551, 333–339.
Haramis, A.P.G., Begthel, H., Van Den Born, M., Van Es, J., Jonkheer, S., Offerhaus, G.J.A., and 
Clevers, H. (2004). De Novo Crypt Formation and Juvenile Polyposis on BMP Inhibition 
in Mouse Intestine. Science (80-. ). 303, 1684–1686.
Hou, Y., Guo, H., Cao, C., Li, X., Hu, B., Zhu, P., Wu, X., Wen, L., Tang, F., Huang, Y., 
et al. (2016). Single-cell triple omics sequencing reveals genetic, epigenetic, and 
transcriptomic heterogeneity in hepatocellular carcinomas. Cell Res. 26, 304–319.
Howitt, M.R., Lavoie, S., Michaud, M., Blum, A.M., Tran, S. V., Weinstock, J. V., Gallini, C.A., 
Redding, K., Margolskee, R.F., Osborne, L.C., et al. (2016). Tuft cells, taste-chemosensory 
cells, orchestrate parasite type 2 immunity in the gut. Science (80-. ). 351, 1329–1333.
Hu, H., Gehart, H., Artegiani, B., LÖpez-Iglesias, C., Dekkers, F., Basak, O., van Es, J., Chuva 
de Sousa Lopes, S.M., Begthel, H., Korving, J., et al. (2018a). Long-Term Expansion of 
Functional Mouse and Human Hepatocytes as 3D Organoids. Cell 175, 1591–1606.
Hu, Y., An, Q., Sheu, K., Trejo, B., Fan, S., and Guo, Y. (2018b). Single Cell Multi-Omics 
Technology: Methodology and Application. Front. Cell Dev. Biol. 6, 28.
Huch, M., Dorrell, C., Boj, S.F., Van Es, J.H., Li, V.S.W., Van De Wetering, M., Sato, T., Hamer, 
K., Sasaki, N., Finegold, M.J., et al. (2013). In vitro expansion of single Lgr5 + liver stem 
cells induced by Wnt-driven regeneration. Nature 494, 247–250.
Huch, M., Gehart, H., van Boxtel, R., Hamer, K., Blokzijl, F., Verstegen, M.M.A., Ellis, E., van 
Wenum, M., Fuchs, S.A., de Ligt, J., et al. (2015). Long-Term Culture of Genome-Stable 
Bipotent Stem Cells from Adult Human Liver. Cell 160, 299–312.
Hughes, C.S., Postovit, L.M., and Lajoie, G.A. (2010). Matrigel: A complex protein mixture 
required for optimal growth of cell culture. Proteomics 10, 1886–1890.
Jadhav, U., Saxena, M., O’Neill, N.K., Saadatpour, A., Yuan, G.-C., Herbert, Z., Murata, K., and 
Shivdasani, R.A. (2017). Dynamic Reorganization of Chromatin Accessibility Signatures 
during Dedifferentiation of Secretory Precursors into Lgr5+ Intestinal Stem Cells. Cell 
Stem Cell 21, 65–77.
Jones, E.J., Matthews, Z.J., Gul, L., Sudhakar, P., Treveil, A., Divekar, D., Buck, J., Wrzesinski, 
T., Jefferson, M., Armstrong, S.D., et al. (2019). Integrative analysis of Paneth cell 
proteomic and transcriptomic data from intestinal organoids reveals functional 
processes dependent on autophagy. Dis. Model. Mech. 12, dmm037069.
Jung, P., Sato, T., Merlos-Suárez, A., Barriga, F.M., Iglesias, M., Rossell, D., Auer, H., Gallardo, 
M., Blasco, M.A., Sancho, E., et al. (2011). Isolation and in vitro expansion of human 
colonic stem cells. Nat. Med. 17, 1225–1227.
Kabiri, Z., Greicius, G., Madan, B., Biechele, S., Zhong, Z., Zaribafzadeh, H., Edison, Aliyev, 
J., Wu, Y., Bunte, R., et al. (2014). Stroma provides an intestinal stem cell niche in the 
absence of epithelial Wnts. Dev. 141, 2206–2215.
549219-L-bw-Voorthuijsen
Processed on: 6-10-2020 PDF page: 26
CHAPTER 1
26
Kanton, S., Boyle, M.J., He, Z., Santel, M., Weigert, A., Sanchís-Calleja, F., Guijarro, P., Sidow, 
L., Fleck, J.S., Han, D., et al. (2019). Organoid single-cell genomic atlas uncovers human-
specific features of brain development. Nature 574, 418–422.
Kleinman, H.K., McGarvey, M.L., Hassell, J.R., Star, V.L., Cannon, F.B., Laurie, G.W., 
and Martin, G.R. (1986). Basement Membrane Complexes with Biological Activity. 
Biochemistry 25, 312–318.
Lancaster, M.A., and Huch, M. (2019). Disease modelling in human organoids. Dis. Model. 
Mech. 12, dmm039347.
Lancaster, M.A., and Knoblich, J.A. (2014). Organogenesis in a dish: Modeling development 
and disease using organoid technologies. Science (80-. ). 345, 1247125–1247125.
Lancaster, M.A., Renner, M., Martin, C.A., Wenzel, D., Bicknell, L.S., Hurles, M.E., Homfray, 
T., Penninger, J.M., Jackson, A.P., and Knoblich, J.A. (2013). Cerebral organoids model 
human brain development and microcephaly. Nature 501, 373–379.
de Lau, W., Kujala, P., Schneeberger, K., Middendorp, S., Li, V.S.W., Barker, N., Martens, A., 
Hofhuis, F., DeKoter, R.P., Peters, P.J., et al. (2012). Peyer’s Patch M Cells Derived from 
Lgr5+ Stem Cells Require SpiB and Are Induced by RankL in Cultured “Miniguts.” Mol. 
Cell. Biol. 32, 3639–3647.
de Lau, W., Peng, W.C., Gros, P., and Clevers, H. (2014). The R-spondin/Lgr5/Rnf43 module: 
Regulator of Wnt signal strength. Genes Dev. 28, 305–316.
Li, L., Knutsdottir, H., Hui, K., Weiss, M.J., He, J., Philosophe, B., Cameron, A.M., Wolfgang, 
C.L., Pawlik, T.M., Ghiaur, G., et al. (2019). Human primary liver cancer organoids reveal 
intratumor and interpatient drug response heterogeneity. JCI Insight 4, e121490.
Li, M.L., Aggeler, J., Farson, D.A., Hatier, C., Hassell, J., and Bissell, M.J. (1987). Influence of a 
reconstituted basement membrane and its components on casein gene expression and 
secretion in mouse mammary epithelial cells. Proc. Natl. Acad. Sci. 84, 136–140.
Lindeboom, R.G., Voorthuijsen, L., Oost, K.C., Rodríguez-Colman, M.J., Luna-Velez, M. V, 
Furlan, C., Baraille, F., Jansen, P.W., Ribeiro, A., Burgering, B.M., et al. (2018). Integrative 
multi-omics analysis of intestinal organoid differentiation. Mol. Syst. Biol. 14, e8227.
Lindemans, C.A., Calafiore, M., Mertelsmann, A.M., O’Connor, M.H., Dudakov, J.A., Jenq, 
R.R., Velardi, E., Young, L.F., Smith, O.M., Lawrence, G., et al. (2015). Interleukin-22 
promotes intestinal-stem-cell-mediated epithelial regeneration. Nature 528, 560–564.
Liu, L., Liu, C., Quintero, A., Wu, L., Yuan, Y., Wang, M., Cheng, M., Leng, L., Xu, L., Dong, 
G., et al. (2019). Deconvolution of single-cell multi-omics layers reveals regulatory 
heterogeneity. Nat. Commun. 10, 470.
Macaulay, I.C., Haerty, W., Kumar, P., Li, Y.I., Hu, T.X., Teng, M.J., Goolam, M., Saurat, N., 
Coupland, P., Shirley, L.M., et al. (2015). G&amp;T-seq: parallel sequencing of single-cell 
genomes and transcriptomes. Nat. Methods 12, 519–522.
Magami, Y., Azuma, T., Inokuchi, H., Kokuno, S., Moriyasu, F., Kawai, K., and Hattori, T. 
(2002). Cell proliferation and renewal of normal hepatocytes and bile duct cells in adult 
mouse liver. Liver Int. 22, 419–425.
549219-L-bw-Voorthuijsen











1Matano, M., Date, S., Shimokawa, M., Takano, A., Fujii, M., Ohta, Y., Watanabe, T., Kanai, 
T., and Sato, T. (2015). Modeling colorectal cancer using CRISPR-Cas9–mediated 
engineering of human intestinal organoids. Nat. Med. 21, 256–262.
Metcalfe, C., Kljavin, N.M., Ybarra, R., and de Sauvage, F.J. (2014). Lgr5+ Stem Cells Are 
Indispensable for Radiation-Induced Intestinal Regeneration. Cell Stem Cell 14, 
149–159.
Miele, L., Miao, H., and Nickoloff, B. (2006). NOTCH Signaling as a Novel Cancer 
Therapeutic Target. Curr. Cancer Drug Targets 6, 313–323.
Miyajima, A., Tanaka, M., and Itoh, T. (2014). Stem/Progenitor Cells in Liver Development, 
Homeostasis, Regeneration, and Reprogramming. Cell Stem Cell 14, 561–574.
von Moltke, J., Ji, M., Liang, H.-E., and Locksley, R.M. (2016). Tuft-cell-derived IL-25 
regulates an intestinal ILC2–epithelial response circuit. Nature 529, 221–225.
Murata, K., Jadhav, U., Madha, S., van Es, J., Dean, J., Cavazza, A., Wucherpfennig, 
K., Michor, F., Clevers, H., and Shivdasani, R.A. (2020). Ascl2-Dependent Cell 
Dedifferentiation Drives Regeneration of Ablated Intestinal Stem Cells. Cell Stem Cell 
26, 377–390.
Nakano, T., Ando, S., Takata, N., Kawada, M., Muguruma, K., Sekiguchi, K., Saito, K., 
Yonemura, S., Eiraku, M., and Sasai, Y. (2012). Self-Formation of Optic Cups and Storable 
Stratified Neural Retina from Human ESCs. Cell Stem Cell 10, 771–785.
Nozaki, K., Mochizuki, W., Matsumoto, Y., Matsumoto, T., Fukuda, M., Mizutani, T., 
Watanabe, M., and Nakamura, T. (2016). Co-culture with intestinal epithelial organoids 
allows efficient expansion and motility analysis of intraepithelial lymphocytes. J. 
Gastroenterol. 51, 206–213.
Nuciforo, S., Fofana, I., Matter, M.S., Blumer, T., Calabrese, D., Boldanova, T., Piscuoglio, S., 
Wieland, S., Ringnalda, F., Schwank, G., et al. (2018). Organoid Models of Human Liver 
Cancers Derived from Tumor Needle Biopsies. Cell Rep. 24, 1363–1376.
Oittinen, M., Popp, A., Kurppa, K., Lindfors, K., Mäki, M., Kaikkonen, M.U., and Viiri, K. 
(2017). Polycomb Repressive Complex 2 Enacts Wnt Signaling in Intestinal Homeostasis 
and Contributes to the Instigation of Stemness in Diseases Entailing Epithelial 
Hyperplasia or Neoplasia. Stem Cells 35, 445–457.
Peng, W.C., Logan, C.Y., Fish, M., Anbarchian, T., Aguisanda, F., Álvarez-Varela, A., Wu, P., 
Jin, Y., Zhu, J., Li, B., et al. (2018). Inflammatory Cytokine TNFα Promotes the Long-Term 
Expansion of Primary Hepatocytes in 3D Culture. Cell 175, 1607–1619.
Peterson, V.M., Zhang, K.X., Kumar, N., Wong, J., Li, L., Wilson, D.C., Moore, R., 
McClanahan, T.K., Sadekova, S., and Klappenbach, J.A. (2017). Multiplexed 
quantification of proteins and transcripts in single cells. Nat. Biotechnol. 35, 936–939.
Pinto, D., Gregorieff, A., Begthel, H., and Clevers, H. (2003). Canonical Wnt signals are 
essential for homeostasis of the intestinal epithelium. Genes Dev. 17, 1709–1713.
Prior, N., Inacio, P., and Huch, M. (2019). Liver organoids: from basic research to therapeutic 
applications. Gut 68, 2228–2237.
549219-L-bw-Voorthuijsen
Processed on: 6-10-2020 PDF page: 28
CHAPTER 1
28
Qi, Z., Li, Y., Zhao, B., Xu, C., Liu, Y., Li, H., Zhang, B., Wang, X., Yang, X., Xie, W., et al. (2017). 
BMP restricts stemness of intestinal Lgr5+ stem cells by directly suppressing their 
signature genes. Nat. Commun. 8, 13824.
Rooijers, K., Markodimitraki, C.M., Rang, F.J., de Vries, S.S., Chialastri, A., de Luca, K.L., 
Mooijman, D., Dey, S.S., and Kind, J. (2019). Simultaneous quantification of protein–
DNA contacts and transcriptomes in single cells. Nat. Biotechnol. 37, 766–772.
Sato, T., Vries, R.G., Snippert, H.J., Van De Wetering, M., Barker, N., Stange, D.E., Van Es, 
J.H., Abo, A., Kujala, P., Peters, P.J., et al. (2009). Single Lgr5 stem cells build crypt-villus 
structures in vitro without a mesenchymal niche. Nature 459, 262–265.
Sato, T., Stange, D.E., Ferrante, M., Vries, R.G.J., Van Es, J.H., Van Den Brink, S., Van Houdt, 
W.J., Pronk, A., Van Gorp, J., Siersema, P.D., et al. (2011a). Long-term expansion of 
epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s 
epithelium. Gastroenterology 141, 1762–1772.
Sato, T., van Es, J.H., Snippert, H.J., Stange, D.E., Vries, R.G., van den Born, M., Barker, N., 
Shroyer, N.F., van de Wetering, M., and Clevers, H. (2011b). Paneth cells constitute the 
niche for Lgr5 stem cells in intestinal crypts. Nature 469, 415–418.
Schmidl, C., Rendeiro, A.F., Sheffield, N.C., and Bock, C. (2015). ChIPmentation: fast, robust, 
low-input ChIP-seq for histones and transcription factors. Nat. Methods 12, 963–965.
Serra, D., Mayr, U., Boni, A., Lukonin, I., Rempfler, M., Challet Meylan, L., Stadler, M.B., 
Strnad, P., Papasaikas, P., Vischi, D., et al. (2019). Self-organization and symmetry 
breaking in intestinal organoid development. Nature 569, 66–72.
Shannon, J.M., Mason, R.J., and Jennings, S.D. (1987). Functional differentiation of alveolar 
type II epithelial cells in vitro: Effects of cell shape, cell-matrix interactions and cell-cell 
interactions. Biochim. Biophys. Acta - Mol. Cell Res. 931, 143–156.
Skene, P.J., and Henikoff, S. (2017). An efficient targeted nuclease strategy for high-
resolution mapping of DNA binding sites. Elife 6, e21856.
Spence, J.R., Mayhew, C.N., Rankin, S.A., Kuhar, M.F., Vallance, J.E., Tolle, K., Hoskins, E.E., 
Kalinichenko, V. V, Wells, S.I., Zorn, A.M., et al. (2011). Directed differentiation of human 
pluripotent stem cells into intestinal tissue in vitro. Nature 470, 105–109.
Spit, M., Koo, B.-K., and Maurice, M.M. (2018). Tales from the crypt: intestinal niche signals 
in tissue renewal, plasticity and cancer. Open Biol. 8, 180120.
Stoeckius, M., Hafemeister, C., Stephenson, W., Houck-Loomis, B., Chattopadhyay, P.K., 
Swerdlow, H., Satija, R., and Smibert, P. (2017). Simultaneous epitope and transcriptome 
measurement in single cells. Nat. Methods 14, 865–868.
Takada, R., Satomi, Y., Kurata, T., Ueno, N., Norioka, S., Kondoh, H., Takao, T., and Takada, 
S. (2006). Monounsaturated Fatty Acid Modification of Wnt Protein: Its Role in Wnt 
Secretion. Dev. Cell 11, 791–801.
Tetteh, P.W., Basak, O., Farin, H.F., Wiebrands, K., Kretzschmar, K., Begthel, H., van den 
Born, M., Korving, J., de Sauvage, F., van Es, J.H., et al. (2016). Replacement of Lost Lgr5-
Positive Stem Cells through Plasticity of Their Enterocyte-Lineage Daughters. Cell Stem 
Cell 18, 203–213.
549219-L-bw-Voorthuijsen











1Tian, H., Biehs, B., Warming, S., Leong, K.G., Rangell, L., Klein, O.D., and de Sauvage, F.J. 
(2011). A reserve stem cell population in small intestine renders Lgr5-positive cells 
dispensable. Nature 478, 255–259.
Tojo, M., Hamashima, Y., Hanyu, A., Kajimoto, T., Saitoh, M., Miyazono, K., Node, M., and 
Imamura, T. (2005). The ALK-5 inhibitor A-83-01 inhibits Smad signaling and epithelial-
to-mesenchymal transition by transforming growth factor-β. Cancer Sci. 96, 791–800.
Tsai, S., McOlash, L., Palen, K., Johnson, B., Duris, C., Yang, Q., Dwinell, M.B., Hunt, B., 
Evans, D.B., Gershan, J., et al. (2018). Development of primary human pancreatic cancer 
organoids, matched stromal and immune cells and 3D tumor microenvironment 
models. BMC Cancer 18, 335.
van de Wetering, M., Sancho, E., Verweij, C., de Lau, W., Oving, I., Hurlstone, A., van der 
Horn, K., Batlle, E., Coudreuse, D., Haramis, A.-P., et al. (2002). The β-Catenin/TCF-4 
Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells. Cell 111, 
241–250.
Van De Wetering, M., Francies, H.E., Francis, J.M., Bounova, G., Iorio, F., Pronk, A., Van 
Houdt, W., Van Gorp, J., Taylor-Weiner, A., Kester, L., et al. (2015). Prospective derivation 
of a living organoid biobank of colorectal cancer patients. Cell 161, 933–945.
Williams, K.E., Lemieux, G.A., Hassis, M.E., Olshen, A.B., Fisher, S.J., and Werb, Z. (2016). 
Quantitative proteomic analyses of mammary organoids reveals distinct signatures 
after exposure to environmental chemicals. Proc. Natl. Acad. Sci. 113, E1343–E1351.
Wong, V.W.Y., Stange, D.E., Page, M.E., Buczacki, S., Wabik, A., Itami, S., Van De Wetering, M., 
Poulsom, R., Wright, N.A., Trotter, M.W.B., et al. (2012). Lrig1 controls intestinal stem-
cell homeostasis by negative regulation of ErbB signalling. Nat. Cell Biol. 14, 401–408.
Yan, K.S., Janda, C.Y., Chang, J., Zheng, G.X.Y., Larkin, K.A., Luca, V.C., Chia, L.A., Mah, A.T., 
Han, A., Terry, J.M., et al. (2017a). Non-equivalence of Wnt and R-spondin ligands during 
Lgr5+ intestinal stem-cell self-renewal. Nature 545, 238–242.
Yan, K.S., Gevaert, O., Zheng, G.X.Y., Anchang, B., Probert, C.S., Larkin, K.A., Davies, P.S., 
Cheng, Z., Kaddis, J.S., Han, A., et al. (2017b). Intestinal Enteroendocrine Lineage Cells 
Possess Homeostatic and Injury-Inducible Stem Cell Activity. Cell Stem Cell 21, 78–90.
Yin, X., Farin, H.F., van Es, J.H., Clevers, H., Langer, R., and Karp, J.M. (2014). Niche-
independent high-purity cultures of Lgr5+ intestinal stem cells and their progeny. Nat. 
Methods 11, 106–112.
Yin, X., Mead, B.E., Safaee, H., Langer, R., Karp, J.M., and Levy, O. (2016). Engineering Stem 
Cell Organoids. Cell Stem Cell 18, 25–38.
Yu, S., Tong, K., Zhao, Y., Balasubramanian, I., Yap, G.S., Ferraris, R.P., Bonder, E.M., 
Verzi, M.P., and Gao, N. (2018). Paneth Cell Multipotency Induced by Notch Activation 
following Injury. Cell Stem Cell 23, 46–59.
Yui, S., Azzolin, L., Maimets, M., Pedersen, M.T., Fordham, R.P., Hansen, S.L., Larsen, H.L., 
Guiu, J., Alves, M.R.P., Rundsten, C.F., et al. (2018). YAP/TAZ-Dependent Reprogramming 
of Colonic Epithelium Links ECM Remodeling to Tissue Regeneration. Cell Stem Cell 22, 
35–49.
549219-L-bw-Voorthuijsen
Processed on: 6-10-2020 PDF page: 30
30
549219-L-bw-Voorthuijsen
Processed on: 6-10-2020 PDF page: 31
CHAPTER 2
Integrative multi-omics analysis of 
intestinal organoid differentiation
Rik GH Lindeboom1,†, Lisa van Voorthuijsen1,†, Koen C Oost2, Maria J Rodríguez-
Colman2, Maria V Luna-Velez1, Cristina Furlan1, Floriane Baraille3, Pascal WTC Jansen1, 
Agnès Ribeiro3, Boudewijn MT Burgering2, Hugo J Snippert2,* and Michiel Vermeulen1,**
1   Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Oncode 
Institute, Radboud University Nijmegen, Nijmegen, The Netherlands
2   Molecular Cancer Research, Center for Molecular Medicine, Oncode Institute, University Medical Center 
Utrecht, University Utrecht, Utrecht, The Netherlands
3   Centre de Recherche des Cordeliers, INSERM, IHU ICAN, Sorbonne Université, Université Paris Descartes, 
Paris, France
*  Corresponding author. Tel: +31 887568989; E-mail: h.j.g.snippert@umcutrecht.nl
**  Corresponding author. Tel: +31 243610562; E-mail: michiel.vermeulen@science.ru.nl 
†  These authors contributed equally to this work
Published in Molecular Systems Biology, 2018. 
549219-L-bw-Voorthuijsen




Intestinal organoids accurately recapitulate epithelial homeostasis in vivo, thereby 
representing a powerful in vitro system to investigate lineage specification and cellular 
differentiation. Here, we applied a multi-omics framework on stem cell-enriched 
and stem cell-depleted mouse intestinal organoids to obtain a holistic view of the 
molecular mechanisms that drive differential gene expression during adult intestinal 
stem cell differentiation. Our data revealed a global rewiring of the transcriptome 
and proteome between intestinal stem cells and enterocytes, with the majority 
of dynamic protein expression being transcription-driven. Integrating absolute 
mRNA and protein copy numbers revealed post-transcriptional regulation of gene 
expression. Probing the epigenetic landscape identified a large number of cell-type-
specific regulatory elements, which revealed Hnf4g as a major driver of enterocyte 
differentiation. In summary, by applying an integrative systems biology approach, we 
uncovered multiple layers of gene expression regulation, which contribute to lineage 
specification and plasticity of the mouse small intestinal epithelium.
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SYNOPSIS
An integrative multi-omics approach reveals global rewiring of gene expression 
both at the transcript and protein level during intestinal stem cell differentiation. 
Hepatocyte nuclear factor 4 gamma (Hnf4g) is identified as a major driver of enterocyte 
differentiation.
 
•  A multi-omics framework is applied on stem-cell-enriched and -depleted mouse 
intestinal organoids.
•  System wide rewiring of the transcriptome and proteome is observed during 
intestinal stem cell differentiation.
•  Epigenetic modulation facilitates transcription factor driven differentiation. Hnf4g 
is identified as a major driver of enterocyte differentiation.
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The mammalian small intestinal epithelium is organized in glandular structures called 
crypts of Lieberkühn and finger-like structures called villi. New cells are constantly 
generated in the crypts to replace differentiated cells at the flanks of the villi, making 
the intestinal epithelium one of the fastest proliferating mammalian tissues. The 
driving force behind this constant self-renewal are adult stem cells that are located 
at the crypt base and divide once a day. These stem cells, marked by expression of the 
leucine-rich repeat G-protein-coupled receptor Lgr5 (Barker et al., 2007), give rise to a 
dividing pool of progenitor cells that migrate upward to differentiate and populate the 
villi with various specialized cell types that are involved in processes such as nutrient 
uptake, secretion of hormones, and mucus secretion. Interestingly, the intestinal 
epithelium displays remarkable cellular plasticity. Models making use of irradiation 
and specific depletion of the stem cell pool have demonstrated rapid regeneration 
of fully functional crypt units, suggesting that plasticity of non-proliferative cells 
contributes to the regeneration process (Metcalfe et al., 2014; Tian et al., 2011). Indeed, 
recent evidence suggests that a variety of committed progenitor cells can convert 
back to Lgr5+ stem cells upon external stimuli to ensure intestinal homeostasis (van 
Es et al., 2012; Jadhav et al., 2017; Tetteh et al., 2016; Yan et al., 2017). The molecular 
mechanisms, which facilitate this cellular plasticity, are just becoming to be unraveled. 
Among others, previous work has revealed a broadly permissive chromatin structure 
that remains present upon differentiation of Lgr5+ stem cells toward secretory and 
enterocyte precursors, suggesting that modular expression of one or a few transcription 
factors may be sufficient to trigger a global rewiring of gene expression and cellular 
phenotype. Indeed, broadly permissive chromatin that remains shared between cell-
type progenitors provides a possible molecular explanation for the high degree of 
cellular plasticity in the intestinal epithelium (Kim et al., 2014).
Studying gene expression regulation in adult intestinal stem cells and their 
differentiated progeny has been quite challenging. Mouse models only provide 
limited amounts of material for resource-demanding technologies, while protocols 
to culture these cells in vitro have been lacking. However, recently, it was shown that 
isolated Lgr5+ adult stem cells from the mouse gut can form “miniguts” or organoids 
in vitro in a well-defined semi-solid culture medium supplemented with essential 
growth factors (Sato et al., 2009). These organoids self-organize into an epithelial 
structure that is phenotypically and functionally reminiscent of the in vivo situation 
in the intestine of an adult mouse. Most importantly, all major intestinal cell types are 
continuously generated from the proliferative stem cell/progenitor pool followed by 
differentiation and migration toward their correct positioning along the crypt–villus 
axis. Intestinal organoids have great potential to study cell-type specification in the 
intestine, but their inherent multicellular heterogeneity represents a major drawback 
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when combined with systems biology approaches to study gene expression regulation 
per cellular lineage.
Here, we show that minor modifications of the organoid culture medium to generate 
cell-type enriched mouse intestinal organoids, e.g., stem cell or enterocyte, can 
be used in combination with a multi-omics framework to decipher the molecular 
mechanisms that drive cell fate changes in small intestinal organoids. Our data reveal 
a global rewiring of the proteome and transcriptome during adult intestinal stem 
cell differentiation, with the large majority of dynamic protein expression being 
accompanied by a change in the corresponding transcript. Furthermore, we show that 
the Polycomb machinery represses a small but important subset of transcripts during 
adult intestinal stem cell differentiation. Finally, we identified the nuclear receptor 
hepatocyte nuclear factor 4 gamma (Hnf4g) as a major driver of enterocyte-specific 
gene expression patterns in intestinal organoids. Remarkably, loss of Hnf4g results 
in a partial loss of enterocyte-specific gene expression and an increase in secretory 
cells such as goblet cells in organoids and in the mouse small intestine. These datasets 
provide a rich resource for the community. Moreover, being applicable to all types of 
organoid cultures, including of human origin, our workflows represent a blueprint for 
future endeavors aimed at deciphering gene expression regulation in heterogeneous 
epithelial organoid cultures.
RESULTS
Generation of stem cell-enriched and stem cell-depleted mouse small 
intestinal organoid cultures
To study in vitro differentiation of adult intestinal stem cells in a controlled manner, 
we generated cell-type enriched mouse small intestinal organoid cultures. To generate 
Lgr5- intestinal stem cell-enriched organoids, we supplemented the organoid culture 
medium (ENR; EGF, Noggin, R-Spondin; (Sato et al., 2009)) with CHIR99021 and 
valproic acid (CV), to influence Wnt and Notch signaling, respectively (Kishida et al., 
2017; Yin et al., 2014). To induce overall differentiation, mainly toward enterocytes, 
we removed R-Spondin, a Wnt signaling enhancer, from the culture medium (EN) 
to mimic the diminishing Wnt gradient along the crypt flanks (Fig 1A; (Farin et al., 
2016; Yin et al., 2014)). As a reference, we compared cell-type-enriched organoids to 
organoids grown in regular culture medium (ENR). To evaluate the efficiency of stem 
cell enrichment and depletion in CV and EN organoids, respectively, we made use 
of organoids containing a GFP reporter at the endogenous Lgr5 locus, thus enabling 
visualization of the adult Lgr5+ intestinal stem cells ((Tian et al., 2011); Fig 1B). 
Reassuringly, while Lgr5+ stem cells are restricted to the bottom of the crypts in ENR 
organoids, they become the dominating cell type in CV organoids, while they are absent 
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after R-Spondin removal in EN organoids. To evaluate whether in vitro differentiation 
of organoids recapitulates in vivo differentiation along the intestinal crypt–villus axis, 
we compared deep proteomes of the organoid cultures (> 8,600 identified proteins) to 
proteomes from freshly isolated crypts and villi from the mouse small intestine (Fig 
1C). When comparing dynamically expressed proteins in CV, ENR, and EN organoids 
to crypt and villi samples, we observed a striking correlation between the EN and the 
villus proteome, while ENR and CV show a reduced correlation. Thus, in agreement 
with inactivity of the Wnt pathway to stimulate enterocyte differentiation, the 
molecular signature of the EN organoid culture closely resembles the in vivo villus 
FIGURE 1 | Small-molecule-driven cell-type enrichment as a model for intestinal differentiation
(A) Illustration of the small intestinal crypt–villus structure and the organoid culture conditions that 
are used to enrich for specific cell types.
(B) Fluorescence microscopy images of typical mouse small intestinal organoids under different 
culture conditions. Lgr5+ intestinal stem cells are labeled with GFP, which are ubiquitously 
present, restricted to the bottom of the crypts and absent in CV, ENR and EN, respectively. * is auto-
fluorescence.
(C) Pearson correlations between villus proteome and the different organoid samples when focusing 
on proteins that are significantly changing between CV, ENR, and EN organoids, where the EN 
proteome correlates best with the villus proteome. The central line in each boxplot represents the 
median, the hinges are the first and third quartile, and the whiskers extend to the lowest and highest 
values within 1.5× the interquartile range from the hinges. Each sample was measured three times.
(D) Schematic overview of the multi-omics approach that was taken to get a system-wide profile of 
cell-type-enriched organoid cultures.
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proteome, which is made up by more than 80% of enterocytes (van der Flier and 
Clevers, 2009). To determine whether these cell-type enrichment methods are mouse 
strain independent, we compared the proteome of CV, ENR, and EN cultured small 
intestinal organoids from different genetic backgrounds (Fig EV1C). Reassuringly, a 
strong correlation between the enriched organoids cultures is observed. This indicates 
that cell-type-enriched organoid cultures can be used as an in vitro culture system 
to study adult intestinal stem cell maintenance and differentiation in a controlled 
manner. In this study, we employed a multi-modal framework of state-of-the-art 
techniques to study the global molecular landscape of these organoid cultures in an 
unbiased and comprehensive manner (Fig 1D).
Global rewiring of the proteome and transcriptome during adult 
intestinal stem cell differentiation
To study gene expression dynamics in the different organoid cultures at the mRNA 
and protein level, we integrated mass spectrometry-based proteomics and RNA 
sequencing data. We made use of spike-ins, both at the mRNA and at protein level, thus 
facilitating absolute quantification of the proteome and transcriptome. Reassuringly, 
both at the protein and at mRNA level, intestinal stem cell markers are significantly 
enriched and depleted in CV and EN, respectively, while known differentiation 
markers show opposite dynamics (Figs 2A and EV1A, Dataset EV1). As expected, both 
stem cell and differentiation markers are expressed in the ENR organoid culture. 
Interestingly, while the EN organoids are strongly enriched for enterocyte markers Vil1 
(Sato et al., 2011), Alpi (Tetteh et al., 2016), Ptk6 (Haegebarth et al., 2006), Krt20 and 
Anpep (Merlos-Suárez et al., 2011), other differentiation markers are not enriched in 
EN compared to ENR. These include Defa6, Muc2, Dclk1, and Reg4, which are markers 
for Paneth, goblet, tuft, and enteroendocrine cells, respectively. This further indicates 
that the EN organoid culture is strongly enriched for mature enterocytes.
Given the fact that, both in vivo and in vitro, turnover of intestinal cells can be as short 
as 2 days, we hypothesized that time constraints only allow a minimal differential gene 
expression program to facilitate phenotypic changes between stem cells and mature 
enterocytes. Strikingly, however, we observed a global rewiring of the proteome during 
differentiation (Fig 2A). Of the 7,459 proteins that could be accurately quantified on 
both the mRNA and protein level, 59% are significantly changing in abundance in our 
differentiation model. Furthermore, the large majority of dynamic protein expression 
is being accompanied by changes at the transcriptome level, indicating that the 
observed rewiring of gene expression has a transcriptional foundation. As reported 
before (Schwanhäusser et al., 2011), absolute mRNA and protein copy numbers correlate 
poorly when compared within the same sample (R 2 = 0.40, Fig EV2A). However, here 
we show that transcriptomic changes between intestinal cell fates lead to correlated 
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changes at the proteome (Fig 2A). As expected, the stem cell-enriched gene expression 
signature is significantly enriched for proteins involved in cell cycle and DNA 
replication, while enterocyte-enriched organoids express many proteins involved 
in different metabolic pathways (Fig 2B). This likely reflects the nutrient absorption 
function of mature enterocytes in vivo. To investigate the consequences of these 
abundant metabolic programs, we performed mass spectrometry-based lipidomics 
and metabolomics on the cell-type-enriched organoids and integrated this with gene 
expression dynamics (Fig EV1B, Dataset EV2). This revealed a correlation between 
the abundance of certain enzymatic activities and their involved metabolites. For 
example, we observed an upregulation of enzymes related to glutathione metabolism 
coinciding with a strong upregulation of glutathione in the EN organoids. Interestingly, 
we observed a global decrease in glycerolipids in EN versus CV organoids, which could 
be linked to increased fat metabolism in EN organoids and the need for a steady supply 
of cellular organelles such as mitochondria in rapidly dividing stem cells. Indeed, it 
was recently shown that intestinal stem cells use mitochondria as their main source 
of energy (Rodríguez-Colman et al., 2017). Compared to ENR organoids, we observe 
that both mitochondrial proteins and mitochondrial DNA copies are higher in the 
stem cell-enriched population (CV) and in a lesser extent in the enterocyte-enriched 
condition (EN; Fig EV1E and F). In order to analyze the contribution of mitochondria 
to energy production, we performed bioenergetics analysis using Seahorse technology 
(Seahorse Bioscience). Interestingly, a hypermetabolic phenotype is observed in 
the EN organoids based on increased glycolysis and mitochondrial respiration (Fig 
EV1D), while the relative contribution of mitochondrial respiration to cellular energy 
is higher in CV organoids (Fig EV1G). Furthermore, we observed a stem cell-specific 
upregulation of several amino acids, which, together with the upregulated expression 
of the ribosome biogenesis pathway could hint toward dynamic protein translation 
rates during adult intestinal stem cell differentiation.
Because amino acid levels can regulate translation efficiency of mRNAs through mTOR 
signaling (Zoncu et al., 2011), we investigated to what extent this could contribute to 
the observed proteome dynamics in the organoid cultures. Comparing protein copy 
numbers to mRNA copy numbers allows deducing the amount of proteins that are 
present per mRNA molecule, which acts as a measure for translation efficiency and 
protein stability. First, we verified that there are significant differences in protein 
translation and degradation rates between stem cell-enriched and enterocyte-enriched 
organoids (Fig EV2B). Next, we compared the protein to mRNA levels individually 
between CV and EN organoids (Fig 2C, Dataset EV3). Importantly, we see many known 
regulatory proteins of stem cell maintenance with significantly higher protein 
to mRNA ratios in the CV organoids. This could suggest that post-transcriptional 
regulation of transcription factors such as E2f4 and Sox9 might contribute to adult 
stem cell fate.
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FIGURE 2 | Intestinal differentiation is coupled with global rewiring of gene expression
(A) Two row-matched heatmaps showing the relative change in mRNA expression (left) and protein 
expression (right) of significantly changing proteins. Known markers of intestinal homeostasis are 
highlighted. Relative expression is shown as log2 fold change over the row mean.
(B) KEGG pathways that are significantly enriched (FDR < 0.01) in stem cell-enriched organoids (blue) 
and differentiated organoids (red). Colors correspond to lines in (A) to show which gene clusters 
were used for enrichment analysis.
(C) Scatterplot showing the amount of protein copy numbers per mRNA molecule in CV and EN 
organoids. Proteins with significantly changing protein over mRNA ratios (FDR < 0.05 and fold 
change > 3 in both CV/EN and ENR/EN) are plotted in blue. Significantly changing known markers of 
intestinal homeostasis are highlighted.
 
Widespread epigenetic modulation facilitates transcription factor 
driven differentiation
Based on the observed extensive transcriptional regulation during enterocyte 
differentiation, we hypothesized that global remodeling of the epigenome must 
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precede or at least accompany rewiring of the transcriptome and proteome. To 
investigate this, we used ATAC-seq to profile DNA accessibility and we performed 
ChIPmentation to map histone modifications H3K27ac, H3K4me3, and H3K27me3 
in the organoid cultures. A total of 94,340 peaks could be detected in at least one 
replicate of the different sequencing datasets, which we used to identify genomic 
regulatory elements that undergo a significant change in DNA accessibility or histone 
modification occupancy between the different cell-type-enriched organoid cultures 
(Fig 3A, Dataset EV4).
 
FIGURE 3 |  Widespread modulation of epigenetic landscape for differentiated organoids is 
driven by Hnf4g
(A) Heatmaps showing epigenome dynamics on peaks with significant changes in DNA accessibility 
and histone modifications between CV, ENR, and EN organoids. Heatmaps are split on their location 
near a transcription start site (< 500 bp from TSS, top heatmaps) or other location. Heatmaps are 
further subdivided based on the dataset it was found significantly changing in (shown at the left). 
Shown P-values are corrected for multiple testing hypotheses with the BH method.
(B) Clustered genomic regions from (A) are shown. Regions were associated with their single closest 
TSS and corresponding mRNA expression changes are shown in the most left heatmaps. The best 
match score for the HNF4G motif is shown in the middle heatmap. Hnf4g binding is shown in the 
most right heatmaps.
(C) Scatterplot with the transcription factors that are most likely to explain the dynamics shown in 
(A). The x-axis is the linear correlation between the best motif score and the log2-fold change EN 
over ENR under each significantly changing peak for a given dataset as shown in (A). The y-axis 
is the feature importance of the motif in a random forest model in percentage increase in mean-
squared error (MSE), where motifs that are important for the model to accurately predict the given 
fold changes get a high error increase. Different datasets are color-coded. For motifs with more 
than one transcription factors associated to it, we show the transcription factor name with the most 
significant change in protein expression. The vertical line over each dot represents two times the 
standard deviation of the MSE.
(D) Heatmaps showing change in protein (left) and mRNA (right) expression of selected transcription 
factors, compared to ENR organoids.
Data information: In panels (A and B), relative changes between different organoids are shown as 
log2 row mean subtractions (RMS) where the signal is compared to the row mean of all samples.
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Hyperaccessible regions, and regions marked with H3K27ac and H3K4me3, are 
associated with active regulatory elements in the genome such as enhancers and 
promoters. As expected, we found that a large portion of the epigenome is subjected 
to significant regulation of these activity marks; we observed significant dynamics 
in more than 12,000 identified genomic regions. We observed regulation of histone 
modification occupancies at both promoter and enhancer sites, while the most 
significant changes in DNA accessibility predominantly occur at TSS distant sites 
(enhancers). Reassuringly, changes in ATAC, H3K27ac, and H3K4me3 signal often 
correlate with each other, which further substantiates regulation by activation or 
repression of the identified regulatory elements. In contrast, a relatively small cluster 
of regulatory elements gain the transcriptionally repressive H3K27me3 Polycomb mark, 
which strongly anti-correlates with the active marks. This cluster contains regulatory 
loci associated with for example Lgr5 and Sox9 that are only active and open in stem cells 
and become repressed during differentiation. These observations are in agreement 
with previous studies showing that Polycomb repressive complex 2 (PRC2), which is 
responsible for deposition of H3K27me3, is essential for maintenance of the intestinal 
epithelium and intestinal homeostasis (Koppens et al., 2016). Furthermore, we see that 
the regulation of the epigenome is not restricted to isolated promoters and enhancers, 
but also happens at the level of much larger topologically associated domains (TADs; 
Materials and Methods, Fig EV3C). Some of the TADs that show significant regulation 
contain important regulators of intestinal stem cells such as Sox9, Myc, and Ascl2, 
indicating that intestinal differentiation requires nuclear reorganization that leads 
to switching between so-called A and B compartments (Lieberman-Aiden et al., 2009) 
that contain regulators of intestinal homeostasis. To investigate to what extent the 
observed epigenetic changes contribute to transcriptional regulation in organoids, 
we employed a single-nearest-gene association rule to assign gene expression to 
identified regulatory elements. Indeed, we observe that gene expression dynamics 
globally correlates with dynamics of the active chromatin marks and DNA accessibility 
and anti-correlates with the heterochromatin mark (Fig 3B, left heatmap).
Since the observed rewiring of gene expression is transcriptionally regulated and 
associated with epigenetic remodeling, we set out to investigate which transcription 
factors could facilitate these observations. To this end, we used motif-score regression 
modeling on the differences in DNA accessibility and histone modification profiles. 
First, we reduced a list of non-redundant transcription factor motifs by filtering on 
transcription factor protein expression, and by LASSO and random forest feature 
selection (Materials and Methods). Next, we asked how important the selected motifs 
were to predict the dynamics in DNA accessibility and histone modification profiles of 
enterocyte-enriched organoids (Fig 3C). Remarkably, only a single transcription factor 
motif, namely Hnf4g, was selected that correlated with DNA accessibility and activity 
during differentiation. Hepatocyte nuclear factor 4 gamma (Hnf4g) is reported to be 
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expressed in the small intestine (Bookout et al., 2006) and is known to be involved in 
intestinal development (Li et al., 2009), but its contribution as a global driver of epigenetic 
modulation and induction of gene expression during enterocyte differentiation was thus 
far unknown (Fig 3B, middle heatmap). In contrast, several transcription factor motifs 
were identified to correlate with active regulatory elements in ENR organoids (Fig 3C), 
which is likely a reflection of cellular heterogeneity in these ENR organoids. Motifs 
enriched in ENR organoids include Foxa2, a known regulator of enteroendocrine cell 
formation, and Nfkb1, which is reported to be important for intestinal homeostasis 
(Wullaert et al., 2011), and Sp1, which is known to be essential for intestine-specific gene 
expression through its interaction with Cdx2 (Shimakura et al., 2006).
To investigate whether the identified transcription factors are more abundant in the 
associated cell-type-enriched organoids, we looked at the mRNA and protein expression 
with respect to the ENR organoids (Fig 3D). Hnf4g shows a conspicuous high expression 
in the enterocyte-enriched organoids, while most of the other selected transcription 
factors are enriched in ENR organoids. Indeed, our absolutely quantified expression 
data show that enterocytes have a steady-state protein expression of more than a million 
Hnf4g molecules in every cell, clearly saturating every possible transcription factor 
binding site it can bind to. Interestingly, zinc finger and BTB domain-containing protein 
7a and 7b (Zbtb7a and Zbtb7b), and ligand-dependent nuclear receptor corepressor (Lcor) 
are known transcriptional repressors that are more abundant in EN organoids, and 
their motifs correlate with regulatory elements that are repressed in these organoids. It 
is conceivable that these transcription factors contribute to enterocyte differentiation 
through epigenetic repression instead of classical activation.
Given the strong association between Hnf4g binding and the observed epigenetic 
remodeling, we were interested to see whether the observed rewiring of gene 
expression could also be explained by Hnf4g binding. To this end, we focused on genes 
with significant upregulation in mRNA and protein expression in EN organoids to see 
which transcription factor binding sites were overrepresented in their promoters. 
Strikingly, we identify a Hnf4g binding motif in 62% of the upregulated genes (Fig 
EV3E), making it the most enriched and most abundant motif in these genes. The genes 
that can be activated by Hnf4g are significantly associated with metabolic pathways 
and protein digestion and absorption pathways, which represent the classical 
biological functions of enterocytes.
Finally, to validate the transcription factor model in which binding of Hnf4g can 
explain the epigenetic dynamics we observe during differentiation, we performed 
ChIPmentation for Hnf4g to identify the Hnf4g binding sites in CV, ENR, and EN 
organoids. Hnf4g binding is near absent in CV organoids whereas more than 12,000 
Hnf4g peaks are identified in EN organoids (Fig 3B, right heatmap; Fig EV3D). 
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Importantly, Hnf4g bound genomic regions in EN overlap with the predicted HNF4 
motif sites, the open and active chromatin regions, and the associated gene expression 
in EN, whereas regulatory regions that are active in CV are devoid of Hnf4g binding. 
As an example, the promoter of the enterocyte marker Alpi is bound by Hnf4g in EN 
together with an increase in Alpi gene expression (Fig EV3B). Together, this indicates 
that Hnf4g is a driver of major epigenetic, transcriptomic and proteomic rewiring 
during enterocyte differentiation.
Hnf4g drives enterocyte differentiation
Given the strong potential of Hnf4g to induce an enterocyte-specific epigenome and 
transcriptome in wild-type intestinal organoids, we set out to investigate the effect of 
Hnf4g loss in the small intestine using Hnf4g knockout (KO) mice and Hnf4g KO small 
intestinal organoids ((Baraille et al., 2015); Fig EV3A). Transcriptome analysis of Hnf4g 
KO organoids reveals a significant loss of the enterocyte gene expression signature 
upon Hnf4g KO, while gene sets for secretory cells become significantly more abundant 
(Fig 4A). Previously, it was shown that loss of Hnf4g in mice results in increased 
numbers of enteroendocrine cells in the mouse intestine (Baraille et al., 2015). Here, 
we show in addition that upon a loss of Hnf4g increased numbers of goblet cells are 
observed in vitro and in vivo (Fig 4B and C). Moreover, goblet cell numbers show a higher 
degree of variation between individual villi (Fig 4E). Based on the observed decrease 
in enterocyte-specific gene expression concomitant with an increase in differentiated 
secretory cells in Hnf4g-deficient mice and organoids, we conclude that Hnf4g is 
a major driver of enterocyte differentiation and that Hnf4g is essential to maintain a 
proper balance between differentiating cells from the secretory and absorptive lineage.
FIGURE 4 | Hnf4g drives differentiation of enterocytes
(A) Gene Set Enrichment Analysis (GSEA) of Hnf4g KO organoids compared to WT organoids. 
Significantly changing intestinal cell-type gene sets from (Haber et al., 2017) are shown (FDR < 0.05).
(B) Hematoxylin and PAS (periodic acid–Schiff) staining of WT (left) and Hnf4g KO (right) intestine. 
Nuclei are visualized using hematoxylin and goblet cells stain positive for PAS.
(C) Alcian Blue and Nuclear Fast Red staining of WT (left) and Hnf4g KO (right) small intestinal 
organoids. Cells are visualized using Nuclear Fast Red. Intra- and extracellular mucus that is produced 
in goblet cells stain positive for Alcian blue.
(D) Strand-specific RNA-seq data, Hnf4g ChIP-seq in EN, and promoter-specific histone modification 
H3K4me3 over the Hnf4a locus are shown. Data from different organoid cultures are color-coded. 
RNA-seq reads mapping to the positive strand (sense strand) are plotted in the top window of every 
sample, while RNA-seq reads that map to the negative strand are mirrored and shown in the bottom 
window of every sample. The two isoforms of Hnf4a that are expressed are shown in the bottom, 
together with the antisense transcript Hnf4aos. The “phyloP30way” track from the UCSC genome 
browser is plotted at the bottom to show sequence conservation.
(E) Quantification of the amount of goblet cells per villus for WT and Hnf4g KO intestine. Dots 
represent the amount of goblet cells counted per villus. (n = 7–25 villi from 11 WT mice and 3–17 
villi from 14 Hnf4g KO mice). P-value is from two-tailed Mann–Whitney U-test. The central line in 
each boxplot represents the median, the notch around this line is the approximate 95% confidence 
interval, the hinges are the first and third quartile, and the whiskers extend to the lowest and highest 
values within 1.5× the interquartile range from the hinges.
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To investigate the molecular mechanisms that regulate Hnf4g-mediated 
differentiation, we examined the list of significantly changing genes with Hnf4g 
binding for potential regulators. Here, we found that hepatocyte nuclear factor alfa 
opposite strand (Hnf4aos) is the most significantly regulated long non-coding RNA 
in organoids and has a Hnf4g binding site with dynamic H3K4me3 occupancy at its 
promoter (Figs 4D and EV4C). Importantly, this enterocyte-specific lncRNA exhibits 
strong antisense transcription over one of the promoters of hepatocyte nuclear 
factor 4 alpha (Hnf4a). Hnf4a and Hnf4g are paralogs, but unlike Hnf4g, Hnf4a is 
ubiquitously expressed in both the intestinal crypt and villus (Sauvaget et al., 2002). 
Hnf4a is reported to be important for intestinal epithelial homeostasis by modulating 
Wnt signaling (Cattin et al., 2009) and can act as a tumor suppressor in colorectal 
cancer (Saandi et al., 2013). Interestingly, while the canonical Hnf4a transcript is not 
dynamically expressed in our system, we see a strong downregulation of an alternative 
isoform of Hnf4a during enterocyte differentiation. Here, we report that the antisense 
transcript Hnf4aos, presumably a direct target of Hnf4g, strongly anti-correlates with 
the expression of the alternative Hnf4a isoform it overlaps with, possibly through 
direct repression (Fig 4D).
To investigate the relevance of our findings for human biology and disease, we 
analyzed cancer stem cell (CSC) transcriptomes from patient-derived and CRISPR-
engineered colorectal cancer organoids (Oost et al., 2018) for evidence of regulation 
by Hnf4g. Strikingly, Hnf4g is one of the most downregulated transcription factors 
in these CSCs (Fig EV4A). Consequently, the binding motif of Hnf4g is the most 
significantly enriched transcription factor motif in the promoters of genes that are 
specifically upregulated in those tumor cells that lack a CSC phenotype (Fig EV4B). This 
suggests that Hnf4g is playing a role in gene regulation even in transformed cancer 
cells, which is in line with recent reports on other cancer types, which revealed that 
dysregulated Hnf4g is associated with pancreatic (Klein et al., 2018), prostate (Shukla 
et al., 2017), and lung cancer (Wang et al., 2018). Overall, these observations illustrate 
the importance of system-wide interrogation and the power of integrative analyses to 
uncover novel biology related to intestinal homeostasis.
DISCUSSION
Here, we presented an integrative systems biology approach that in combination with 
organoid technology can disentangle the complex regulatory networks that underlie 
lineage specification in the mouse small intestine. Our study shows that profiling 
the epigenome, transcriptome, proteome, and metabolome represents a powerful 
approach to obtain a system-wide overview of the regulatory mechanisms, which 
enable gene expression regulation in cell-type-enriched organoid cultures. We show 
that, while each single technique is informative on its own, performing multiple 
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complementary techniques will strengthen each other such that completely new 
questions can be answered after integrating a system-wide dataset.
The two major bottlenecks for employing a large set of “omics” techniques to study 
epithelial homeostasis in the intestine are (i) the need for large quantities of cellular 
material for high-resolution data generation. Especially to study rare cell types such 
as stem cells, this requires extensive animal resources. (ii) It is difficult to extract 
epithelial intrinsic processes from in vivo material due to variable interactions and 
signals from, for example the fluctuating microbiome, feeding patterns, and the 
immune system. To tackle these problems, intestinal organoids cultures were recently 
developed. Intestinal organoids can be cultured in fairly large amounts in defined 
medium while maintaining intestinal homeostasis that includes maintenance of an 
adult stem cell pool while also permitting differentiation to all major intestinal cell 
lineages. Through minor modifications of the culture medium, we have subsequently 
enriched for one of these cell types to study their characteristics in a comprehensive 
manner. Alternative methods that have been recently used to study differences 
between intestinal cell types include isolating specific cell types with fluorescence-
activated cell sorting (FACS; (Jadhav et al., 2017; Yan et al., 2017)) and profiling intestinal 
samples at single-cell resolution (Haber et al., 2017). While such approaches have 
better discriminative power between cell types compared to our cell-type enrichment 
strategy, they are limited to techniques that are compatible with very small amounts of 
cells which often restricts the depth of the generated data and makes employment of 
several omics approaches in an integrative manner impossible. Moreover, in contrast 
to relying on mouse data, the platform as presented today is readily applicable to 
organoid cultures of human tissues, both from normal and from diseased origin.
While the focus of this study resulted in the discovery of a transcription factor as a 
regulator of intestinal stem cell differentiation, different analyses can be performed 
on our datasets as a resource to uncover additional layers of regulation, for example, 
when focusing on cell-type-specific metabolic processes or chromatin remodeling 
complexes. Indeed, we show that changes in the lipidome during differentiation 
reveal a change in mitochondrial load and energy metabolism. However, future efforts 
are needed to investigate the importance of other metabolic changes we observed, 
such as the drastic increase in glutathione, an important endogenous antioxidant 
capable of regulating redox signaling (Circu and Aw, 2012), and the global decrease 
in amino acids, which can affect post-transcriptional regulation (Zoncu et al., 2011). 
While we show that there could be possible post-transcriptional regulation of 
regulators of stem cell maintenance by integrating absolute gene expression data, 
additional experiments are required to further elucidate the importance of post-
transcriptional regulation in the intestinal epithelium. Finally, previous studies 
revealed that PRC2 is essential for stem cell maintenance (Koppens et al., 2016) and 
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can directly regulate differentiation by repressing Atoh1 (Chiacchiera et al., 2016), an 
essential transcription factor for secretory cell differentiation. In line with this, our 
study also reveals regulation of Polycomb domains, and activation of TADs that harbor 
stem cell maintenance regulators. Together, this poses opportunities for future efforts 
to investigate how chromatin remodeling is changing the epigenetic landscape and 
what the interplay with the identified transcription factors is.
Enterocytes are replenished every 4–5 days, which requires an extremely fast cell 
fate switch from adult stem cell to functional absorptive enterocyte. Consequently, 
others have characterized Lgr5+ stem cells as broadly permissive cell states at the 
epigenome level, to allow for quick transitions to differentiated cell types (Jadhav et 
al., 2017; Kim et al., 2014). Reanalyzing epigenetic data of FACS-sorted secretory and 
enterocyte progenitor cells shows that EN organoids are indeed differentiating toward 
the enterocyte lineage (Fig EV5A). Importantly, when comparing the histone marks 
and DNA accessibility of these progenitor cells, we detect a significant enrichment 
of the Hnf4g binding motif (Fig EV5B), validating its specificity to the enterocyte 
lineage. Using single-cell RNA sequencing, others have observed that the trajectory 
from intestinal stem cell to enterocyte is the shortest path in intestinal differentiation 
space (Yan et al., 2017). In contrast, we show that despite the short time-frame of 
differentiation, major changes in both gene expression and epigenetics are required 
for enterocyte differentiation. However, a large part of these changes can be attributed 
to a relatively simple differentiation trajectory, where a single transcription factor can 
be associated with most of the epigenetic dynamics, resulting in regulation of RNA 
expression which is directly translated in a proteomic landscape needed for mature 
enterocyte function.
Our integrative approach revealed that Hnf4g drives intestinal stem cell differentiation 
toward enterocytes. However, it is quite likely that other transcription factors regulate 
a smaller but equally important subset of genes that are essential to acquire an 
enterocyte phenotype. Indeed, very recently Regev and colleagues used single-cell 
RNA-seq to identify a handful of transcription factors that are specifically expressed 
in mature enterocytes, including Hnf4g (Haber et al., 2017). Interestingly, the same 
paper reports Hnf4a to be specific for intestinal stem cells, whose expression we 
found to be regulated by an Hnf4g-inducible non-coding RNA, postulating a possible 
self-reinforcing transcription factor switch between these two paralogs during adult 
intestinal stem cell commitment toward the enterocyte lineage.
Reassuringly, previously applied bioinformatics approaches also identified the 
HNF4 DNA binding motif to be most overrepresented in genes that are upregulated in 
enterocytes, but proposed Hnf4a as the central regulator for enterocyte differentiation 
(Stegmann et al., 2006). However, based on our absolute protein quantification 
549219-L-bw-Voorthuijsen










INTEGRATIVE MULTI-OMICS ANALYSIS OF INTESTINAL ORGANOID DIFFERENTIATION
49
and experimentally validated importance of Hnf4g, and in agreement with results 
from others (Haber et al., 2017; Sauvaget et al., 2002), we now show that Hnf4g is 
the most likely regulator of these genes. While we propose that Hnf4g is a major 
effector for enterocyte differentiation, Hnf4g knockout mice are viable with minor 
gastrointestinal complications (Baraille et al., 2015). While enterocytes are still 
present, intestinal differentiation is skewed toward the secretory cell lineage in 
Hnf4g−/− mice and Hnf4g−/− small intestinal organoids. This implicates that Hnf4g is 
indeed able to drive enterocyte differentiation. However, we cannot exclude that other 
factors are likely to compensate for its absence from organogenesis onwards and can 
partially rescue a complete differentiation defect. Therefore, it will be of interest to 
study the molecular mechanisms that drive the residual enterocyte differentiation in 
Hnf4g−/− mice.
Organoid technology emerged as a powerful model system to study adult stem cell 
maintenance and differentiation for various organs, including liver, pancreas, and 
brain (Clevers, 2016). However, the inherent strength of these culture systems, namely 
cellular heterogeneity, also represents a challenge when combined with system-wide 
approaches to study gene expression regulation and cell fate switches per cellular 
lineage. Here, we have shown that small-molecule-driven perturbations to enrich 
for specific cell types represent a solution to this problem. Applying the system-wide 
approaches presented here to cell-type-enriched organoid cultures, complemented 
with time-course experiments and follow-up studies employing CRISPR-based 
perturbation and single-cell RNA-seq approaches (Datlinger et al., 2017; Dixit et al., 
2016; Jaitin et al., 2016), represents a paradigm for future efforts aimed at deciphering 
gene expression regulation and cell fate switches in complex tissues.
MATERIALS AND METHODS
Hnf4g knockout mouse model
Total and constitutive Hnf4g gene invalidation was performed as previously described 
(Baraille et al., 2015). Hnf4g+/− mice, obtained from Deltagen Company on a C57Bl/6J 
genetic background, were mated to obtain Hnf4g−/− mice on the same genetic 
background. In experiments, we compared Hnf4g−/− male mice with C57Bl/6J wild-
type male Hnf4g+/+ mice, matched in age and housed in the same room. All animals 
were housed in the SPF facility of the Centre de Recherche des Cordeliers on a 12 
h-light/12 h-dark cycle and were fed with a standard diet (A03, Safe). Experimental 
procedures were in agreement with the French guidelines for animal studies from the 
Comité National de Réflexion Ethique sur l'Expérimentation Animale Charles Darwin 
(Ce5/2009/045).
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Mouse small intestinal organoids Lgr5GFPDTR/+ (Basak et al., 2017) were cultured as 
described previously (Sato et al., 2009). In short, the organoids were maintained 
using ENR medium which contained Dulbecco's modified Eagle's medium/Ham's 
F-12 supplemented with Pen/Strep, 10 mM HEPES, 1× Glutamax, 5% R-Spondin-1 
(conditioned medium), 10% Noggin (conditioned medium), 1× B27 supplement, 
1.25 mM n-acetyl cysteine, and recombinant mouse epidermal growth factor (50 ng/
ml). Organoids were split every 4–5 days in a 1:4 ratio using mechanical dissociation 
and plated in fresh BME (Cultrex Reduced Growth Factor Membrane Extract, 
Type 2, PathClear). Stem cell-enriched organoid cultures (CV) were grown in ENR 
supplemented with CHIR99021 (3 μM) and valproic acid (1 mM) for 5 days. Stem cell-
depleted organoid cultures (EN) were grown for 2.5 days using ENR medium without 
R-Spondin-1. Organoids were harvested by using mechanical dissociation followed 
by multiple ice-cold PBS washes (400 × g, 4°C, 5 min). Organoids were aliquoted for 
proteomics, metabolomics, RNA sequencing, ATAC sequencing, and ChIPmentation.
Crypt and villus sample preparation
The small intestine was harvested from a wild-type (C57BL/6), Lgr5GFPDTR/+ (C57BL/6 and 
129/ola), and Hnf4g−/− mouse and directly put on ice. We only used PBS without calcium 
and magnesium (PBS0) for harvesting of the crypts and villi. The small intestine was 
flushed three times with ice-cold PBS0 and cut open along its length. The villi of the 
small intestine were separated from the crypts using a cover glass, and the tissue was 
washed in ice-cold PBS0. Next, tissues were separately incubated for 30 min in 50-ml 
tubes with 25 ml ice-cold PBS0 with 5 mM EDTA. After incubation, 50-ml tubes were 
shaken five times. Now the supernatant contained crypts and villi, while the tissues 
were transferred to a new tube with 20 ml PBS0 to be shaken ten times again. The 
shaking and transferring step was repeated several times. Aliquots of the different 
supernatant samples were quickly examined under microscope for concentration and 
ratio between crypts and villi. Most optimal tubes were filtered with a 70-μm filter, 
and samples were collected by centrifugation at 800 rpm. For organoids culture, crypt 
pellets were embedded in BME and cultured in ENR supplemented for the first two 
passages with Y-27632 and Primocin. For the crypts and villi proteomic experiments, 
pellets were frozen prior to lysis. Frozen pellets were thawed and lysed in five volumes 
lysis buffer containing 1% NP-40, 0.5 M NaCl, 10% glycerol, 1× protease inhibitor 
cocktail (Roche), 0.5 mM DTT, and 0.1 M Tris–HCl at pH 8.5. Lysis was performed by 
vortexing at maximum speed for 1 min, 10 min on ice, and 1.5 h gentle rotation at 
4°C. Finally, supernatant was directly used for proteomics mass spectrometry after 
centrifugation for 15 min at 21,100 × g.
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Organoid and BME proteomics sample preparation
SDS lysis buffer (4% SDS, 1 mM DTT, 100 mM Tris pH 7.5) was added to the organoid 
cell pellet and incubated for 3 min at 95°C. Samples were sonicated for five cycles (30 s 
on/30 s off, high) and spun down at 16,000 × g for 5 min. Supernatant was transferred 
to a new tube and stored at −80°C. UA buffer (8 M urea, 0.1 M Tris pH 8.5, 5 mM DTT) was 
added to the BME and incubated at room temperature for 30 min shaking at 800 rpm. 
Organoid and BME samples were used for FASP-SAX and FASP, respectively.
Proteomics mass spectrometry
Protein lysates were digested with a trypsin/LysC combination using Filter Aided 
Sample-Preparation (FASP; (Wiśniewski et al., 2009)). For absolute quantification, 2 μg 
of a standard range of proteins (UPS2, Sigma) was added to each lysate (Schwanhäusser 
et al., 2011). For deep-coverage proteomics, we subjected the digested peptides to a 
strong anion exchange (SAX; (Wiśniewski et al., 2009)) fractionation and collected a 
flow through, pH 11, pH 8, pH 5, and pH 2 fraction. Peptides were desalted and stored 
on StageTips (Rappsilber et al., 2007) prior to mass spectrometry analysis. Samples 
were applied to on-line Easy-nLC 1000 (Thermo) separation using different 214-min 
gradients of acetonitrile (7–30%, 5–23%, 8–27%, 9–30%, 11–32%, and 14–32% for 
unfractionated, flow through, pH 11, 8, 5, and 2, respectively) followed by washes at 
60% followed by 95% acetonitrile for 240 min of total data collection. Mass spectra 
were collected on a LTQ-Orbitrap Fusion Tribrid mass spectrometer (Thermo) in data-
dependent top-speed mode with dynamic exclusion set at 60 s.
Raw mass spectra were analyzed in MaxQuant 1.5.1.0 (Cox and Mann, 2008) with 
match-between-runs, iBAQ, and label-free quantification enabled. A mouse RefSeq 
protein sequence database downloaded at 28-06-2016 from UCSC was used to identify 
proteins. Identified proteins were filtered for reverse hits and potential contaminants. 
Proteins detected in the BME gel were blacklisted for downstream analyses. We only 
considered proteins that were identified in at least all of the triplicates of the same 
sample, for downstream analyses. Missing values were semi-randomly imputed based 
on the assumption that they were not detected because they were under the detection 
limit of the mass spectrometer (in Perseus, MaxQuant software package). For absolute 
quantification, we applied a linear regression between supplied amounts and the 
iBAQ intensities of the spike-in proteins in the unfractionated sample, followed by a 
second linear regression between the absolute abundances and iBAQ intensities in the 
fractionated sample.
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For metabolomics triplicates of organoid samples, medium was removed from the 
well, washed with ice-cold 0.9% (w/v) NaCl, and transferred to 15-ml tubes. Tubes 
were centrifuged at 800 rpm for 3 min at 4°C, and the pellets were briefly trypsinized 
in order to remove BME (3 min at 37°C). Tubes were centrifuged at 800 rpm for 5 min at 
4°C, and the organoid pellet was resuspended and homogenized in ice-cold methanol. 
Metabolite extraction was performed by mechanical disruption with silica beads. For 
Folch extraction, a volume of 200 μl sample in methanol is mixed with 100 μl internal 
standards in methanol and 75 μl of methanol. An amount of 750 μl dichloromethane is 
added and after vortex mixing the sample is incubated for 1 h at room temperature and 
regularly mixed. Phase separation is induced by adding 360 μl of ultrapure water. After 
vortex mixing the sample is allowed to stand at room temperature for 10 min after 
which it is centrifuged at 14,000 × g for 10 min. The lower organic phase and upper 
aqueous phase are transferred to separate vials and evaporated to dryness. The residue 
of the organic phase is dissolved in 100 μl acetonitrile and subjected to lipidomics 
analysis. The residue of the aqueous phase is dissolved in 100 μl 10% methanol and 
subjected to metabolomics analysis.
Lipidomics mass spectrometry
Lipidomics LC-MS/MS (data-dependent) analysis was performed using a Thermo 
Scientific Acella UHPLC system and an Acquity BEH C-18 column (1 × 100 mm, 1.7 μm). 
The column outlet was coupled to a Thermo Scientific Orbitrap XL equipped with an 
electrospray ion source operated in either negative or positive mode. The system was 
operated at a flow rate of 80 μl/min and 60°C. The mobile phases consisted of 40% 
acetonitrile in ultrapure water (v/v) also containing 10 mM ammonium acetate (solvent 
A), and 10% acetonitrile and 90% isopropanol (v/v) also containing 10 mM ammonium 
acetate (solvent B). A 10-min linear gradient of 40–100% B was started 1 min after the 
injection of the sample and was at 100% B for the next 5 min. Thereafter, the system 
was returned to its starting situation. Total run time was 21 min. All acquired MS data 
were searched against available databases.
Metabolomics mass spectrometry
Metabolomics LC-MS/MS (data-dependent) analysis was conducted with a Thermo 
Scientific Acella UHPLC system and an Acquity BEH C-8 column (1 × 150 mm, 1.7 μm). 
The column outlet was coupled to a Thermo Scientific Orbitrap XL equipped with 
an electrospray ion source operated in either negative or positive mode. The system 
was operated at a flow rate of 150 μl/min and 40°C. The mobile phases consisted of 
6.5 mM ammonium carbonate pH 8 (solvent A), and 6.5 mM ammonium carbonate 
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in 95% methanol (v/v, solvent B) in negative mode. For positive mode analysis, the 
solvents were 0.1% formic acid in ultrapure water and 0.1% formic acid in methanol, 
respectively. A 5-min linear gradient of 0–70% B was started 1 min after the injection 
of the sample. The gradient was increased to 98% B in 0.5 min and was at 98% B for 
the next 10 min. Thereafter, the system was returned to its starting situation. Total run 
time was 22 min. All acquired MS data were searched against available databases.
mtDNA copy number
For DNA extraction, organoids were washed once with cold PBS and DNA was extracted 
with the QIAamp DNA Micro Kit (Qiagen). DNA was used as a template to amplify 
nuclear and mitochondria-encoded genes. qPCR was performed with FastStart SYBR 







Seahorse Bioscience XFe24 Analyzer was used to measure extracellular acidification 
rates (ECAR) and oxygen consumption rates (OCR), and mitochondrial stress test was 
performed as previously described (Rodríguez-Colman et al., 2017). After Seahorse 
run, organoids were collected, DNA was extracted and quantified, and used for 
normalization.
RNA sequencing sample preparation
RNA was extracted from snap-frozen cell pellets using the RNeasy RNA extraction 
kit (Qiagen) with DNaseI treatment. Ribosomal RNA depletion (Ribo-Zero Gold rRNA 
removal kit, Illumina) was performed using 725 ng of total RNA per sample followed 
by ethanol precipitation. 1 μl ERCC spike-in mix 1 (1:100, Ambion) was added to all 
samples during the rRNA depletion. rRNA-depleted samples were fragmented for 5 
min at 95°C using 5× fragmentation buffer (200 mM Tris acetate, 500 mM potassium 
acetate, 150 mM magnesium acetate, pH 8.2) followed by ethanol precipitation. 
First-strand cDNA synthesis was performed using Superscript III (Invitrogen) with 
the addition of random hexamer primers and actinomycin D (9 ng/ml). Afterward, 
second-strand cDNA synthesis (SuperScript, Invitrogen) was performed with the 
addition of dUNTPs and random hexamer primers. Samples were cleaned using 
Qiaquick MinElute Columns (Qiagen) after first- and second-strand cDNA synthesis. 
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A maximum of 5 ng cDNA was used for sample preparation using the KAPA Hyper 
Prep Kit (KAPA Biosystems). NextFlex DNA barcodes (Bioo Scientific) were used for 
adapter ligation. Treatment for 15 min at 37°C with USER enzyme was done prior to 
library amplification. Libraries were amplified using 10 amplification cycles. Post-
amplification cleanup was done using Qiaquick MinElute Columns (Qiagen) followed 
by size selection of 300 base pairs using E-Gel SizeSelect Agarose Gels 2% (Invitrogen). 
Library concentration was measured using the KAPA Library Quantification Kit (KAPA 
Biosystems), and library size was determined using the BioAnalyzer High Sensitivity 
DNA Kit (Agilent). Sequencing was performed using an Illumina HiSeq 2000, and 50-
bp paired-end reads were generated.
RNA sequencing analysis
Paired-end reads were aligned to mm9 using Genomic Short-read Alignment Program 
(Wu and Watanabe, 2005) with batch mode set to 5, novel splicing enabled and distance 
splice penalty set to 100. Transcript expression was quantified by kallisto (Bray et al., 
2016) version 0.43.1 with a mouse RefSeq transcriptome index downloaded on June 28, 
2016, from UCSC. One-hundred bootstrap samples were generated for each sample and 
strand-specific reads—first read reverse was enabled.
Integration of proteome and transcriptome data
To accurately integrate the protein and transcript expression data, we used matched 
proteome and transcriptome RefSeq databases and quantified expression as described 
above. To ensure correct matching of isoforms, we restricted the transcriptome 
database to only transcripts that were already quantified at the protein level. 
Significantly regulated proteins were identified with an adapted Student's t-test 
on LFQ values while controlling for the multiple testing hypothesis with a 10,000× 
permutation-based false discovery rate [Perseus, MaxQuant software package (Cox 
and Mann, 2008)]. To calculate the amount of proteins per mRNA transcript, we 
performed absolute quantification of both mRNA and proteins as described above. 
Next, we calculated the protein over mRNA ratios by comparing all replicates to 
each other and taking the median ratio. P-values for differences in overall protein 
translation and degradation rates were determined by t-test on the Fisher-transformed 
Pearson correlations on protein over mRNA ratios. To test for significant differences in 
individual protein over mRNA ratios between organoid samples, we used a modified 
Student's t-test by comparing ratios from all replicates but by manually restricting the 
test to an appropriate amount of degrees of freedom.
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Gene ontology enrichment analysis
KEGG pathway enrichment analysis was done in DAVID 6.8 (Huang et al., 2009). For 
enrichment analysis on proteomics data, a background protein list of all identified 
proteins was submitted. P-values were corrected by the Benjamini–Hochberg 
procedure. Integrated gene expression and metabolomics Reactome pathway 
enrichment analysis were done in IMPaLA (Kamburov et al., 2011).
ATAC sequencing
ATAC-seq was performed on approximately 50,000 cells. Organoids were resuspended 
in Recovery Cell Culture Freezing Medium (Gibco) and stored at −80°C prior to the 
ATAC-seq procedure. Once thawed, they were washed with PBS and ATAC-seq was 
performed as described in (Buenrostro et al., 2015) with three modifications. First, the 
total volume of the tagmentation reaction with in-house made Tn5 enzyme was halved. 
Second, the tagmentation reaction was stopped with 44 mM EDTA, 131 mM NaCl, 0.3% 
SDS, and 600 μg/ml proteinase K. Last, a reverse-phase 0.65× SPRI beads (Ampure) 
DNA purification was done after the first PCR. Amplified DNA was sequenced with an 
Illumina HiSeq 2000. Paired-end 50-bp sequencing reads were aligned to mm9 with 
BWA (Li and Durbin, 2009) allowing one mismatch. Reads were filtered for a quality 
score of at least 1, PCR duplicates were removed with Picard, and reads mapping to 
the mitochondrial chromosome were discarded. Peaks were identified with MACS 2.0 
(Zhang et al., 2008) with a false discovery rate of 0.01.
Chromatin harvesting
Cell pellets were dissolved in PBS and crosslinked in solution by using formaldehyde 
(1% final volume, shaking 10 min at room temperature). Glycine (0.125 M) was added to 
quench the reaction. Cell pellets were lysed in a volume of 110 μl using lysis buffer (20 
mM HEPES pH 7.6, 1% SDS, 1× Protease Inhibitor Cocktails). Samples were sonicated 
using the Biorupter Pico (Diagenode) with six cycles (30 s on/30 s off). Afterward, the 
samples were spun at 16,200 × g for 5 min at room temperature and the supernatant 
was stored at −80°C.
ChIPmentation sample preparation
Chromatin from 80,000 to 150,000 cells was used for ChIPmentation. ChIPmentation 
was performed as described earlier (Schmidl et al., 2015) with several modifications. 
In short, the chromatin was incubated overnight at 4°C rotating in dilution buffer 
(1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris pH 8, 167 mM NaCl), 1× Protease 
Inhibitor Cocktail (Roche), and 1 μg of antibody [H3K4me3 (C15410003, Diagenode)/
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H3K27ac (C15410196, Diagenode)/H3K27me3 (C15410195, Diagenode), Hnf4g (Sigma, 
HPA005438)]. Per ChIP 10 μl protein A Dynabeads and 10 μl protein G Dynabeads were 
used. Beads were washed using dilution buffer (+0.15% SDS, +0.1% BSA) and incubated 
with the chromatin and antibody mix for 60 min at 4°C rotating. Afterward, the beads 
were washed at 4°C once with ChIP wash buffer 1 (2 mM EDTA, 20 mM Tris pH 8, 1% 
Triton X-100, 0.1% SDS, 150 mM NaCl), twice with ChIP wash buffer 2 (2 mM EDTA, 20 
mM Tris pH 8, 1% Triton X-100, 0.1% SDS, 500 mM NaCl), and twice with TE (1 mM EDTA, 
10 mM Tris pH 8). Beads were resuspended in Tagment DNA buffer and 1 μl Tn5 enzyme 
(produced in-house) and incubated for 10 min at 37°C with 550 rpm shaking. Afterward, 
the beads were washed twice with WBI (20 mM HEPES, 150 mM NaCl, 0.1% SDS, 0.1% 
DOC, 1% Triton X-100, 1 mM EDTA, 0.5 mM EGTA) and twice with WBIV (20 mM HEPES, 
1 mM EDTA, 0.5 mM EGTA) with 5 min rotating at room temperature in between. 
Samples were decrosslinked for 1 h at 55°C 1,000 rpm shaking followed by an overnight 
incubation at 65°C using elution buffer (0.5% SDS, 300 mM NaCl, 5 mM EDTA, 10 mM 
Tris pH 8) and proteinase K. Samples were incubated one additional hour the next day 
with elution buffer and proteinase K for 1 h at 55°C. The samples were purified using 2× 
SPRI AMPureXP beads. qPCR was used to determine the sufficient amount of PCR cycles 
needed to amplify the library. The libraries were amplified using the KAPA HiFi Hotstart 
Ready Mix (KAPA Biosystems) and Nextera Index Kit 1 (i7) and 2 (i5) primers (Illumina). 
Amplified libraries were purified using a 0.65× SPRI AMPureXP beads incubation 
followed by a 1.8× SPRI AMPureXP beads incubation. Library concentration was 
measured using the KAPA Library Quantification Kit (KAPA Biosystems); library size was 
determined using the BioAnalyzer High Sensitivity DNA Kit (Agilent). Sequencing was 
performed using an Illumina HiSeq 2000, and 50-bp paired-end reads were generated.
ChIPmentation analysis
Paired-end sequencing reads were aligned to mm9 with BWA (Li and Durbin, 2009) 
allowing one mismatch. Reads were filtered for a quality score of at least 1, and PCR 
duplicates were removed with Picard. Peaks were identified with MACS 2.0 (Zhang et 
al., 2008) with a false discovery rate of 0.01.
TAD activity analysis
To test for significant differences in enhancer and promoter activation at the 
topological associated domain level, we used publicly available TADs from (Dixon 
et al., 2012). We assigned every identified ATAC or ChIPmentation peak to a TAD and 
only considered TADs with at least 20 identified peaks for further analysis. Next, we 
quantified how much percent of the peaks had a fold change in H3K27ac signal in the 
same direction (percentage agreement). To identify a significance cutoff, we compared 
the results to 100 identical matrices with shuffled fold changes.
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Gene set enrichment analysis
Consensus cell-type-specific signature genes from (Haber et al., 2017) were used to 
find enrichment of intestinal cell types. The Lgr5+ intestinal stem cell signature from 
(Muñoz et al., 2012) was used as a stem cell gene set. We created a Lgr5− gene set from 
the data in (Muñoz et al., 2012) in the same way the Lgr5+ intestinal stem cell signature 
was defined. To calculate the false discovery rate of every GSEA, we performed 10,000 
gene set perturbations.
Transcription factor selection
To identify transcription factors that are most likely to explain observed dynamics in 
our DNA accessibility and ChIPmentation data, we used a non-redundant vertebrate 
motif database (https://doi.org/10.6084/m9.figshare.1555851) and selected motifs 
on transcription factor protein expression, and by LASSO and random forest feature 
selection. First, we reasoned that transcription factors that are not found in our deep 
proteome data are unlikely to contribute to gene expression. LASSO and random 
forest regression were used to select the best candidate motifs to explain the observed 
epigenetic changes. LASSO reduces the number of features while maintaining high 
prediction accuracy. Random forest is an easily interpretable and robust machine-
learning method that is able to identify non-linear relations and internally controls 
for overfitting. In more detail, to narrow down the list of possible transcription factor 
candidates, we first selected only motifs that are linked to transcription factors with 
significant dynamic protein expression in our data (FDR < 0.01). Next, we used the 
GimmeMotifs motif tool suite (van Heeringen and Veenstra, 2011) to calculate the 
motif score for all motifs under a union of all identified ATAC and ChIPmentation 
peaks. We then calculated noise-stabilized log2-transformed fold changes in ATAC 
or ChIPmentation signal between ENR and EN by using DESeq2 (Love et al., 2014) to 
identify significantly changing regulatory elements. For the broad histone mark 
H3K27me3, we extended all peaks to 1,000 base pairs to ensure capturing robust signal. 
We used a tenfold cross-validated least absolute shrinkage and selection operator 
(LASSO; glmnet R package) to predict the significant log2 fold changes with a matrix 
of motif scores and used its variable selection to further filter the possible motifs. 
Last, we used random forest regression (randomForest R package, 5,000 trees) on 
the remaining motif scores to predict the log2 fold changes. To account for possible 
redundancy, we used the percentage increase in mean-squared error to select the 
motif with most predictive power, subtracted the variance that could be explained 
by that single motif, removed that motif from the matrix, and run the random forest 
regressor again on the residual variance. This was repeated until the individual motif 
that was selected as best predictor was not able to predict any residual variance on its 
own anymore. The whole analysis was repeated five times and only motifs that were 
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always selected were kept. For every selected motif, the transcription factor with 
the most significant fold change in protein expression was shown as the most likely 
transcription factor candidate.
Tissue isolation and histology
Two- to six-month-old mice were euthanized, and jejuna were removed and flushed 
gently with phosphate-buffered saline (PBS). For histological analyses, pieces of 
proximal jejunum (1 cm) were immediately fixed overnight at 4°C in paraformaldehyde 
4% before embedding in paraffin. Periodic acid–Schiff staining was performed by 
using a standard histological protocol (Cattin et al., 2009). Staining was examined 
by bright field microscopy using an Axiophot microscope connected to an Axiocam 
camera using the Axiovision 4.5 software (Zeiss). Goblet cells (PAS-positive cells) were 
counted in villi on one section of jejunum from WT and Hnf4g KO mice without mouse 
or tissue selection exclusion.
Immunohistochemistry and staining organoids
Organoids in BME were fixed in 4% paraformaldehyde (PFA) for 15 min. To prevent 
depolymerization of BME hydrogel, 0.1% glutaraldehyde was added to the fixative. 
BME domes were incubated in 20% sucrose for 72 h at 4°C before being embedded in 
optimal cutting temperature (OCT) compound and snap-frozen. Cryotome sections of 4 
μm thickness were subjected to hematoxylin and eosin staining for standard histology 
analysis. Acidic mucosubstances from goblet cells were detected with Alcian blue 
solution (1 g of Alcian blue, pH 2.5, 3 ml/l of acetic acid, and 97 ml of distilled water). After 
30-min incubation, Nuclear Fast Red (0.1 g of Nuclear Fast Red, 5 g of aluminum sulfate 
hydrate, and 100 ml of distilled water) was used to counterstain. Organoid section images 
were taken by bright field microscopy using an AxioCam MRc5 microscope (Zeiss).
Live-cell confocal imaging
Live-cell images were captured with a Leica SP8X microscope. The organoids were held 
at 37°C in a microscope box and equipped with a culture chamber for humidity and 
6.4% CO2 overflow. Organoids were imaged in XYZ mode using a water 40× objective 
(HC PL APO CS2, N.A. 1.1). Post-acquisition analyses of phenotypes were performed 
manually using ImageJ.
Western blot
For Hnf4g expression in WT and KO organoids: Organoid pellets were resuspended 
in 100 μl whole cell lysis buffer per well of a 6-well plate (150 mM NaCl, 50 mM Tris 
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pH 8, 10% glycerol, 1% NP-40, 1 mM DTT, 1× CPI). Extracts were rotated for 1.5 h at 4°C 
followed by seven cycles of 30 s on and 30 s off sonication (Biorupter Pico, Diagenode). 
Afterward, the samples were spun at 16,200 × g for 5 min at room temperature and the 
supernatant was stored at −80°C. Samples were loaded on an 8% SDS–PAGE gel and 
afterward transferred to a nitrocellulose membrane. Membranes were incubated with 
primary antibody in 5% milk/TBST overnight at 4°C [anti-beta actin 1:5,000 (Abcam, 
ab16039), and anti-HNF4G 1:500 (Sigma, HPA005438)]. Afterward, membranes were 
incubated with secondary antibody [Polyclonal Swine Anti-Rabbit Immunoglobulins/
HRP 1:3,000 (Dako, P0399)] and imaged using chemiluminescent substrate (Thermo 
Fisher, 34580).
For mitochondrial ETC complexes: Organoids were washed once and Matrigel was 
mechanically removed in cold PBS. Total proteins were collected by direct lysis of 
organoids in Laemmli sample buffer. Proteins were run in SDS–PAGE and transferred 
to Polyscreen PVDF transfer membranes (PerkinElmer). Antibodies: Total OXPHOS 
Rodent WB Antibody Cocktail (ab110413, Abcam) and anti-vinculin (V9131, Sigma).
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FIGURE EV1 | Validation cell-type-enriched culturing methods, metabolome dynamics, and 
mitochondria abundance and bioenergetics in differentiating organoids
(A) GSEA of Lgr+ and Lgr- intestinal cell signatures from (Muñoz et al., 2012) for CV- and EN-enriched 
proteins.
(B) Heatmap showing the relative abundances of significantly changing metabolites measured with 
mass spectrometry-based lipidomics and metabolomics. Relative change in abundance is shown as 
the log2 fold change over the row mean. Different classes of metabolites are color-coded. Significantly 
enriched Reactome pathways (P < 0.05) are shown next to the corresponding cluster of metabolites.
(C) Correlation heatmap of two independent proteomics datasets of cell-type-enriched organoids 
cultures. The different genetic background organoids lack the GFP reporter compared to the Lgr5-
GFP-DTR organoids.
(D) Overview of basal ECAR (glycolysis) and OCR (mitochondrial respiration) rates during basal 
measurements. Plotted data represent mean and SD of 4 independent experiments. Bioenergetics 
analysis was performed by Seahorse technology (mitochondrial stress test).
(E) Mitochondrial electron transport chain (ETC) complexes were analyzed by Western blot. Values 
indicate the sum of all complexes normalized by vinculin as a loading control. Representative image 
of four independent experiments.
(F) Mitochondrial DNA copy number was assessed by quantitative PCR of mitochondrial-encoded 
genes and a nuclear-encoded gene using total DNA as template. Bars indicate the mean and error 
bars SEM of four independent experiments.
(G) Basal OCR/ECAR ratio. Plotted data represent mean and SD of four independent experiments. 
Bioenergetics analysis was performed by Seahorse technology (mitochondrial stress test). P-value is 
calculated with an unpaired two-sided Student’s t-test.
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FIGURE EV2 | Correlating protein to mRNA and proteins per mRNA ratios
(A) Scatterplots showing the correlation between the proteome and transcriptome in the different 
organoid cultures.
(B) Correlation heatmap of the protein copies per mRNA molecule ratios for all different replicates. 
Test for significant difference between technical and biological variation was done with a t-test on 
the Fisher-transformed Pearson correlations.
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FIGURE EV3 | Hnf4g dynamics and importance in the different cell-type-enriched organoids
(A) Western blot for Hnf4g on whole cell extract of CV, ENR, and EN cultured WT and Hnf4g KO 
organoids. b-Actin is used as a loading control.
(B) ChIP-seq and RNA-seq profiles of CV, ENR, and EN WT organoids at the Alpi locus.
(C) Scatterplot showing the percentage of peaks inside a TAD that have fold change in H3K27ac 
signal in the same direction as the average fold change in H3K27ac of the whole TAD. Striped line 
demarcates the empirical 0.05 FDR cutoff. Significantly changing TADs that contain a known marker 
of intestinal homeostasis are highlighted.
(D) Number of identified peaks of the Hnf4g ChIP-seq in the different cell-type-enriched WT 
organoids.
(E) Pie chart showing all significantly upregulated genes in EN organoids. Genes with a Hnf4g 
motif in their promoter are highlighted in pink. Normalized enrichment score (NES) and motif 
association were determined in iRegulon ( Janky et al., 2014). KEGG pathways that were significantly 
overrepresented (FDR < 0.01) in upregulated genes with a Hnf4g motif are listed.
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FIGURE EV4 |  Hnf4g importance in human colon cancer organoids and regulation of the 
Hnf4a locus
(A) S-curve scatterplot with genes ranked by their average fold changes between STem cell Ascl2 
Reporter (STAR) negative over STAR positive is plotted. HNF4G is highlighted in red. Average fold 
change is calculated from the colorectal tumor progression models and colorectal cancer patients 
reported in (Oost et al., 2018).
(B) Transcription factors ranked by their normalized enrichment score in the promoters of 
significantly downregulated genes (P < 0.001) in the STAR-positive samples from (A) were shown. 
Normalized enrichment score (NES) and motif association were determined in iRegulon ( Janky et 
al., 2014).
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FIGURE EV5 |  Comparing histone profiles and DNA accessibility of secretory and enterocyte 
progenitor cells
(A) Correlation heatmap comparing histone profiles and ATAC data from ( Jadhav et al., 2017) to DNA 
accessibility and H3K27ac profiles of cell-type-enriched organoid cultures. Relative changes between 
CV and EN on significantly changing H3K27ac peaks were correlated to relative changes at the same 
sites between samples from each dataset of ( Jadhav et al., 2017).
(B) Significantly changing sites between enterocyte and secretory progenitors were identified with 
the shown P-value threshold, and split in enterocyte or secretory specific groups. Boxplot with the 
best HNF4 binding motif scores in enterocyte progenitor and secretory progenitor specific sites were 
plotted for each dataset. P-values comparing boxes are determined by two-tailed Mann–Whitney 
U-test. The central line in each boxplot represents the median, the notch around this line is the 
approximate 95% confidence interval, the hinges are the first and third quartile, and the whiskers 
extend to the lowest and highest values within 1.5× the interquartile range from the hinges.
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See Supporting Information at https://doi.org/10.15252/msb.20188227
Expanded View Dataset 1, related to Figure 2A
Relative protein and RNA expression dynamics. Genes identified by mass spectrometry are 
quantified at the transcript level by RNA-seq, and at the protein level by mass spectrometry.
Dataset EV2
See Supporting Information at https://doi.org/10.15252/msb.20188227
Expanded View Dataset 2, related to Expanded View Figure 1B
Relative abundances of polar and organic metabolites. Relative metabolite abundances 
were quantified with mass spectrometry based lipidomics and metabolomics.
Dataset EV3
See Supporting Information at https://doi.org/10.15252/msb.20188227
Expanded View Dataset 3, related to Figure 2C and Expanded View Figure 2
Absolute quantification of protein and mRNA copy numbers and proteins per mRNA ratios. 
Spike-ins were added to RNA seq and proteomics experiments to calculate mRNA and 
protein abundances per gene per cell. Proteins per mRNA molecule ratios were calculated to 
investigate post-transcriptional gene regulation.
Dataset EV4
See Supporting Information at https://doi.org/10.15252/msb.20188227
Expanded View Dataset 4, related to Figure 3A
Identified genomic loci with significantly changing DNA accessibility or histone 
modifications. ChIPmentation was performed on histone marks H3K4me3, H3K27ac and 
H3K27me3, and DNA accessibility was profiled with ATAC seq. Peak calling was done for all 
samples at FDR = 0.01, and a union of all identified peaks was used to search for significant 
changes between organoids cultures.
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Oost et al. present an ASCL2-responsive minigene (STAR) that enables stem cell 
labeling in patient-derived colorectal cancer organoids, as well as in normal and 
benign colorectal tumor samples. The user-friendly nature of STAR applications in 
combination with organoid technology will facilitate basic research into human adult 
stem cell biology.
HIGHLIGHTS
• ASCL2-responsive minigene (STAR) is specific for intestinal stem cells
• STAR is compatible with user-friendly techniques like lentiviral infections
• STAR enables stem cell labeling in normal and in cancer organoids of human colon
• Cellular plasticity is present at all stages of colorectal cancer development
SUMMARY
Organoid technology provides the possibility of culturing patient-derived colon 
tissue and colorectal cancers (CRCs) while maintaining all functional and phenotypic 
characteristics. Labeling stem cells, especially in normal and benign tumor organoids 
of human colon, is challenging and therefore limits maximal exploitation of organoid 
libraries for human stem cell research. Here, we developed STAR (stem cell Ascl2 
reporter), a minimal enhancer/promoter element that reports transcriptional activity of 
ASCL2, a master regulator of LGR5+ intestinal stem cells. Using lentiviral infection, STAR 
drives specific expression in stem cells of normal organoids and in multiple engineered 
and patient-derived CRC organoids of different genetic makeup. STAR reveals that 
differentiation hierarchies and the potential for cell fate plasticity are present at all 
stages of human CRC development. Organoid technology, in combination with the user-
friendly nature of STAR, will facilitate basic research into human adult stem cell biology.
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INTRODUCTION
The cancer stem cell model was postulated after initial transplantation experiments 
demonstrated that only small subpopulations of tumor cells, as few as 100, turned out 
to be tumorigenic while tens of thousands of cancer cells with alternative phenotypes 
did not (Al-Hajj et al., 2003; Bonnet and Dick, 1997; Lapidot et al., 1994). For colorectal 
cancer (CRC), the concept gained impact by the detection of stem cell-like cancer cells 
that shared functional (Kreso et al., 2013; O’Brien et al., 2007; Ricci-Vitiani et al., 2007) 
as well as molecular properties with normal stem cells, like co-expression of stem 
cell marker genes Lgr5 and Ascl2 (Dalerba et al., 2011). Using Lgr5 as a marker gene, 
the presence of cancer stem cells in colon cancer is now well established, revealing 
self-renewal and differentiation capacity for LGR5+ tumor cells (Cortina et al., 2017; 
Schepers et al., 2012; Shimokawa et al., 2017; de Sousa e Melo et al., 2017). Moreover, re-
emergence of LGR5+ cancer stem cells after their selective targeting revealed extensive 
plasticity in CRCs (Shimokawa et al., 2017; de Sousa e Melo et al., 2017), underscoring 
the importance to understand the biological cues that mediate plasticity and stem 
cell function in tumors in order to design effective anti-cancer therapies. Although 
CRISPR-mediated labeling of cancer stem cells have been achieved in CRC organoids 
(Cortina et al., 2017; Shimokawa et al., 2017), it is currently still technically challenging 
to mark stem cells in human colorectal organoids, especially from normal tissue 
and benign tumors. As a result, it is currently unresolved to what extent stem cell 
characteristics evolve while colorectal tumors progress along the adenoma-carcinoma 
sequence.
The establishment of CRC organoid biobanks, derived from multiple patients, can 
capture the genetic diversity of the disease (Fujii et al., 2016; Van De Wetering et al., 
2015) and allow the faithful evaluation of personalized drug responses to therapies in 
a preclinical setting (Verissimo et al., 2016). As such, patient-derived CRC organoids 
have the potential to enable comparative studies how diverse mutational landscapes 
of cancer genomes from different patients affect the functional properties of cancer 
stem cells.
To include multiple organoid lines for basic research into human (cancer) stem cell 
biology, e.g., from many different patients, disease stages, and settings, including 
normal and benign colorectal tumors, we developed an ASCL2-responsive minigene 
called STAR (stem cell ASCL2 reporter). STAR is compatible with user-friendly strategies 
(e.g., lentiviral infections) to report stem cell activity in human colon organoids. Using 
STAR, we demonstrate that stem cell-driven differentiation hierarchies and cell fate 
plasticity are present at all stages of the adenoma-carcinoma-sequence of human CRC 
progression.
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Intestinal Stem Cell-Specific Reporters
β-Catenin/Tcf4 transcriptional activity is key for intestinal stem cell (ISC) fate but is 
also active in non-stem cells (van Es et al., 2005; Van der Flier et al., 2007). In search 
of an ISC-specific reporter, the transcription factor Ascl2 is of particular interest 
considering its role as the master regulator of ISC fate (van der Flier et al., 2009). Ascl2 
synergistically enhances the expression level of a subset of Wnt/β-catenin target 
genes, thereby imposing a stem cell-specific expression pattern on combined Wnt/β-
catenin and Ascl2 target genes such as Lgr5, Rnf43, EphB2, and notably Ascl2 itself. As 
a consequence of the positive transcriptional feedback loop of Ascl2 on its own gene 
transcription, Ascl2 converts the Wnt morphogen gradient that is present along the 
crypt-villus axes into an almost binary signal for ISC fate (Schuijers et al., 2015).
FIGURE 1 | ISC-Specific Reporters
(A) Transcriptional activity of indicated reporters measured by luciferase assay in HEK293T cells 
co-transfected with a dominant-positive mutant of β-catenin (S33Y), ASCL2, the combination, or 
none. A synthetic promoter with five optimal ASCL2 binding sites is non-responsive, whereas a TOP 
reporter (5× TCF sites) is predominantly sensitive to active WNT/β-catenin signaling. Combining 
ASCL2 and TCF sites (both 5×) demonstrates a synergistic activation upon presence of β-catenin 
and ASCL2. Luciferase activity was normalized to the “empty” pGL4.10 backbone. All transcriptional 
elements include TATA-box. RLU, relative luciferase units. Triplicates of a representative experiment 
are shown. Data are represented as mean ± SEM.
(B) Stably integrated TOP reporter (red) reveals Wnt activity in mouse small intestinal organoids. 
High levels of Wnt activity are observed in WGA+ Paneth cells (green), while only low levels are 
observed in CBC stem cells (arrows). DAPI (blue) marks nuclei.
(C) Stably integrated ASCL2-TOP reporter (red) reveals similar expression levels between WGA+ 
(green) Paneth cells (dashed lines) and intercalating CBC stem cells (arrows) at the bottom of crypt 
compartments in mouse small intestinal organoids. WGA (green) stains Paneth cells (dashed lines). 
DAPI (blue) marks nuclei. *Autofluorescence.
(D) Transcriptional activity of indicated reporters measured by luciferase assay in HEK293T cells 
in co-presence of a dominant-positive mutant of β-catenin (S33Y), ASCL2, both, or none. KLHDC4 
enhancer shows ASCL2-dependent transcriptional activity and is insensitive to active Wnt/β-
catenin signaling. Like TATA box, minimal LGR5 promoter on itself is non-responsive but facilitates 
transcriptional activity mediated by enhancer. Addition of TOP sites to enhancer yields β-catenin-
responsive effects, as well as synergism to co-presence of ASCL2 and β-catenin. Triplicates of a 
representative experiment are shown. RLU, relative luciferase units. Data are represented as mean 
± SEM.
(E) Stably integrated KLHDC4 reporter (red) reveals bright signal at crypt bottoms with the exclusion 
of CD24+ Paneth cells (green). Hoechst (blue) marks nuclei. Scale bars: 50 μm.
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To test transcriptional activity of different ASCL2-dependent reporters, we performed 
luciferase assays in human embryonic kidney cells (HEK293T) that contain a fully 
functional yet inactive Wnt signaling pathway. As expected based on previous reports 
(Schuijers et al., 2015), we hardly observed any transcriptional activity of five optimal 
ASCL2 binding sites in the presence of active Wnt/β-catenin signaling, presence 
of ASCL2, or both combined (Figure 1A). Indeed, in line with the proposed model 
that β-catenin/TCF and ASCL2 can function as a tripartite transcriptional complex 
(Schuijers et al., 2015), the addition of five Wnt-responsive TCF optimal binding motifs 
(TOP) to ASCL2 sites provided a synergistic effect on transcriptional activity (Figure 
1A). The minimal 150-bp promoter element of LGR5 (100-bp promoter region plus 
first 50-bp 5′-UTR) that includes an endogenous TATA box sequence demonstrates no 
transcriptional activity by itself (Figure 1A).
To validate expression patterns of functional reporters in intestinal epithelia, we 
generated small intestinal mouse (SIM) organoids with stable integration of the 
reporter plasmids. Although Wnt/β-catenin signaling is well known for its effects in 
stem (arrows) and progenitor cells, the TOP reporter predominantly shows strong Wnt 
activity in Paneth cells in agreement with its reported role in specializing terminally 
differentiated Paneth cells (Figure 1B) (van Es et al., 2005; Farin et al., 2012). In addition, 
supplementing TOP with ASCL2 sites confirmed enhanced reporter expression in 
Lgr5+ crypt base columnar (CBC) stem cells of SIM organoids (arrows), in line with 
the measurements in cell lines (Figure 1C). However, while the signal became much 
enhanced in CBC stem cells, i.e., almost equalized in relation to Paneth cells, the lack 
of exclusivity for CBC cells disqualifies this reporter for specific visualization and 
manipulation of Lgr5+ CBC stem cells.
To obtain stem cell specificity, we searched for enhancer elements with exclusive 
responsiveness to stem cell specific ASCL2 in publicly available chromatin 
immunoprecipitation (ChIP) sequencing data of ASCL2 and TCF4 (Schuijers et al., 
2015). Intriguingly, while most binding elements revealed co-occupancy of both 
transcription factors, a single 700-bp enhancer element in closest proximity, and thus 
annotated, to the KLHDC4 gene stood out with significant levels of ASCL2 binding 
without any detectable TCF (Schuijers et al., 2015). Intriguing, the KLHDC4 gene itself 
is not enriched in ISCs, nor is it known to be important for stem cell biology. Moreover, 
the enhancer element, identified in the human genome, does not seem to be conserved 
among species (data not shown). Nevertheless, the KLHDC4 enhancer in combination 
with the minimal LGR5 promoter indeed revealed ASCL2-specific transcriptional 
activity in a luciferase assay without any responsiveness to Wnt/β-catenin (Figure 
1D). To assess influence of the minimal LGR5 promoter on transcriptional activity, we 
replaced this sequence for synthetic TATA box sequences and obtained similar, albeit 
lower, ASCL2-dependent effects (Figure 1D). Importantly, introduction of the KLHDC4 
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enhancer that is driving expression of a fluorescent marker in SIM organoids, revealed 
high activity at the crypt base, flanked by non-positive CD24+ Paneth cells (Figure 1E).
Identification of Stem Cell Activity Using an ASCL2-Responsive 
Minigene
We observed that the core of the KLHDC4-related enhancer element contained 11 near-
perfect repeats of 41 bp that are interspersed with three random base pairs. Each 41-bp 
repeat contained an optimal 10-bp ASCL2-binding motif (Figure 2A). To test whether 
these repeats are responsible for ASCL2-dependent transcriptional activation, we 
repeated the luciferase assay in 293T cells. Moreover, to validate ASCL2 specificity, we 
generated a mutant repeat with directed point mutations within the core of the ASCL2 
binding motif (Figure 2A). As expected, the 41-bp repeats became transcriptionally 
active only in the presence of ASCL2. Moreover, its activity strongly increased upon 
multiplying the number of repeats, while the mutant versions remained inactive 
(Figure 2B). From now, on we refer to the 41-bp repeat as STAR.
To confirm transcriptional activity of STAR repeats in combination with endogenous 
ASCL2 expression levels, we performed the luciferase assay in LS174T CRC cell line. 
These human CRC cells show robust expression levels of multiple Wnt-dependent ISC 
markers such as LGR5, RNF43, and ASCL2 (Van der Flier et al., 2007; van de Wetering 
et al., 2002). As expected, multiplying the number of STAR repeats enhanced activity, 
while mutant STAR repeats remained inactive. Strikingly, four or more (eight) STAR 
repeats showed activity that surpassed the original KLHDC4 enhancer element (Figure 
S1A).
For molecular validation of STAR repeat-driven transcription, we performed a DNA 
pull-down with STAR repeats in LS174T CRC cells for subsequent identification of all 
interacting proteins using mass spectrometry (Figure S1B). We indeed identify ASCL2-
specific binding to the STAR repeats mediated by its consensus binding motif (Figures 
2C and S1C). Moreover, the experiment shows that STAR DNA sequences interact with 
two general heterotypic binding partners of the E protein family of bHLH transcription 
factors, namely HEB (TCF12) and E2A (TCF3). Subsequently, we performed an ASCL2 
pull-down in LS174 CRC cells to identify direct protein-protein interaction partners 
of ASCL2 by mass spectrometry. In agreement with previous reports (van der Flier et 
al., 2009; Johnson et al., 1992; Scott et al., 2000), HEB and E2A were observed to be the 
most common binding partners of ASCL2 (Figure 2D). Moreover, due to the presence 
of ethidium bromide during the experiment, we disrupt protein DNA-dependent 
interactions, suggesting that ASCL2 binds in a protein complex with HEB and/or E2A 
to the STAR repeat.
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FIGURE 2 | Identification of Stem Cell Activity Using an ASCL2-Responsive Minigene
(A) Representation of the KLHDC4 enhancer that contains 11 near-identical 41-bp repeats. Based on 
these repeats, reporters were generated consisting of normal repeats (STAR, red box) that includes 
an optimal binding motif for ASCL2 (red font) driving transcription of all possible genes of interest 
(GOIs). In contrast, repeats with mutations in ASCL2 binding motif (blue font) function as control 
elements named mSTAR (blue box).
(B) Transcriptional activity of indicated reporters measured by luciferase assay in HEK293T cells co-
transfected with a dominant-positive mutant of β-catenin (S33Y), ASCL2, the combination, or none. 
STAR repeats are responsive to ASCL2 and insensitive to active WNT/β-catenin signaling. Moreover, 
mSTAR is inactive under all conditions, underscoring ASCL2-specific transcriptional activity of STAR 
repeats. As a positive control, combining TCF binding sites (TOP) with minimal ASCL2 binding sites 
renders responsiveness to WNT/β-catenin and provides synergistic activity with co-occupancy of 
β-catenin/TCF and ASCL2. All transcriptional elements are supplemented with min.LGR5 promoter. 
RLU, relative luciferase units. Triplicates of a representative experiment are shown. Data are 
represented as mean ± SEM.
(C) Pulldown of DNA oligos containing 4× STAR or 4× mSTAR repeats in CRC cell line LS174T 
followed by mass spectrometry to identify STAR-specific interacting proteins. Scatterplot indicates 
significant interactors (red circles) that show specific binding to the STAR repeat. As expected, bHLH 
transcription factor ASCL2, as well as its heterodimeric binding partners HEB (TCF12) and E2A (TCF3) 
show specific binding.
(D) Mass spectrometry-based identification of non-DNA-mediated protein-protein interaction 
partners of ASCL2 in LS174T CRC cells. Volcano plot indicates specific interactors with pulled-down 
flag-ASCL2.
(E) Left: Immunofluorescence cross-section image of stably integrated STAR minigene reveals 
STAR activity (red) in mouse small intestinal organoids. Middle: Enlargement of stem cell niche 
reveals specific expression in CBC stem cells (arrowheads) that directly flank post-mitotic Paneth 
cells stained with lysozyme (blue). Right: 3D rendering of the same organoid, clearly indicating the 
restrictive expression pattern of the STAR minigene in the direct vicinity of Paneth cells. DAPI (white) 
marks nuclei.
(F) Left: Immunofluorescence image of stably integrated STAR minigene in mouse small intestinal 
organoids derived from Lgr5-DTR-eGFP knock-in mice. Co-expression of STAR minigene (red) with 
Lgr5 (green) in CBC stem cells. Right panel: Enlargement of crypt compartment. Lysozyme (blue) 
stains Paneth cells. DAPI (white) marks nuclei. Scale bars: 50 μm (left) and 25 μm (right). See also 
Figure S1.
549219-L-bw-Voorthuijsen










DEVELOPMENT OF THE STEM CELL ASCL2 REPORTER (STAR)
85
549219-L-bw-Voorthuijsen
Processed on: 6-10-2020 PDF page: 86
CHAPTER 3
86
FIGURE 3 | STAR Minigene Reveals Stem Cell Activity in Human Organoids of Normal Colon
(A) Cross-section of crypt structure of normal human colon organoids with stable integration of 
the STAR minigene. Stem cells visualized by STAR activity (second panel in white) are confined to 
cells at the crypt base. In line with cellular positioning in in vivo crypt, STAR+ cells are intermingled 
with STARneg cells (arrowheads). Nuclei are marked with H2B-mNeonGreen expression (third panel 
in white). Right panel: Overlay of STAR expression (red) and nuclei (green). *Autofluorescence. Scale 
bar: 25 μm.
(B) Colony-forming efficiency of single STAR+ and STARneg cells, FACS isolated from mature organoid 
structures with crypt and villus-like structures. At day 5 and 10 after plating, STAR+ colon cells are 
most potent in organoid formation. Increasing activity of the WNT signaling pathway with WNT and 
R-spondin ligands enhances organoid formation efficiency of STAR+ colon cells, but not of STARneg 
cells. N = 3 independent experiments. Data are represented as mean ± SEM.
(C) Gene expression profiling of STAR+ versus STARneg cells from normal human colon organoids. 
Shown are the changes in expression levels of genes between STAR+ and STARneg cells.
(D) GSEA on gene expression dynamics of STAR+ versus STARneg colon cells with the previously 
published gene set that is specific for Lgr5+ ISCs. The strong ISC signature in STAR+ cells confirm that 
the STAR minigene indeed marks stem cells in normal human colon organoids. See also Figure S2.
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To test the STAR-mediated expression pattern in intestinal organoid cultures, we 
generated a STAR minigene that combines 41-bp STAR repeats with the minimal LGR5 
promoter to drive expression of a fluorescent marker. As expected, introduction of 
a STAR minigene into SIM organoids resulted in restricted activity in CBC stem cells 
at the base of crypt structures with the notable exception of Lysozyme+ Paneth cells 
(Figure 2E). To confirm stem cell-specific STAR activity, we determined its expression 
pattern in relation to stem cell marker gene Lgr5. We isolated SIM organoids from 
the Lgr5-DTR-GFP mouse in which Lgr5+ CBC stem cells are marked with DTR-GFP 
(Tian et al., 2011). We observed co-expression of STAR in DTR-GFP+ Lgr5 stem cells 
as assessed by their GFP+ membranes, as well as exclusion of STAR expression in 
Lysozyme+ Paneth cells (Figure 2F). In contrast to the observed heterogeneity in 
organoids, STAR activity in clonal human CRC cell lines showed a more homogeneous 
expression pattern, where averaged levels of STAR activity correlated with previous 
reported ASCL2 expression levels for the different cell lines (Figure S1D) (Van der 
Flier et al., 2007). Notably, upon induced differentiation of these cancer cells using 
transient transfection of dnTCF4, we noticed that the activity of STAR correlates with 
downregulation of LGR5 expression on the single-cell level (Figure S1E). In summary, 
activity of the STAR minigene faithfully represents ISC activity that is mediated by the 
stem cell-specific transcription factor ASCL2.
STAR Minigene Reveals Stem Cell Activity in Human Organoids of 
Normal Colon
Considering the unmet demand for selective labeling of stem cells in colon organoids of 
human origin, we tested the expression pattern of lentiviral STAR minigenes in human 
colon organoid lines. We first validated its expression pattern in normal human colon 
organoids and noticed restricted expression in crypt-like structures reminiscent of 
the expression pattern in mouse small intestinal organoids and in agreement with the 
in vivo localization of Lgr5+ stem cell activity at the crypt base (Figure 3A). Moreover, 
STAR+ cells were intercalated between STAR-negative cells (arrowheads), most likely 
reflecting “Paneth cell-equivalent” deep crypt secretory (DCS) cells that support stem 
cell function in the colon (Rothenberg et al., 2012; Sasaki et al., 2016).
Next, we determined outgrowth potential of fluorescence-activated cell sorting (FACS)-
sorted STAR+ and STARneg cells from normal human colon organoids that contain crypt 
and villus-like structures. As expected, colony formation was most robust for colon 
cells with STAR-labeled stem cell activity, and almost negligible for non-STAR cells. 
Moreover, we noticed that the amount of WNT and R-spondin in the culture medium 
corresponded with the overall efficiency of colony formation for the STAR+ colon cells, 
but not for the non-STAR cells (Figure 3B). Independently, when normal human colon 
organoids are grown in previous reported expansion medium (Sato et al., 2011), we 
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noticed significantly improved outgrowth for the non-STAR cells, indicative of fate 
plasticity within this non-stem cell population to dedifferentiate toward stem cell 
state upon stem cell-favorable culture conditions (Figure S2A).
Subsequently, we performed RNA sequencing on sorted colon cells with either 
presence or absence of STAR-labeled stem cell activity (Figure S2B). As expected, 
among the most upregulated genes in STAR+ colon cells is ASCL2, the master regulator 
of stem cell fate and the inducer of STAR activity (Figure 3C). In addition, known stem 
cell genes such as ZNRF3, EPHB3, and LRIG1 were upregulated. In contrast, colon cells 
without stem cell activity express differentiation markers such as BMP3, ALPI, TFFs, 
and Mucins. To assess the gene expression profile of STAR+ cancer stem cells in an 
unbiased manner, we performed a gene set enrichment analysis (GSEA) comparing our 
data with available gene signatures of ISCs (Muñoz et al., 2012). The gene expression 
signature of STAR+ colon cells resembles Lgr5+ ISCs to a large extent (Figure 3D), 
implying that the STAR-labeled cells in normal human colon organoids are indeed 
Lgr5+ colon stem cells.
STAR Minigene Reveals Stem Cell Activity in Engineered Tumor 
Organoids
Tumor progression organoids (TPOs) are normal colon organoids in which various 
combinations of cancer mutations were introduced using CRISPR/Cas9, thereby 
recapitulating various stages of CRC development along the adenoma-carcinoma 
sequence (Drost et al., 2015). STAR activity across the panel of TPOs with identical 
genetic background enables us to study the functional properties of stem cells while 
colon tumors evolve from benign lesions to invasive cancers. All TPO lines of the 
adenoma-carcinoma sequence revealed presence of STAR activity in a heterogeneous 
expression pattern (Figure 4A), in line with previous reports that signaling pathways, 
including Wnt, still display heterogeneous activity patterns in malignant tissue 
(Prasetyanti et al., 2013). Especially the Quadruple mutant TPO line, i.e., APC, KRAS, 
TP53, and SMAD4, showed pronounced STAR activity confined to crypt-like budding 
structures, suggesting intense stem cell activity in TPO subtypes that is associated 
with invasive behavior (Drost et al., 2015; Fumagalli et al., 2017).
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FIGURE 4 | STAR Minigene Reveals Stem Cell Activity in Engineered Tumor Organoids
(A) Tumor progression organoids (TPOs) that are representative of different stages along the 
adenoma-carcinoma sequence. Representative organoids of TPO subtypes are presented at day 10 
after single-cell plating. Top row shows bright field. Middle row depicts STAR expression (white). 
Bottom row shows merge between STAR expression (red) and H2B-mNeon (green). Cellular 
heterogeneity within clonally grown organoids is clearly reflected by the restricted STAR expression 
pattern (dashed lines). Normal human colon and APC organoids were supplemented with Rock-
inhibitor Y-27632 to prevent anoikis at single-cell stage. *Autofluorescence. Scale bars: 50 μm.
(B) Orthotopic transplantation of human TripleAPC/KRAS/TP53 and Quadruple mutant STAR organoids 
into the cecal wall of immune-deficient mice. Tumors were analyzed approximately 8–12 weeks 
after transplantation. TripleAPC/KRAS/TP53 remains tumor in situ and contains clusters of STAR+ cells, 
whereas the Quadruple mutant tumor shows an invasive morphology with STAR+ cells localized 
at the outer regions. STAR activity is depicted in red, and counterstaining with β-catenin in white. 
*Autofluorescence of necrotic debris. Scale bars: 100 μm.
(C) H2B-mNeon+ tumor cells from transplanted TripleAPC/KRAS/TP53 and Quadruple mutant tumor 
organoids were FACS sorted and gated on STAR activity (tagBFP2). Gating settings were defined 
using intestinal cells of the recipient mice.
(D) Scatterplot indicating the correlation between the expression profiles of STAR+ cancer cells from 
the Quadruple mutant tumor organoids that have been cultured in vitro versus grown in vivo as an 
orthotopic transplanted tumor. Red dots represent mRNA transcripts from a previously described 
ISC-specific gene signature (Muñoz et al., 2012). See also Figure S3.
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Since the relative level of STAR activity in TPO subtypes might be influenced by culture 
media with customized growth factor supplements, we xenotransplanted the TPO 
lines into the cecum of mice in order to test whether the proportion of cancer cells with 
STAR+ stem cell activity differs between different stages of tumor development (Figure 
4B). Previous studies (Drost et al., 2015; Fumagalli et al., 2017) indicated successful 
engraftment of the Triple, i.e., APC, KRAS, and TP53, and the Quadruple mutant lines. 
In agreement with those studies, our Triple mutant TPO remains a tumor in situ 
while the Quadruple mutant TPO showed irregular structured epithelium, a feature 
of invasive carcinomas (Figure S3A). In agreement with recent observations of LGR5 
expression patterns in human tumors (Shimokawa et al., 2017), STAR+ cancer cells were 
detected at the outer regions of the tumors. This was particularly pronounced in the 
Quadruple mutant TPO (Figure 4B). Subsequent quantification of STAR+ cancer cells 
by FACS analysis revealed that the invasive Quadruple mutant tumor had an increased 
proportion of cancer stem cells as compared with the Triple mutant tumor (Figure 4C). 
Next, we performed mRNA expression profiling of the STAR+ cells that were derived 
from the Quadruple mutant tumor in the mouse versus STAR+ cells from cultured 
Quadruple mutant TPO line. Reassuringly, the cellular identities of STAR+ cells from 
both sources are very similar in overall expression profile (R2 of 0.94) (Figure 4D). 
Moreover, when specifically analyzing previously determined ISC-enriched genes 
(Muñoz et al., 2012), we noticed that the ISC signature in STAR+ cells is very robust and 
seems largely independent of environmental conditions (R2 of 0.93) (Figure 4D).
STAR
+
 Cancer Cells Contain Stem Cell Activity
In order to define a comprehensive gene expression signature for STAR+ stem cells 
while they evolve along the adenoma-carcinoma sequence of CRC development, we 
performed RNA sequencing on sorted STAR+ and STARneg cancer cells from multiple 
human TPO subtypes (Figures S3B and S4A), including the original normal organoids. 
We consistently identified 638 genes with significant differences in expression levels 
between the two populations. Among the most upregulated genes in STAR+ cancer 
cells is ASCL2, the master regulator of stem cell fate and the inducer of STAR activity 
(Figure 5A). In addition, known stem cell genes such as RGMB, SP5, EPHB3, and LRIG1 
were consistently upregulated. In contrast, cancer cells without stem cell activity had 
consistent expression of differentiation markers such as REG4, VILLIN, and KRT7. To 
assess the gene expression profile of STAR+ cancer stem cells in an unbiased manner, we 
performed a GSEA comparing our data with available gene signatures of ISCs (Muñoz 
et al., 2012). The gene expression signature that is common among STAR+ cells of the 
different TPO subtypes resembles Lgr5+ ISCs to a large extent (Figure 5B), implying 
that the STAR+ cells in human tumor organoids represent the genuine LGR5 stem cell 
lineage. In agreement with the concept that common cancer mutations eliminate the 
dependency of niche signals rather than inducing de novo phenotypes (Fujii et al., 
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2016; Fumagalli et al., 2017), we observed that the general stem cell signature of STAR+ 
cells stays similar during tumor progression along the adenoma-carcinoma sequence.
Normally, colon stem cells and DCS cells are both positioned at the entire base of a 
crypt. Since the STAR minigene marks stem cell activity in a heterogeneous fashion 
in all TPO subtypes, we wondered whether the STARneg population of cancer cells 
include cells that resemble the DCS cells of the colon. From previously performed gene 
expression analysis of Reg4+ DCS cells (Sasaki et al., 2016), we generated a Reg4+ DCS 
cell-specific gene signature consisting of 208 genes that are >2-fold upregulated with 
a p value of <0.05. Although multiple cellular lineages are likely present within the 
STARneg cell population, the STARneg tumor cell population from different TPO subtypes 
shows resemblance to the expression signatures of differentiated DCS cells (Figure 
5B), indicating that at least a subset of tumor cells are DCS-like cells.
To study evolving characteristics of STAR+ stem cells while tumors progress from 
benign lesions to invasive carcinomas, we studied outgrowth potential of FACS-sorted 
STAR+ and STARneg cells of multiple TPO subtypes. The growth course of individual 
organoids was examined over time using brightfield imaging and fluorescent imaging 
of the nuclei (H2B-mNeonGreen) and STAR-labeled stem cell activity. Independent 
of TPO subtype, we observed three modes of outgrowth for STAR+ cells. First, the 
developing tumor organoids remain 100% positive for STAR activity. Alternatively, 
they lose STAR activity completely. In the third scenario, STAR+ cancer cells both 
self-renew into STAR+ daughter cells, but also generate STARneg progeny by means of 
differentiation, yielding organoids with a mixed composition of STAR+ and STARneg 
cells. Profiting from this “mixed” outgrowth scenario, we isolated STAR+ and STARneg 
cells from organoids that developed in 2 weeks from the FACS-sorted STAR+ cell 
population for quantitative follow-up experiments. Importantly, this experimental 
strategy excludes silencing of the minigene as a cause of absence for STAR activity 
(Figure S4A).
We first set out to further define colony-forming efficiencies of STAR+ and STARneg cells 
isolated from the various TPO tumor subtypes. Normal colon and the more benign 
tumor organoid lines, i.e., with single mutations in APC or KRAS, require inhibition of 
anoikis-mediated apoptosis in order to grow out (Figure 5C). Anoikis inhibition can be 
omitted for TPO tumor variants containing two or more cancer mutations. Although 
the TPO line with APC and TP53 deficiency shows modest but significant colony 
formation without anoikis inhibition, combining APC-deficiency with oncogenic 
KRAS shows increased efficiency of organoid formation. Further addition of a third 
(TP53) and/or fourth (SMAD4) mutation show similar efficiencies (Figures 5C and S4B).
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FIGURE 5 | Characterization of STAR+ Cancer Stem Cells during Tumor Progression
(A) Gene expression profiling of STAR+ versus STARneg cells from various TPO subtypes. Shown are 
the 638 transcripts whose average over five samples show >1.25-fold difference. Mann-Whitney U 
test, p value < 0.005.
(B) Top: GSEA on gene expression dynamics of STAR+ versus STARneg cancer cells with the previously 
published gene set that is specific for Lgr5+ ISCs. The strong ISC signature in STAR+ cells confirm 
that the STAR minigene labels cancer cells with stem cell activity in human tumor organoids that is 
independent of mutational landscapes. Bottom: GSEA with the specific gene list for DCS cells shows 
strong DCS cell signature in STARneg cells, suggesting the presence of DCS-like-cancer cells within the 
non-stem cell population.
(C) Colony-forming efficiency of single STAR+ or STARneg cells scored at days 5 and 10 after plating. 
Normal human colon and APC-deficient cells were supplemented with Rock-inhibitor Y-27632 to 
prevent anoikis at the single-cell stage. N = 3 independent experiments. Data are represented as 
mean ± SEM.
(D) Cellular differentiation and fate plasticity create cellular heterogeneity of STAR expression within 
developing organoids. Three categories were assigned for an organoid phenotype: 100% positive 
for STAR expression (red), complete absence of STAR expression (white), or everything in between 
(mixed). Phenotypes were scored at days 0, 5, and 10 after plating. N = 3 independent experiments. 
Data are represented as mean ± SEM. See also Figure S4.
549219-L-bw-Voorthuijsen










DEVELOPMENT OF THE STEM CELL ASCL2 REPORTER (STAR)
95
549219-L-bw-Voorthuijsen
Processed on: 6-10-2020 PDF page: 96
CHAPTER 3
96
Intriguingly, the colony-forming efficiencies for STARneg cells revealed almost 
identical behavior as STAR+ stem cells, albeit with slightly lower efficiencies (Figure 
5C). In a parallel experiment, anoikis was inhibited for all TPO subtypes (Figures S4B 
and S4C), equalizing the overall colony formation efficiencies to similar levels among 
all TPO tumor lines. Also, in this experiment, outgrowth from STAR+ and STARneg cells 
gave strikingly similar results.
Next, we decided to study the outgrowth of STARneg cells in closer detail. At day 0, 
FACS-sorted cells were confirmed to be nearly purely STARneg as assessed under the 
confocal microscope. However, when the same organoids were imaged at later time 
points (day 5 and 10), an increasing number of organoids reobtained STAR+ cells that 
resulted in organoids of mixed composition (Figure 5D, bottom panels), indicative 
of cell fate plasticity. In identical experiments, the STAR+ cells transformed from a 
pure population (day 0) into a population of organoids where an increasing number 
of organoids showed a mixed phenotype (Figure 5D, upper panels), indicative of 
STAR+ stem cells that not only self-renew but also generate STARneg progeny. Besides 
mixed phenotypes, some organoids lost all STAR+ stem cell activity, while a small but 
significant fraction of organoids remained completely composed of STAR+ stem cells 
(Figure 5D, top panels).
In addition to the presence of robust de-differentiation potential of progenitor cells 
within normal crypt compartments in mice (Buczacki et al., 2013; van Es et al., 2012; 
Metcalfe et al., 2014; Tetteh et al., 2016; Tian et al., 2011), we now reveal similar presence 
of de-differentiation capacity in normal human colon. Moreover, the capacity for fate 
plasticity of STARneg progenitors does not seem to be dramatically enhanced after 
acquisition of common cancer mutations.
Cancer stem cells have previously been identified in CRC samples based on their high 
level of Wnt signaling using WNT/β-catenin reporters (i.e., TOP reporters) (Vermeulen 
et al., 2010). As expected, most prominent WNT-responsive cells in tumor organoids 
are also labeled with STAR (Figure S4D). Moreover, reflecting the binary expression 
pattern of ASCL2 in intestinal and colon stem cells as observed in normal crypts, we 
noticed a more restrictive expression pattern of STAR in comparison to the wider WNT 
gradient in tumor organoids. Therefore, in addition to simple labeling of stem cells, 
the stem cell-exclusive expression pattern that is imposed by STAR also provides the 
unique opportunity to specifically manipulate cellular processes that occur in stem 
cells by overexpression of any protein-of-interest, e.g., dominant-negative or active 
effectors of signaling pathways.
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STAR Minigene Labels Cancer Stem Cells in Patient-Derived CRC 
Organoids
Next, we introduced STAR minigenes in three different patient-derived CRC organoid 
lines from a well-characterized multi-patient organoid biobank (Van De Wetering 
et al., 2015). Each of the three lines, i.e., P9T, P16T, and hypermutated P19bT, contain 
different mutational landscapes (Figure 6A). In clonal outgrowths of these patient-
derived CRC organoids, thereby ensuring genetic homogeneity, different levels of 
STAR-labeled stem cell activity were observed (Figure 6A). Thus, heterogeneous 
patterning of STAR reported stem cell activity seems to be a common theme among 
organoids from healthy, early tumorigenic (TPOs) or end-stage CRC tissue.
Next, we performed mRNA expression profiling of the STAR+ and STARneg cells. As 
expected, also in these patient-derived CRC organoids, the STAR minigene marks 
cancer cells with an expression pattern that closely associates with the stem cell 
signature of well-characterized Lgr5+ ISCs from mouse (Figure 6B). Subsequently, we 
compared the STAR-specific expression profiles of patient-derived CRC organoids 
with the RNA expression data from STAR+ stem cells of the TPO subtypes. Genes 
consistently upregulated in STAR+ stem cells when compared to STARneg cancer cells 
include well-known stem cell marker genes such as ASCL2, EPHB3, NOTCH1, SOX4, and 
AXIN2 (Figure 6C). In contrast, among the most differential genes upregulated in the 
STARneg cancer cells is REG4, the marker gene of DCS cells, the Paneth cell equivalent 
cell in colon epithelium that supports stem cell function (Figure 6C).
In addition, we addressed the functional characteristics of the cancer cells with or 
without STAR+ stem cell activity. In line with the observations with the TPO subtypes, 
we observed near-identical colony-forming efficiencies for STAR+ and STARneg cancer 
cells and observed, again, significant fate plasticity (Figures 6D, 6E, and S5A). The 
degree of plasticity varied per patient-derived tumor line, potentially reflecting the 
differences in the mutational landscape.
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FIGURE 6 | STAR Minigene Labels Cancer Stem Cells in Patient-Derived CRC Organoids
(A) Patient-derived CRC organoids P9T, P16T, and P19bT with stable integration of the STAR minigene. 
Top: Bright-field images. Middle: Heterogeneous pattern of STAR activity (white). Bottom: Merge of 
STAR expression (red) with H2B-Neon (green). Dashed lines indicate individual STAR+ cells. Panel at 
the right indicates overview of mutations in frequently mutated genes in cancer. Panel is reproduced 
from van de Wetering et al. (2015). Scale bars: 50 μm.
(B) GSEA on gene expression dynamics of STAR+ versus STARneg cancer cells from TPOs and patient-
derived CRC organoids shows again a strong ISC-specific gene signature in STAR+ cancer cells.
(C) Heatmap of STAR-specific gene expression dynamics (Mann-Whitney U test, p value < 0.005) 
in multiple patient-derived CRC organoids and TPO subtypes reveals stem cell and differentiation 
markers in STAR+ and STARneg cells, respectively.
(D) and (E) Like Figure 5C (D) and Figure 5D (E), but now for indicated patient-derived CRC organoids. 
See also Figure S5.
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Organoid technology is a rapidly expanding research field. Its unique resemblance 
to in vivo epithelia not only draws attention from adult stem cell biologist, but a far 
wider public that ranges from tissue engineers and biophysicist for understanding 
self-organizational properties of tissues to physicians that strive to optimize disease 
modeling (Clevers, 2016). Considering this widespread mode of applications, user-
friendly technology that enables straightforward monitoring and manipulation of 
specific cell types is of great interest. Especially labeling stem cells in human intestinal 
organoids is challenging and has so far only been demonstrated in colon organoids 
of cancerous origin using CRISPR knock in strategies that are both technically 
challenging and time consuming (Shimokawa et al., 2017; de Sousa e Melo et al., 2017).
Here, we report the STAR minigene as an alternative strategy for ISC labeling. The 
STAR minigene reports transcriptional activity of ASCL2, the master regulator of ISC 
fate (van der Flier et al., 2009) and as a result generates an expression pattern that is 
specific for stem cells of the gut. Importantly, due to the small size of the enhancer/
promoter element (~0.5 kb), STAR is compatible with standard transposon-based 
and lentiviral infection protocols for genomic integration. Therefore, in contrast 
to CRISPR-mediated strategies, STAR provides a simple and flexible strategy to 
fluorescently label and/or drive all sorts of proteins-of-interest in ISCs. Illustrative for 
its user friendliness is the successful labeling of stem cells in human colon organoids 
of normal origin using lentiviral infection.
In line with previous reports, we confirm that synthetic promoters with a repeating 
number of minimal ASCL2-optimal binding motifs do not provide transcriptional 
activity in an ASCL2-dependent manner (Schuijers et al., 2015). In contrast, multiple 
41-bp STAR repeats do generate strong transcriptional activity. It will be interesting to 
identify the exact molecular mechanism how ASCL2 initiates transcriptional activity 
from a STAR repeat. Most importantly, all our data indicate that STAR activity is critically 
dependent on the presence of ASCL2 and hence is specific for stem cells of the gut.
Recently, the functional relevance of Lgr5+ cancer stem cells has been reported for 
primary tumor growth in CRC (Cortina et al., 2017; Shimokawa et al., 2017; de Sousa e 
Melo et al., 2017). We confirm their findings of extensive plasticity in different patients 
CRCs, the presence of which seems virtually independent of the mutational landscape 
and that will likely impact the potential of cancer stem cells as a therapeutic target. 
In addition, using TPO subtypes representing the different stages of the adenoma-
carcinoma sequence in CRC, we now show that the capacity for cell fate plasticity is 
present during the entire process of tumorigenesis in human colon. Moreover, in 
line with mouse studies (Buczacki et al., 2013; van Es et al., 2012; Metcalfe et al., 2014; 
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Tetteh et al., 2016; Tian et al., 2011), we now confirm for human colon that the capacity 
of cancer cells to de-differentiate is independent of the acquisition of multiple cancer 
mutations, but predominantly a feature inherited from normal cells. In contrast, 
the acquisition of cancer mutations, especially the addition of oncogenic KRAS on 
top of APC deficiency, does have a significant impact on the efficiency of individual 
cancer cells to form organoids. However, this is independent of stem cell activity, but 
merely reflects the capacity of individual cancer cells to survive at the single-cell stage 
since plating efficiency could be rescued in normal and benign tumor organoids by 
inhibition of anoikis.
Besides stem cell-specific expression in small intestine and colon, expression of 
ASCL2 has recently been documented in cancerous tissues of among others lung, 
stomach, and breast (Wang et al., 2017). Although gene silencing has been reported 
for ASCL2 in a number of individual CRCs, potentially excluding such samples for 
STAR applications (Jubb et al., 2006), it will be of great interest to verify whether 
ASCL2 also marks stem cell activity in tumorigenic lesions of other organs, as well 
as in their corresponding normal epithelia. Libraries of patient-derived colorectal 
organoids have recently been generated that also include benign tumor samples and 
the organoid cultures of the normal epithelia (Fujii et al., 2016; Van De Wetering et al., 
2015). CRISPR/Cas9-mediated knock ins have been used to label stem cell markers in 
human organoids, but their feasibility is technically challenging and has so far only 
been shown in CRC organoids of advanced stages (Cortina et al., 2017; Shimokawa 
et al., 2017). The STAR minigene is an alternative user-friendly strategy to label stem 
cells in intestinal organoids that has the potential to empower easy accessible stem 
cell research using primary human colon tissues from multiple different patients and 
pathogenic conditions.
EXPERIMENTAL PROCEDURES
For a detailed description of experimental procedures, please see Supplemental 
Experimental Procedures.
Organoid Cultures
Mouse organoids were established and maintained as described previously (Sato et 
al., 2009). Patient-derived colon organoids were maintained as described previously 
(Van De Wetering et al., 2015). The TPO series were maintained as described previously 
(Drost et al., 2015). For maturation of normal colon organoids that include true crypt 
and villus-like structures, organoids are grown in 15% Wnt15 culture medium (CM) and 
7.5% R-spondin CM without SB202190 and nicotinamide. To confirm correct sample 
identity in the laboratory, used organoid lines were regularly tested by SNP analysis.
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Organoid transfection using Tol2 transposase was performed with following reporter 
plasmids: Tol2 KLHDC4-min.pLGR5-tagRFPt_PGK-puro (in SIM Bl6 organoids); Tol2 
8xSTAR-min.pLGR5-mNeonGreen_PGK-puro (in SIM Bl6 organoids); Tol2 8xSTAR-
min.pLGR5-tagRFPt_PGK-puro (in SIM Lgr5-DTR-GFP organoids); Tol2 5xTOP-tagRFPt_
PGK-Puro (in SIM Bl6 organoids and in human TripleAPC/KRAS/TP53 and Quadruple mutant 
STAR colon organoids); Tol2 5XAscl2-5xTOP-tagRFPt_PGK-Puro (in SIM Bl6 organoids) 
(genomic location of KLHDC4 enhancer [chr16: 87732692–87733464]).
Alternatively, we infected TPOs and patient-derived CRC organoids P16T and P19bT 
with a lentiviral vector containing 4xSTAR repeats driving TagBFP2 expression linked 
with an IRES sequence to a blasticidin selection cassette (pLV-4xSTAR-min.pLGR5-
TagBFP2-IRES-Blast.) and a pLV-H2B-mNeonGreen-IRES-puro. P9T was infected with 
pLV-4xSTAR-min.pLGR5-TagRFPt::PGK-Puro-P2A-H2B-mNeonGreen. To exclude 
silencing of the minigenes during culture, the STAR-infected organoids were sorted by 
FACS Aria III (BD Biosciences) for STARhigh cells 2 weeks before each experiment.
Microscopy, Live-Cell Imaging, and Colony-Forming Efficiency
Images were captured with a Leica SP8X microscope. For immunofluorescence 
analyses, the mouse organoids were washed with PBS for 1 hr, permeabilized with 
PBD0.2T (48.5 mL of PBS, 1 mL of 10% Triton, 0.5 mL of DMSO, and 0.5 g of BSA), and 
incubated with antibodies at 4°C overnight.
For live-cell analysis, sorted STAR+ and STARneg cells were plated on a glass-bottom 384-
well plate (Corning 4581) and mounted onto a Leica SP8X microscope. The plate was 
held at 37°C in a microscope box and equipped with a culture chamber for humidity 
and 6.4% CO2 overflow. Organoids were imaged in XYZ(T)-mode using a water 25× 
objective (HCX IRAPO L; numerical aperture [N.A.], 0.95) with a tunable white light 
laser. For higher magnification and identification of STAR-positive cells, we used a 
water 40× objective (HC PL APO CS2; N.A., 1.1). Post-acquisition analyses of phenotypes 
were performed manually using ImageJ.
For the colony-forming efficiency assays, 3,000–5,000 viable single cells were 
collected via FACS and plated over five wells with a density of 50–300 cells per well 
of a glass-bottom 384-well plate. Using bright-field and live-fluorescence imaging, 
single cells were monitored at day 0 and at several days of culture organoid to quantify 
organoid formation (colony-forming efficiency %).
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Cell Transfection and Dual-Luciferase Assay
The generated reporters were constructed in a pGL4.10 backbone and transfected with 
Xtremegene9 (Roche) in all cell lines, with Renilla luciferase as a transfection control. 
The dual-luciferase assay system of Promega was used to measure reporter activity. 
Empty pGL4.10 or pGL4.10-min.hLGR5 served as negative controls. All luciferase 
activities were normalized to Renilla. Reporter activities were normalized to pGL4.10-
min.hLGR5 promoter.
STAR Interaction Studies
Nuclear extracts were prepared from LS174T cells. DNA oligos of the 4× STAR and 4× 
mSTAR repeats were amplified using biotinylated primers. LS174T nuclear extract was 
combined with protein incubation buffer and added to the beads. Pull-downs were 
performed in duplicate. Afterward on bead digestion was used to digest the proteins 
in tryptic peptides. The label-free ASCL2-flag pull-down was performed in triplicate 
using 20 μL of anti-FLAG M2 affinity gel (Sigma) per pull-down. Afterward on bead 
digestion was used to digest the affinity purified proteins in tryptic peptides. Finally, 
the tryptic peptides were acidified and desalted using C18 Stagetips prior to mass spec 
analysis. For liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis 
of the DNA pull-down and the label-free FLAG pull-down, the tryptic peptides were 
separated by an Easy-nLC 1000 (Thermo Fisher) connected online to an Orbitrap 
Fusion Tribrid mass spectrometer (Thermo Scientific). MaxQuant (version 1.5.1.0) was 
used to analyze the raw MS spectra by searching against the Uniprot curated human 
proteome (downloaded December 2015).
Orthotopic Xenotransplantation of Organoids
The orthotopic transplantation of organoids was executed as previously described 
(Fumagalli et al., 2017).
RNA Sequencing
RNA from the FACS-sorted organoids was extracted using the RNeasy RNA extraction 
kit (QIAGEN) with DNaseI treatment. A maximum of 250 ng of RNA per sample was 
used for ribosomal RNA depletion using the Ribo-Zero Gold rRNA removal kit 
(Illumina). A maximum of 2 ng of cDNA per sample was used for library preparation 
using the Kapa Hyper Prep Kit (KAPA Biosystems). Sequencing was performed using an 
Illumina HiSeq 2000 machine and generated 50-bp paired-end reads.
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For GSEA, we used the ISC signature from (Muñoz et al., 2012) as ISC gene set. To define 
a REG4+ DCS gene set, we compared available RNA sequencing data of Lgr5+ and Reg4+ 
DCS cells from (Sasaki et al., 2016) and considered the genes with at least a 2-fold 
upregulation and a p value < 0.05 (by Student’s t test) as a REG4+ DCS-specific gene 
signature. Human orthologs of both gene sets were identified with bioDBnet.
DATA AND SOFTWARE AVAILABILITY
The accession number for the RNA sequencing data reported in this paper is GEO: 
GSE99133. The project identifier for the mass spectrometric data reported in this paper 
is PRIDE (ProteomeXchange Consortium via the PRIDE repository): PXD006575.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures and 
five figures and can be found with this article online at https://doi.org/10.1016/j.
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Supplemental Figures and Legends
FIGURE S1 |  Identification of stem cell activity using an ASCL2-responsive minigene, Related 
to Figure 2
(A) Transcriptional activity of indicated reporters measured by luciferase assay in colorectal cancer 
cell line LS174T. Mutated STAR repeats demonstrate no transcriptional activity, whereas enhanced 
activity is observed with increasing number of STAR repeats. Synthetic promoter element with 5 
optimal binding sites for ASCL2 yields minimal activity. All transcriptional elements are supplemented 
with min.LGR5 promoter. RLU = relative luciferase units. Triplicates of a representative experiment 
are shown. N=3 independent experiments. Data are represented as mean ±SEM.
(B) Experimental set-up for DNA pull-downs (biotin-labeled oligos with 4 normal or mutant STAR 
repeats) combined with a mass spectrometry approach to identify endogenous proteins that 
specifically interact with STAR DNA sequences.
(C) Scatterplot of the DNA pulldown with the STAR and mSTAR repeats. Top right quadrant shows the 
specific interactors for the STAR repeat, the left down quadrant shows the interactors for the mSTAR 
repeat. mSTAR is a non-biological relevant repeat used to identify the STAR specific interactors.
(D) Monoclonal colorectal cancer cell lines LS174T and DLD-1 show relative homogeneous STAR 
activity. Left: detected fluorescence in white. Right: fluorescence in red with brightfield overlay.
(E) Upon induced differentiation using transient transfection with dnTCF4 (72hrs), levels of STAR 
activity (white) correlates at the single cell level with expression levels of LGR5 as determined with 
smFISH (dots) against LGR5 mRNA. Circumference of all cells are shown based on brightfield image. 
Arrows indicate clearly differentiated cells that lost STAR and LGR5 expression.
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FIGURE S2 |  STAR minigene reveals stem cell activity in human organoids of normal colon, 
Related to Figure 3
(A) Colony forming efficiency of single STAR+ or STARneg cells, FACS isolated from mature organoids 
with crypt and villus-like structures. 5 and 10 days after plating in expansion medium, including 
Rock-inhibitor Y-27632 to prevent anoikis, reveal capacity of STARneg colon cells to dedifferentiate 
and form organoid structures. Within these stem cell favorable settings, manipulating the activity 
of Wnt signaling pathway with WNT and R-spondin ligands, do not influence organoids formation 
efficiency. N=3 independent experiments. Data are represented as mean ±SEM.
(B) Representative FACS settings for normal human colon organoids with STAR minigene. Gates are 
based on parental organoid line without STAR minigene (left panel).
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FIGURE S3 |  STAR minigene reveals stem cell activity in engineered tumor organoids, Related 
to Figure 4
(A) Overview of tumor morphology, 8-12 weeks after orthotopic transplantation of human TripleAPC/ 
KRAS/ TP53 and Quadruple mutant STAR organoids into the cecal wall of immune-deficient mice. 
TripleAPC/ KRAS/ TP53 remains tumor in situ, whereas the Quadruple mutant tumor demonstrates an 
invasive morphology. The borders between tumor tissue (T) and healthy tissue (Ht) are indicated 
with a dotted line. Tissue is stained for β-catenin (white). Indicated regions (blue boxes) are 
magnified in figure 2C. Scale bars: 100 μm.
(B) Overview of representative FACS settings for organoid lines with STAR minigenes. STARneg gate 
(lower one) is based on, parental organoid line without STAR minigene (control).
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FIGURE S4 |  Characterization of STAR+ cancer stem cells during tumor progression, Related 
to Figure 5
(A) Schematic representation of the experimental set-up for quantitative plating experiments. 
To exclude transcriptional silencing of the STAR minigene, STAR+ cells are FACS isolated from 
mature cultures, plated and cultured again towards mature organoids. After 14 days, organoids 
are dissociated again into single cells prior FACS sorting of both STAR+ cells or STARneg cells. Both 
cell types are plated to monitor growth modes using microscopy. After 14 days, STAR+ and STARneg 
cells can potentially be isolated from the specific cultures for in-depth characterizations, e.g. mRNA 
expression analysis.
(B) Colony forming efficiency of single STAR+ or STARneg cells scored at day 5 and 10 after plating. 
Enhanced survival efficiencies were obtained when TPO subtypes were supplemented with Rock-
inhibitor Y-27632 to prevent anoikis at the single cell stage.
(C) Cellular differentiation and fate plasticity create cellular heterogeneity of STAR expression 
within the developing population of organoids. Three categories were assigned for an organoid 
phenotype: 100% positive for STAR expression (red), complete absence of STAR expression (white), 
or everything in between (mixed). Phenotypes were scored at day 0, 5 and 10 after plating resp. 
In contrast to increased plating efficiency, the degree of cellular differentiation and plasticity are 
not different when TPO subtypes are cultured in the presence of Rock-inhibitor. N=3 independent 
experiments. Data are represented as mean ±SEM.
(D) Representative images of human engineered colon tumor organoids with Triple APC/ KRAS/ 
TP53 (left) and Quadruple (right) mutations. Both have stably integration of TOP reporter (green) 
and STAR (red). Scale bars: 50μm
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FIGURE S5 |  STAR minigene labels cancer stem cells in patient-derived CRC organoids, Related 
to Figure 6
(A) Overview of organoid development of FACS-sorted STAR+ (top) and STARneg (bottom) cancer cells 
from patient-derived CRC organoid line P9T. Insets are enlargements of cellular differentiation (top 
row) and de-differentiation (bottom row). STAR expression (red) and H2B-Neon (green). Scale bars 
50μm.
 
SUPPLEMENTAL EXPERIMENTAL PROCEDURES 
Mouse organoid culture
Mouse organoids were established and maintained as described previously (Sato et 
al., 2009). The basic culture medium (ENR) contained advanced Dulbecco’s modified 
Eagles Medium/F12 supplemented with penicillin/streptomycin, 10mM HEPES and 1x 
Glutamax, 1x B27 [all from Life Technologies], and 1,25mM N-acetylcysteine [Sigma]), 
supplemented with 50ng/mL murine recombinant EGF (Peprotech), RSpondin-1 
(conditioned medium (CM), 5% final volume), and Noggin (CM, 10% final volume).
Human CRC organoid culture
Patient-derived colon organoids were maintained as described previously (Van De 
Wetering et al., 2015). The TPO-series were maintained as described previously (Drost et 
al., 2015). In general, culture medium is based on expansion medium for normal colon 
organoids (Sato et al., 2011). The basic expansion culture medium (WENR) contained 
advanced Dulbecco’s modified Eagles Medium/F12 supplemented with penicillin/
streptomycin, 10mM HEPES and 1x Glutamax, 1x B27 [all from Life Technologies], and 
1,25mM N-acetylcysteine [Sigma]), supplemented with 10mM Nicotinamide, 500nM 
A83-01, 3μM SB202190, 10μM Y-27632, 50ng/mL human recombinant EGF (Peprotech), 
Wnt3A (CM, 50% final volume), RSpondin-1 (CM, 20% final volume), and Noggin (CM, 
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10% final volume). For maturation of normal colon organoids that include true crypt 
and villus-like structures, organoids are grown in 15% Wnt15 CM and 7,5% Rspondin-1 
CM without SB202190 and Nicotinamide. To confirm correct sample identity in the 
lab, used organoid lines were regularly tested by SNP analysis.
Organoid transfection
Before transfection, organoids are cultured on high-WNT medium (50% WNT and 
20% R-spondin-1). Organoids were trypsinized in 2mL Trypsin EDTA (200mg/L) for 1-2 
minutes at 37°C and dissolved in 225μL DMEM/F12 (lacking penicillin/streptomycin) 
containing EGF, Noggin, and R-Spondin-1 (ENR) plus 10μM Y-27632. The transfection 
mixture contained 50μL Opti-MEM, 500ng DNA reporter plasmid, 250ng transposase 
and 2,25μL Xtremegene9 (Roche) transfection reagent for each well of a 24-well 
plate. The transfected organoids were incubated for 5h at 37°C/5%CO2 before plating 
in Matrigel. To boost organoid survival after transfection, culture medium was 
supplemented with WNT CM and 10μM Y-27632 for the first four days. From day two 
onwards, organoids were selected with Puromycin (2mg/ml). Reporter plasmids used: 
Tol2 KLHDC4-min.pLGR5-tagRFPt_PGK-puro (in SIM Bl6 organoids). Tol2 8xSTAR-
min.pLGR5-mNeonGreen_PGK-puro (in SIM Bl6 organoids). Tol2 8xSTAR-min.pLGR5-
tagRFPt_PGK-puro (in SIM Lgr5-DTR-GFP organoids). Tol2 5xTOPtagRFPt_PGK-Puro (in 
SIM Bl6 organoids and in human TripleAPC/ KRAS/ TP53 and Quadruple mutant STAR colon 
organoids). Tol2 5XAscl2-5xTOP-tagRFPt_PGK-Puro (in SIM Bl6 organoids). (Genomic 
location of KLHDC4 enhancer (chr16: 87732692-87733464)).
Organoid transduction
HEK293T cells were plated at 25% confluency in 10cm dishes. The next day, each dish 
was transfected with 5μg lentiviral reporter plasmid (pLV backbone), 1μg pHDM.
Hgpm2, 1μg Rev, 1μg Tat and 2μg HDM.G, dissolved in 100μL Opti-MEM transfection 
medium. Xtremegene9 (Roche) was used as transfection reagent and added in 2:1 ratio 
with DNA and washed away by culture medium after 24h. Viral particles were harvested 
from cells four days after transfection and concentrated by spinning at 32,000 rpm for 
2,5h at 4°C. Pellet was dissolved in 250μL WENR medium supplemented with 10μM 
Y-27632 and Polybrene (8mg/ml). 
Before transduction, organoids were cultured on high WNT medium (50% WNT CM, 
20% R-spondin-1 CM). Organoids were trypsinized in 2mL Trypsin EDTA (200mg/L) for 
1-2 minutes at 37°C until all organoids were in a single cell stage. Reaction was stopped 
with Trypsin inhibitor (Sigma). After 1 washing step, concentrated virus was added 
to the organoid pellet and spun at 600 rpm for 1h at 4°C. Subsequently, organoids 
were incubated for 4h at 37°C/5%CO2 before plating in Matrigel. After transduction 
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organoids were grown on WENR medium supplemented with 10μM Y-27632 for the 
first four days. Selection was carried out from day 2 onwards with either neomycin 
(300mg/ml), blasticidin (150mg/mL) or puromycin (2mg/ml) depending on the 
plasmid selection cassette.
Immunostaining of mouse organoids
Matrigel was dissolved using Dispase (1mg/μL) and centrifuged at 400rpm for 5 
minutes at 4°C. Pellets were gently dissolved in PBS and added to Lab-Tek chambered 
cover glass system. Organoids were fixed using 4% formaldehyde for 10 minutes at 
4°C. For immunofluorescence analyses, the mouse organoids were washed with PBS 
for 1h, permeabilized with PBD0,2T (48,5ml PBS, 1mL 10%Triton, 0,5mL DMSO and 
0,5g BSA), and incubated with primary antibody at 4°C overnight. Primary antibodies 
included anti-Lysozyme (1:1500, Dako). Secondary fluorophore-conjugated antibodies 
include Alexa Fluor 488, Alexa Fluor 563, and Alexa Fluor 647. Wheat Germ Agglutinin 
conjugated fluorophore (Alexa Fluor 488). Nuclei were visualized by DAPI or Hoechst 
3342 (Sigma). Images were captured with a Leica SP8X microscope.
Live-cell imaging and colony forming efficiency
To visualize phenotype and cell number of human organoids over time, we infected 
human TPOs and patient-derived CRC organoids P16T and P19bT with a lentiviral 
vector containing 4xSTAR repeats driving TagBFP2 expression linked with an IRES 
sequence to a blasticidin selection cassette (pLV-4xSTAR-min.pLGR5-TagBFP2-IRES-
Blast.) and a pLV-H2B-mNeonGreen-IRES-puro. Blast selection was only carried out 
from day 2 to 5 after infection. Alternatively, we infected human CRC organoids P9T 
with a lentiviral vector containing 4xSTAR repeats driving TagRFPt expression in 
addition to a general PGK promotor driving H2B-mNeonGreen linked to puromycin 
selection cassette via a P2A sequence (pLV-4xSTAR-min.pLGR5-TagRFPt::PGK-Puro-
P2A-H2BmNeonGreen). To exclude silencing of the minigene during standard culture, 
the STAR infected organoids were sorted by FACS Aria III (BD Sciences) for STARhigh 
cells prior each experiment. Subsequently, mature organoid cultures were grown from 
these STAR+ stem cells for an additional 2 weeks prior a second FACS sort to obtain 
STARhigh and neg cells to start experiments (Figure S5A).
For microscopic analysis, sorted STAR+and STARneg cells were plated in Matrigel and 
accompanying culture media on a glass-bottom 384-well plate (Corning 4581) and 
mounted onto a Leica SP8X microscope. The plate was held at 37°C in a microscope box 
and equipped with a culture chamber for humidity and 6.4% CO2 overflow. Organoids 
were imaged in XYZ(T)-mode using a water 25x objective (HCX IRAPO L, N.A. 0.95) 
with a tunable white light laser. For higher magnification and identification of STAR-
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positive cells we used a water 40x objective (HC PL APO CS2, N.A. 1.1). Post-acquisition 
analyses of phenotypes were performed manually using ImageJ.
For the colony forming efficiency assays, 3000-5000 viable single cells were collected 
via FACS and plated over five wells with a density of 50-300 cells per well of a glass-
bottom 384-well plate. Using bright field and live fluorescence imaging, single cells 
were monitored at day 0 and after 10 days of culture organoid formation was quantified 
(Colony forming efficiency %).
Cell culture and smFISH
LS174T and HEK293T cells were cultured in DMEM supplemented with heat- inactivated 
FBS (Sigma, 10%) and Penicillin/Streptomycin.
LS174T cells were grown on coverslips and transfected with dnTCF4 for 72h. For the 
smFISH, the samples were prepared as previously described (Raj and Tyagi, 2010). 
Briefly, cells were fixed for 10 minutes with 4% Formaldehyde solution (SIGMA) and 
70% Ethanol overnight. Samples were then hybridized with Cy5 labelled Lgr5 probes 
(Stellaris, Biosearch Technologies) and mounted to the microscopy slide using Prolong 
Diamond Antifade (Invitrogen). The images were acquired on a deconvolution system 
(DeltaVision RT; Applied Precision) using 40x lens.
Cell transfection and dual luciferase assay
The generated reporters were constructed in a pGL4.10 backbone and transfected 
with Xtremegene9 (Roche) in all cell lines, with Renilla luciferase as a transfection 
control. The dual luciferase assay system of Promega was used to measure reporter 
activity. Empty pGL4.10 or pGL4.10-min.hLGR5 served as negative controls. All 
luciferase activities were normalized to Renilla. Subsequently, reporter activities were 
normalized to pGL4.10-min.hLGR5 promoter.
Nuclear extracts of LS174T cells
15cm plates were transfected with 15μg pcDNA3-flag-ASCL2 plasmid using PEI and 
harvested after 2 days for the preparation of nuclear extracts (Dignam et al., 1983). 
LS174T cells were harvested from 15cm plates using trypsin and plates were washed 
twice using PBS. Centrifugation at 4⁰C at 500g for 5 minutes was used to pellet the 
cells followed by an additional PBS wash and centrifugation. Afterwards the cell 
pellet was swelled by adding 5 volumes of cold buffer A (10mM HEPES KOH pH 7.9, 
1.5mM MgCl2, 10mM KCl) for 10 minutes on ice followed by centrifugation at 4⁰C for 
5 minutes at 500g. The cell pellet was re-suspended in 2 volumes of buffer A (with 
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the addition of complete protease inhibitors and 0.1% NP-40) and transferred to a 
dounce homogenizer. The cells were homogenized through 30 strokes using a type 
B pestle (tight) on ice. Afterwards the cells were spun for 15 minutes at 3200g at 4⁰C. 
The nuclear pellet was washed once with PBS and centrifuged at 3200g for 5 minutes at 
4⁰C. The pellet of nuclei was re-suspended afterwards in 2 volumes of buffer C (420mM 
NaCl, 20mM HEPES KOH pH 7.9, 20% v/v glycerol, 2mM MgCl2, 0.2mM EDTA) with the 
addition of 0.1% NP-40, complete protease inhibitors, and 0.5mM DTT. Followed by 1h 
rotation of the suspension at 4⁰C and a 30min spin at 18000g at 4⁰C. The supernatant 
was aliquoted for further use and stored at -80⁰C.
DNA pulldown
DNA oligos of the 4x STAR and 4x mSTAR repeats were amplified using the primers 
‘Ascl2_repeats_bio_FW’ and ‘Ascl2_repeats_RV’, followed by 5’-biotinylation of the 
oligo’s using ‘5’ Biotin TAG FW’ and ‘Ascl2_repeats_RV’. For the DNA-pulldown 20μl 
of Streptavidin-Sepharose beads slurry was used per pulldown. Pulldowns were 
performed in duplicate. Beads were washed once with PBS and 0.1% NP-40, spun 2 
minutes at 2000g at 4⁰C and washed once with DNA binding buffer (1M NaCl, 10mM 
Tris pH 8. 1mM EDTA, 0.05% NP40). 1μg of oligo was combined with a total volume 
of 600ul DNA binding buffer and incubated with the beads for 30 minutes rotating 
at 4⁰C. Beads were spun for 2 minutes at 2000g at 4⁰C and washed once with DNA 
binding buffer and twice with protein incubation buffer (150mM NaCl, 50mM Tris pH 
8, complete protease inhibitors, 0.25% NP-40, and 1mM DTT). 500μg of LS174T nuclear 
extract was combined with a total volume of 600μl protein incubation buffer and 
added to the beads. 10μg of competitor DNA (5μg poly-dldC, and 5μg poly-dAdT) was 
added and the beads with the extract were incubated for 90 minutes rotating at 4⁰C. 
Beads were spun for 2 minutes at 2000g at 4⁰C and washed three times with protein 
incubation buffer and twice with PBS, followed by removal of the supernatant using 
a 30G syringe. The proteins bound to the beads were reduced using elution buffer 
(2M urea, 100mM ammonium bicarbonate, and 10mM DTT) for 20 minutes shaking 
at room temperature. Alkylation of the samples was subsequently done by adding 
50mM iodoacetamide (IAA) and incubated for 10 minutes shaking at the dark at room 
temperature (Makowski et al., 2016). Afterwards on bead digestion was used to digest 
the proteins in tryptic peptides (Smits et al., 2013).
Label-free FLAG pulldown
The label-free pulldown was performed in triplicate (Smits et al., 2013) using 20μl of 
anti-FLAG M2 affinity gel (Sigma) per pulldown. Beads were washed three times with 
buffer C (300mM NaCl, 0.5% NP-40, complete protease inhibitors, and 0.5mM DTT) for 
2 minutes at 2000g. Afterwards the beads were incubated for 90 minutes on a rotating 
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wheel at 4⁰C with 1mg LS174T nuclear extract per pulldown and 50mg/ml ethidium 
bromide in a volume of 400μl buffer C. After incubation, the beads were washed twice 
with buffer C (300mM NaCl, 1% NP40), twice with PBS (1% NP-40), and twice with PBS. 
Afterwards on bead digestion was used to digest the affinity purified proteins in tryptic 
peptides (Smits et al., 2013). Finally, the tryptic peptides were acidified and desalted 
using C18 Stagetips prior to mass spec analysis (Rappsilber et al., 2007).
Dimethyl labeling on stage tip
The tryptic peptides from the DNA pulldown were applied to C18 Stagetips (without 
acidification) (Rappsilber et al., 2007). Afterwards the Stagetips were labelled using 
dimethyl labeling (Lau et al., 2014). Label swapping was performed for each replicate 
(forward and reverse). 300μl of labeling reagent light (16.2 μl CH2O 37%) or medium 
(30μl CD2O 20%) in 3mL dimethyl labeling buffer (10mM NaH2PO4, and 35mM Na2HPO4) 
and 6 mg NaBH3CN was added to each Stagetip and spun at 2200g for 10 minutes at room 
temperature. Afterwards, Stagetips were washed once with buffer A (0.1% formic acid).
LC-MS/MS analysis and data analysis
For LC-MS/MS analysis of the DNA-pulldown and the label free FLAG-pulldown (Kloet 
et al., 2016), the tryptic peptides were separated by an Easy-nLC 1000 (Thermo Fisher) 
connected online to an Orbitrap Fusion Tribrid mass spectrometer (Thermo Scientific). 
MaxQuant (version 1.5.1.0) (Cox and Mann, 2008) was used to analyze the raw MS spectra 
by searching against the Uniprot curated human proteome (downloaded December 
2015). For the analysis of the label-free FLAG pulldown and the DNA pulldown LFQ, 
iBAQ, and match between runs were enabled. Additional, for the analysis of the DNA 
pulldown, the multiplicity was set to 2, labels were specified (dimethylLys0, dimethyl 
Nter0, dimethylLys4, dimethylNter4), and re-quantify was enabled. Scatter plots 
were generated using in-house R scripts. Volcano plots were produced as described 
earlier (Hubner and Mann, 2011) by using Perseus (1.4.0.20). Briefly, filtering on the 
protein list was applied for contaminant and reverse hits. Transformation in log2 was 
done for the LFQ values and missing values were imputed by normal distribution. The 
significant proteins were determined using a two samples t-test. Finally, volcano plots 
were generated using in-house R scripts.
Orthotopic xenotransplantation of organoids
The orthotopic transplantation of organoids executed as previously described 
(Fumagalli et al., 2017). In short, the day before transplantation organoids were 
collected and dissociated in 3 – 5 cell clumps using TrypLE Express (Life Technologies) 
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and mechanical dissociation. About 250,000 cells were plated in 15 µl neutralized Rat 
Tail High Concentrated Type I Collagen (Corning) drops and let recover overnight at 
37°C, 5% CO2. 8 – 12 weeks old females NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) mice were 
used as acceptors. The animal experiments were performed according to the national 
and institutional guidelines. Animals were kept at the Hubrecht animal facility in 
Utrecht, The Netherlands. Before surgery, the mice were administered with a sub-
cutaneous dose of buprenorphine (3µg per mouse, Buprecare, ASTfarma). The animals 
were subsequently sedated using isoflurane inhalation anesthesia (~2% isoflurane/
O2 mixture). The cecum was exteriorized through a midline abdominal incision and 
a single collagen drop containing the cells was surgically transplanted in the cecal 
submucosa. The mice were checked weekly for presence of tumors via abdominal 
palpation.
Flow cytometry of tumor cells
Mice were sacrificed four months after transplantation and orthotopic tumors were 
carefully dissected. Tumors were minced in pieces of about 1-2 mm and digested in 
Collagenase Type II (Thermo Fisher Scientific) for 1h hour at 37 ⁰C while shaking. Next, 
cells were filtered through a 70 µm cell strainer, washed and spun down at 1200 RPM 
at 4 ⁰C. Finally, the pellet was collected into culture medium (human CRC as described 
above, including 10μM Y-27632). To label dead cells we incubated single cells with 3μM 
Draq7 (Cell Signaling) for 10 minutes. Viable cells were sorted using the Aria III (Becton 
Dickinson) and data was analyzed with FACS Diva software.
Flow cytometry of organoid cells
Organoids were harvested and trypsinized for 1-2 minutes at 37 ⁰C. Trypsin inhibitor 
in a 1:1 ratio with trypsin blocked the reaction. Cells were washed and spun down at 
1200 RPM at 4 ⁰C. Next, the pellet was taken up into culture medium (human CRC or 
mouse intestinal organoid medium as described above, including 10μM Y-27632 and 
2% Matrigel of the final volume) and passed through a 40μm filter. To label dead cells 
we incubated single cells with 3μM Draq7 (Cell Signaling) for 10 minutes. Viable cells 
were sorted using the Aria III (Becton Dickinson) and data was analyzed with FACS Diva 
software.
RNA sequencing 
RNA from the FACS sorted organoids was extracted using the RNeasy RNA extraction 
kit (Qiagen) with DNAseI treatment. A maximum of 250ng RNA per sample was 
used for ribosomal RNA depletion using the Ribo-Zero Gold rRNA removal kit 
(Illumina) followed by an ethanol precipitation. Afterwards the RNA was fragmented 
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for 5 minutes at 95⁰C using 5x fragmentation buffer (200mM tris-acetate, 500mM 
potassium acetate, 150mM magnesium acetate, pH 8.2). Ethanol precipitation was 
used to precipitate the fragmented RNA followed by first strand cDNA synthesis with 
Superscript III (Life Technologies) and second strand cDNA synthesis. Samples were 
purified using QIAquick MinElute columns (Qiagen) with ERC buffer. A maximum of 
2ng cDNA per sample was used for library preparation using the Kapa Hyper Prep Kit 
(KAPA Biosystems). In short, end repair and A-tailing of the double stranded cDNA 
was done by incubating de cDNA with end repair and A-tailing buffer and enzyme mix 
followed by incubation at 20⁰C for 30 minutes and 65⁰C for 30 minutes. Afterwards, 
unique NEXTflex DNA barcodes (Bioo Scientific) were ligated to the samples by 
incubation with ligation buffer, DNA ligase, and the NEXTflex DNA barcode (14nM) 
for 15 minutes at 20⁰C. The barcode ligated samples were purified using a 0.8x SPRI 
magnetic beads cleanup (Agencourt AMPure XP reagent). The purified samples were 
incubated for 15 minutes at 37⁰C with USER enzyme (New England Biolabs) to digest the 
2nd cDNA strand. Libraries were amplified by adding 2x KAPA HiFi Hotstart ReadyMix 
and 10x Library Amplification Primer Mix to the purified samples followed by PCR 
amplification (10 cycles). Amplified libraries were purified using QIAquick MinElute 
columns (Qiagen) followed by size selection of 300bp using E-Gel SizeSelect Agarose 
Gels 2% (Thermo Fisher Scientific). Size selected libraries were controlled for correct 
size selection using the BioAnalyzer (Agilent) and the concentration was measured 
using the KAPA Library Quantification Kit (KAPA Biosystems). Sequencing was 
performed using a Illumina HiSeq 2000 machine and generated 50bp paired-end reads. 
RNA sequencing analysis
Paired-end reads were aligned to the hg38 transcriptome annotation from UCSC 
(Rosenbloom et al., 2015) with Hierarchical Indexing for Spliced Alignment of 
Transcripts (HISAT2) version 2.0.4 with reporting alignments tailored for transcript 
assemblers enabled (Kim et al., 2015). Reads were counted with the htseq-count script 
in the HTSeq framework (Anders et al., 2015), followed by differential gene expression 
analysis in DESeq2 (Love et al., 2014). Surrogate Variable Analysis (Leek and Storey, 
2007) was used to account for possible batch effects and the 'rlogTransformation' 
function in DESeq2 was used for variance stabilization of the gene expression data. 
Prior to investigating STAR specific gene expression, dynamics between different 
organoid strains were regressed out.
Gene Set Enrichment Analysis
For Gene Set Enrichment Analysis (GSEA) we used the ISC signature from (Muñoz et 
al., 2012) as ISC gene set. To define a REG4+ DCS gene set, we compared available RNA 
sequencing data of Lgr5+ and Reg4+ DCS cells from (Sasaki et al., 2016), and considered 
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the genes with at least a two-fold upregulation and a p-value < 0.05 (by Student T 
Test) as a REG4+ DCS specific gene signature. Human orthologs of both gene sets were 
identified with bioDBnet (Mudunuri et al., 2009).
Statistics
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Artegiani et al. show that BAP1 mutation 
in human liver organoids coincides with 
loss of multiple epithelial characteristics 
through impairment of chromatin 
accessibility and gene expression, and 
this is critical for the acquisition of 
malignant features in a human model of 
cholangiocarcinoma.
HIGHLIGHTS
• BAP1 loss affects cell polarity and epithelial organization in human liver tissue
• BAP1 controls chromatin accessibility of junctional and cytoskeletal genes
• Rescuing BAP1 catalytic activity in the nucleus restores epithelial organization
•  In an engineered human cancer model, malignant features are induced upon BAP1 loss
SUMMARY
The deubiquitinating enzyme BAP1 is a tumor suppressor, among others involved in 
cholangiocarcinoma. BAP1 has many proposed molecular targets, while its Drosophila 
homolog is known to deubiquitinate histone H2AK119. We introduce BAP1 loss-of-
function by CRISPR/Cas9 in normal human cholangiocyte organoids. We find that 
BAP1 controls the expression of junctional and cytoskeleton components by regulating 
chromatin accessibility. Consequently, we observe loss of multiple epithelial 
characteristics while motility increases. Importantly, restoring the catalytic activity of 
BAP1 in the nucleus rescues these cellular and molecular changes. We engineer human 
liver organoids to combine four common cholangiocarcinoma mutations (TP53, 
PTEN, SMAD4, and NF1). In this genetic background, BAP1 loss results in acquisition 
of malignant features upon xenotransplantation. Thus, control of epithelial identity 
through the regulation of chromatin accessibility appears to be a key aspect of BAP1’s 
tumor suppressor function. Organoid technology combined with CRISPR/Cas9 
provides an experimental platform for mechanistic studies of cancer gene function in 
a human context.
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INTRODUCTION
Primary liver cancer is one of the deadliest cancers worldwide. It can be classified 
into two main types: hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC). 
CC displays a more aggressive phenotype (Blechacz and Gores, 2008) and, other than 
surgical resection, an effective cancer therapy does not exist (Rizvi et al., 2018). In 
recent years, exome and whole-genome sequencing together with transcriptomic 
analysis have described the genetic landscape of CC (Chan-on et al., 2013; Farshidfar 
et al., 2017; Fujimoto et al., 2016; Jiao et al., 2013; Jusakul et al., 2017; Nakamura et al., 
2015; Woo et al., 2017). In addition to some well-understood cancer genes (e.g., TP53, 
SMAD4, KRAS), several less characterized genes are frequently mutated in this tumor 
type. Among these, mutations affecting proposed epigenetic regulators and chromatin 
remodelers, such as BAP1, PBRM1, IDH1 and IDH2, and ARID1A are common, with 
almost 50% of the CC harboring mutations in at least one of these genes (Andrici et 
al., 2016; Chan-on et al., 2013; Jiao et al., 2013; Nakamura et al., 2015). Yet, their specific 
role in the context of CC remains largely unknown. Interestingly, the presence of 
specific mutations correlates with certain pathological and clinical features. While 
some studies report that loss of BAP1 expression coincides with high vascular invasion 
(Fujimoto et al., 2015), high histological grade (Andrici et al., 2016), and poor prognosis 
(Woo et al., 2017), others report a correlation with better prognosis (Andrici et al., 2016) 
or no specific association with histological grade or invasion (Misumi et al., 2017). 
The BAP1 gene encodes a deubiquitinating enzyme (DUB). It is inactivated in 
mesothelioma, uveal cell melanoma, and renal cell carcinoma, in addition to CC 
(Andrici et al., 2016; Carbone et al., 2013). Furthermore, germline heterozygous 
BAP1 mutations cause a cancer predisposition syndrome (Testa et al., 2011). Genetic 
experiments in mice have shown that deletion of Bap1 is lethal during embryogenesis. 
Conditional ubiquitous deletion in adult mice leads to myeloid neoplasia (Dey et al., 
2012), but not to any of the common BAP1-mutated tumors observed in man, likely 
underscoring inherent differences between mouse and human.
BAP1 was identified as the mammalian homolog of Calypso, a component of a protein 
complex called Polycomb repressive deubiquitinase (PR-DUB) that targets H2AK119Ub1 
(Scheuermann et al., 2010), a histone modification generally correlated with repression 
of gene expression (Balasubramani et al., 2015; Gao et al., 2012). De-ubiquitination 
activity of mammalian BAP1 is reported to control stability of proteins, such as the 
cytoplasmic IP3R3 (Bononi et al., 2017), HCF-1, and OGT (Dey et al., 2012). Studies 
performed in cell line models propose mammalian BAP1 activity to be involved in various 
cellular functions that might be linked to tumorigenesis, including maintenance of 
genomic stability and control of double strand-break repair by stabilizing Ino80 (Ismail 
et al., 2014; Lee et al., 2014; Yu et al., 2014; Zarrizi et al., 2014), regulation of cell-cycle 
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progression (Eletr and Wilkinson, 2011), apoptosis (Bononi et al., 2017; Sime et al., 2018), 
and very recently, ferroptosis (Zhang et al., 2018). Yet, how BAP1 is involved in adult 
human liver homeostasis and in cancer development remains unclear.
Our laboratory has previously developed tissue stem cell-based, genetically stable 
3D structures, called “organoids” from multiple human epithelia (for review, see 
(Artegiani and Clevers, 2018)), including human liver cholangiocytes (Huch et al., 
2015). The organoids grossly recapitulate the physiology and epithelial architecture 
of the tissue of origin and have been used for a plethora of applications, including 
modeling of human cancer and hereditary disease (Dekkers et al., 2013; Drost et al., 
2015, 2017; Huch et al., 2015; Matano et al., 2015), biobanking (Boj et al., 2015; Broutier 
et al., 2017; Fujii et al., 2016; Lee et al., 2018; Sachs et al., 2018; Seino et al., 2018; Van De 
Wetering et al., 2015) infectious disease modeling (Bartfeld et al., 2015; Garcez et al., 
2016; Heo et al., 2018; Qian et al., 2016; Yin et al., 2015), and for CRISPR-mediated gene 
correction (Schwank et al., 2013).
Here, we use an integrative approach combining CRISPR and organoid technology 
with “multi-omics,” histological imaging, electron microscopy imaging, time-lapse-
imaging, and chromatin analyses to determine BAP1 function and interpret the 
changes induced by its loss in the process of human liver cell transformation.
RESULTS
BAP1 Loss in Human Ductal Liver Organoids Yields Major 
Morphological Changes
We sought to employ human ductal liver organoids (Huch et al., 2015) as a platform 
to unravel the function of uncharacterized genes involved in human liver biology 
and cancer such as BAP1. Single cells isolated from human ductal liver organoids 
and transfected by lipofection (Broutier et al., 2016) fail to regrow into organoids. We 
established an electroporation protocol that allows the generation of human liver 
knock-out (KO) organoids. A plasmid encoding Cas9, a guide RNA (gRNA) targeting 
BAP1, and GFP to visualize the transfected cells (pCas9-gRNABAP1-GFP) was injected 
into the intact lumen of human liver organoids growing in a drop of BMER gel 
(Figure 1A). Electroporation of the entire gel drop was then performed using tweezer 
electrodes, a procedure resembling the in utero electroporation of mouse embryonic 
brain (Artegiani et al., 2012). By maintaining cell-to-cell contact in the intact organoid 
and interaction with BMER, cells recovered readily. Approximately 10% of cells in 
single injected organoids were GFP+ upon electroporation, although this number 
obviously varied (Figure 1A). 48 h later, single organoids harboring GFP+ cells were 
picked and trypsinized, and single cells were replated.
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BAP1 loss alone did not allow for an a priori selection method of mutant clones. We 
therefore co-injected a plasmid expressing a gRNA targeting the TP53 gene (pCas9-
gRNATP53-GFP) together with pCas9-gRNABAP1-GFP. Nutlin-3 allows selection 
of TP53 mutant organoids (Drost et al., 2015). Given the high efficiency of plasmid 
co-transfection in our system, Nutlin-3-resistent clones were very likely to be also 
BAP1 mutant. Single Nutlin-3-resistent cells grew into organoids (Figure 1A). In the 
sample co-electroporated with pCas9-gRNABAP1-GFP, some organoids appeared 
with a very distinct morphology from control organoids (Figure 1A). We found a 
100% correspondence (5 single organoids sequenced for each of the two different 
morphologies) between this distinct phenotypic appearance and the presence of 
frameshift mutations in both alleles of BAP1 (Figure 1A). The consequent loss of BAP1 
protein was verified by western blot (Figure S1A). Wild-type (WT) liver ductal organoids 
were cystic, consisting of a thin layer of polarized epithelial cells surrounding a large 
central lumen (Figures 1B and 1D). By contrast, TP53−/− BAP1−/− organoids (that we will 
refer to as BAP1−/− for simplicity) appeared darker, with a thick wall that progressively 
invaginated into the lumen, until the organoids were entirely filled by convoluted 
cellular invaginations, and started to display several internal lumina and buds 
on the organoid surface (Figures 1B and 1C). In addition, KI67+ cell numbers were 
increased in BAP1−/− organoids as compared to WT organoids (Figure S1B). Importantly, 
this phenotype was never observed in single TP53−/−BAP1+/+ lines, which are 
morphologically indistinguishable from WT (Figure S1C). Of note, individually picked 
mutant organoids could be expanded, and sequencing of the targeted locus confirmed 
that these organoid lines were clonal. The phenotype was reproducibly observed in all 
BAP1−/− organoids lines derived from 3 different human donors (Figure 1D) and using 2 
different BAP1 gRNAs.
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FIGURE 1 | Engineered BAP1−/− Human Ductal Organoids Lead to a Severe Morphological Phenotype
(A) Strategy to obtain mutant clonal lines of liver organoids: (i) cystic organoids growing in a BMER 
drop are microinjected with a plasmid expressing Cas9, GFP and a specific targeting gRNA, and the 
entire BMER  drop is electroporated. 48 h later, organoids display wide areas containing GFP+ cells. 
(ii) GFP+ organoids are picked, dissociated into single cells, and re-seeded in a fresh BMER  drop. Co-
electroporation of BAP1 and TP53 gRNAs allows functional selection of targeted cells by Nutlin-3, 
given the high rate of co-electroporation and mutation. Organoids growing from single cells 
electroporated with gRNA for BAP1 displayed a different morphological phenotype. (iii) Sequencing 
of the targeted BAP1 exon confirmed a complete correlation between the phenotype and BAP1−/− 
genotype. gRNA targeting sequence is highlighted in light blue. Scale bars, 1,000 μm in (i); 2,000 μm 
in (ii); 500 μm in (iii).
(B) Images of H&E staining at low (left) and high (right) magnification of WT and BAP1−/−  mutants. 
Scale bars, 300 μm.
(C) Bright-field pictures of BAP1−/−  organoids evolution over time.
(D) Bright-field pictures of expanded individual clonal lines independently derived from 3 different 
human donors and comparison with a WT line. Scale bars in (C) and (D), 400 μm.
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BAP1 Mutation Results in Loss of Cell Polarity, Disruption of 
Epithelium Organization, and Increased Motility
Thanks to their 3D organization as a near-physiological epithelium, organoids offer 
the unique opportunity to explore modification of epithelium integrity, assembly, 
and cell-cell interaction. Prompted by the dramatic phenotype observed upon 
BAP1 deletion (Figure 1), we investigated in depth these structural changes. First, 
we performed transmission electron microscopy (TEM) imaging. WT organoids 
were organized as a simple (monolayered) epithelium (Figure 2A, left). Cells were 
polarized and possessed a basolateral and an apical domain, the latter characterized by 
microvilli (Figure 2A, left). Tight junctions are a crucial exponent of cell polarity (Shin 
et al., 2006). As magnified in the inset, they were located near the apical membrane 
(Figure 2A, left). The nucleus was regular and round, and a few vesicles were located 
in the cytoplasm. In BAP1 mutant organoids, cell organization and polarity were 
completely lost (Figure 2A, right). Cells presented with a very irregular shape, with long 
cytoplasmic protrusions extending between them. Although cells maintained points 
of contact, the intercellular space was considerably wider then in WT organoids. Some 
tight junctions were recognizable (see magnification in the inset), but their location 
was random, not necessarily defining apical domains. In addition, cells contained 
intracellular inclusions (arrowheads). These results were also confirmed with 
scanning electron microscopy (SEM) imaging. From the luminal side of WT organoids, 
a tightly organized cellular epithelium was visible, while a much looser organization 
was observed in BAP1−/− organoids. From the outside, we identified an extremely 
irregular surface upon BAP1 deletion (Figure 2B).
FIGURE 2 | BAP1 Mutation Results in Disruption of Epithelium Organization
(A) Representative TEM images of WT and BAP1−/− organoids. A tight junction is magnified in the 
inset. Black arrows indicate intracellular inclusions. Scale bar, 5 μm. N, nucleus.
(B) Representative SEM images of WT and BAP1−/− organoids from the luminal (left) and from the 
outer (right) side.
(C) Confocal immunofluorescent images of WT and BAP1−/− organoids stained for the different 
markers as indicated. For ZO-1 staining, pictures represent single focal planes on the x (left) and on 
the y (right) axis, to show the polarization of the ZO-1 expression. Arrowheads point at localization 
of ZO-1 that considerably differs upon BAP1 loss. Scale bars, 50 μm. For vinculin staining, pictures 
represent single focal planes (low and high magnification). Arrowheads point at mislocalization 
of vinculin upon BAP1 loss. Scale bars, 50 μm. For the plakoglobin staining, pictures represent a 
3D-reconstruction of the epithelium (low and high magnification). Scale bars, 50 and 20 μm. Pictures 
are representative of 3 different experiments reproduced using different lines.
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We performed 72 h time-lapse live imaging to visualize how these changes on cellular 
organization correlated with organoid growth and behavior. WT organoids were 
cystic and grew simply by radial expansion (Video S1). While doing so, they rotated 
and sometime showed minor contractions. BAP1−/− organoids invaded the BME 
with cellular protrusions often oriented toward neighboring organoids, mediating 
frequent fusion between mutant organoids. Video S2 and the actin staining in Figure 
S2A visualize cellular protrusions that bulge from the body of organoids toward 
neighboring organoids. In addition, cells were continuously shed and reabsorbed 
into the organoid. These features became more evident when we live-imaged BAP1−/− 
organoids directly after dissociation into small clumps, which highlighted the 
dramatically increased cellular mobility and the formation into larger 3D structures by 
active fusion (Figure S2B; Video S3).
We observed changes in the expression and distribution of junctional and membrane 
proteins by immunofluorescence. The abundant tight-junction protein ZO-1 localized 
apically in the well-polarized WT organoids (Figure 2C, left). In BAP1−/− organoids, its 
expression was strongly reduced (Figure 2C, right). In addition, while in WT organoids 
the apical domain faced the lumen, this appeared inverted in BAP1−/− (at least when 
some degree of expression and polarization was maintained) (Figure 2C). The focal 
adhesion protein vinculin (Ziegler et al., 2006) did not localize to the cell surface as 
in WT, but localized perinuclearly (Figure 2C). Staining for plakoglobin (PG), normally 
expressed in adherent junctions and desmosomes, revealed a highly disorganized 
epithelium as well as an inversion of cell polarity (Figures 2C and S2C). Altogether, 
these data showed massive architectural changes upon BAP1 mutation, with reduced 
cell-to-cell adhesion, increased motility, and impaired epithelial polarity.
Transcriptomic Profiling and Quantitative Mass Spectrometry Analysis 
Uncover Alterations in Junctional and Cytoskeleton Components
To identify global transcriptomic changes occurring upon BAP1 loss, we performed 
RNA sequencing of BAP1−/− and the matching parental organoid lines. As highlighted 
by the PCA plot (Figure 3A), hierarchical clustering, and correlation analysis (Figure 
S3A), the transcriptome of the BAP1 mutants derived from the 3 different donors were 
highly similar and diverged from the parental lines. Over a total of 16,112 detected 
genes, differential gene expression analysis identified a surprisingly small set of 135 
downregulated and 124 upregulated genes upon BAP1 KO (adjusted p value [padj] 
< 0.05) (Figure 3B; Table S1). Sequencing of TP53−/− only KO lines showed essentially 
no difference when compared to WT (only 6 genes were changed even using the 
less stringent significance criteria of padj < 0.1, and those were excluded from the 
following analyses) (Figure S1D). Transcriptomic changes, as for the morphological 
changes before, can be therefore attributed to the BAP1 mutation only.
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BAP1−/− displayed similar effects on gene expression as found in human hepatocellular 
carcinomas that carry BAP1 mutations (as given in (Woo et al., 2017)) (Figure S3B), 
implying that BAP1 mutation in WT liver organoids faithfully phenocopies some of 
the transcriptional changes observed in human liver carcinomas. (Woo et al., 2017) 
reported that BAP1 deficiency is often observed in poorly differentiated cancer and 
correlates with increased expression of markers of poor prognosis, such as CA9. Indeed, 
we found a downregulation of specific markers of differentiated ductal cells (such as 
KRT7, KRT13, and HNF1B) and of liver functions (such as A1AT, SERPINA5, GSTM genes, 
and FABP1) (Figure S3C). Instead, some progenitor markers (such as EPCAM, LGR4, 
and TBX3) and CA9 were upregulated in BAP1−/− together with some genes typically 
upregulated upon regeneration of the liver following partially hepatectomy, such as 
MT1 and MT2 (Su et al., 2002) (Figure S3C).
As previously mentioned, BAP1 is associated with removal of monoubiquitin from 
histone H2A (Scheuermann et al., 2010). In addition, it has been proposed to directly 
regulate protein degradation, as, for instance, of IP3R3 in cell lines (Bononi et al., 
2017) or HCF-1 and OGT in a mouse model for BAP1 loss (Dey et al., 2012). We therefore 
investigated the effect of BAP1 at proteome-wide level by performing quantitative 
mass spectrometry analysis of the BAP1−/− organoids and of the matching parental 
lines. In total, we were able to confidently quantify 6,652 proteins, of which 539 were 
differentially expressed upon BAP1 mutation (false discovery rate [FDR] < 0.05) (Figure 
3C; Table S1).
Among the upregulated proteins, we identified regulators of cell-cycle progression 
and proliferation (Figure S3D, top), in agreement with the increase in KI67+ cells in 
BAP1−/−. As also observed at transcriptomic level, we found a striking downregulation 
of proteins involved in liver-related function, such as fatty acid metabolism (e.g., 
FABP1, FABP1, APOE, UGT1A6, LIPC, and LIPA) and detoxification of xenobiotics (e.g., 
GSTM4, GSTM3, ADH1C, and ALDH1B) (Figure S3D, bottom).
Among the differentially expressed proteins, we noted a number of key cell junction 
components, factors promoting cell adhesion and migration, and cytoskeleton 
assembly-proteins (Figure 3C, right) including CLDN1, CLDN2, periplakin, GJA1, GJB1, 
AIM1, and tensins, which were all downregulated. Of note, dysregulation of epithelial 
junction components could possibly explain the architectural changes that we 
observed in BAP1−/− organoids.
In the attempt to discriminate between effects of BAP1 deletion on target protein 
levels versus transcriptional effects via chromatin modification, we integrated the 
transcriptomic and proteomic data. We compared absolute quantification of the 
corresponding mRNA and protein levels in our samples, assuming that their ratio 
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is a measurement of protein stability (Lindeboom et al., 2018). Approximately 80 
molecules showed a lower protein/mRNA ratio in BAP1−/− as compared to WT (Figure 
S3F; Table S1). Clearly, abundance of these proteins could either be affected by direct 
BAP1 regulation of their stability or could be influenced as a secondary effect exerted 
through a direct BAP1 target gene. However, despite the difference in total numbers 
of identified transcripts or proteins in the two datasets (Figure S3G), comparison of 
relative protein abundance and of the corresponding mRNAs expression showed a 
consistent correlation (Figures 3D and S3H). This indicated that proteomic changes are 
largely a consequence of transcriptomic rewiring and suggested that, in general, BAP1 
might act through regulating mRNA expression rather than by directly altering target 
protein levels.
FIGURE 3 | Transcriptomic Profiling and Quantitative Mass Spectrometry Analysis of BAP1−/− 
Mutants Discover Alterations in Junctional and Cytoskeleton Components
(A) PCA plot showing the clustering of BAP1−/− organoid lines (in red), which are distinct from the 
parental WT lines (in green).
(B) Volcano plot showing the differential gene expression of BAP1−/− versus WT organoids. Fold 
change of gene expression versus the statistical significance of this change for each gene detected 
in the dataset is depicted. Each dot represents a gene. Genes in blue have a significant differential 
expression (padj value < 0.05) and the purple are the ones showing a trend of differential expression 
(padj value < 0.1).
(C) Volcano plot showing the differentially protein abundance of BAP1−/− versus WT organoids (left). 
Proteins in red have a significant differential abundance (FDR < 0.05) and the green are the ones 
showing a trend of differential abundance (FDR < 0.1). Significance was calculated using an adapted 
t test that is corrected for multiple testing by permutation-based estimation of the false discovery 
rate. On the right, the same volcano plot highlights fold change and significance values for specific 
proteins related to cell adhesion, migration, and cytoskeleton organization.
(D) Scatterplot showing correlation of transcriptome-proteome. The fold change of expression for 
each gene (RNA) is plotted against the fold change of abundance of the respective protein in BAP1−/− 
versus WT (for all the genes and proteins with a log2 fold change >1.5 or <1.5). Each dot represents a 
gene or protein.
(E) Scatterplot showing the significance of differential gene expression versus differential protein 
abundance. Molecules that are significant at both RNA and protein level (red), at RNA level but with 
a trend at protein level (purple), and at protein level but with a trend at RNA level (yellow) were 
selected. **p < 0.05, *p < 0.1.
(F) Heatmap showing the correlation between gene expression and protein abundance fold change 
upon BAP1 mutation for the gene and protein pairs selected in (E). Note that only 2 RNAs and/or 
proteins did not show a positive correlation.
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In order to specifically identify genes that are differentially expressed both at mRNA 
and protein level, we plotted the significance of differential protein versus mRNA 
expression (Figure 3E). We therefore considered genes that were either highly 
significantly changed both at RNA and protein levels (RNA padj < 0.05, protein FDR 
< 0.05), highly significantly changed at protein and changed at RNA (RNA padj > 0.05 
and < 0.1, protein FDR < 0.05), or highly significantly changed at RNA and changed 
at protein level (RNA padj < 0.05, protein FDR > 0.05 and < 0.1) (Figure 3D). This 
generated a list of ~100 genes. Importantly, although we considered significance 
only, independent of up- or downregulation, we found a nearly 100% proteome-
transcriptome correlation in this dataset (Figure 3F). Interestingly, as also confirmed 
by Gene Ontology (GO) term analysis (Figure S3E; Table S2), within this restricted list 
we again identified multiple genes involved in epithelial cell adhesion, cytoskeleton 
organization, and cell migration (Figure 3F and Table S1 for a full list), altogether 
suggesting a causal link with the major morphological alterations that we observed in 
BAP1−/− organoids.
BAP1 Restoration Rescues the Architectural Phenotype Induced by Its 
Loss and Requires Catalytic Activity and Nuclear Localization
To assess whether the phenotype induced by BAP1 loss was reversible and to document 
early or direct versus late or indirect effects of such restoration, we inducibly restored 
BAP1 expression. For this purpose, we generated a lentiviral construct allowing the 
expression of BAP1 in an inducible manner (Figures 4A and S4A). Co-induced GFP 
allowed monitoring of gene induction (Figure 4A).
FIGURE 4 | The Effect of BAP1 Mutation Can be Rescued by Inducible BAP1 Re-expression
(A) and (B). Schematic representation of the constructs (A) and of the experimental design (B) to 
rescue BAP1 expression in mutant organoids.
(C) From left to right, bright-field and immunofluorescent pictures of a representative rescue 
organoid line without dox administration, 12 h, 24 h, 48 h, 72 h, and 1 week after dox administration. 
Similar results were obtained when BAP1 expression was induced with (top) or without (bottom) 
concomitant expression of GFP. Experiments were reproduced in 3 lines derived from 3 different 
donors with the same outcome. Scale bars, 1,000 μm.
(D) Scatterplot showing the positive correlation of fold change in gene expression when comparing 
rescue (24 h after dox administration) or WT to BAP1−/− mutants. Each dot represents a gene. Only the 
genes that were differentially expressed upon BAP1 loss are represented (padj < 0.01).
(E) Clustering of genes based on their expression pattern in WT, BAP1−/−, and rescue (24 h). Each line 
represents average expression of differentially expressed genes between WT and BAP1−/− (padj < 
0.05) and BAP1−/− and rescue (p < 0.05).
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After infecting BAP1−/− organoids with the lentiviruses, puromycin selection was applied 
(Figure 4B). We did not observe any morphological changes or GFP fluorescence in 
non-induced organoids, indicative of tight regulation of expression (Figure 4C). Upon 
dox-induction, we observed GFP expression and noticed a rapid change in organoid 
morphology, which resembled WT epithelium architecture over time. Thus, BAP1 
acute re-expression alone was sufficient to re-establish normal morphology in BAP1 
KO lines, showing that the tissue organization phenotype was a direct consequence of 
BAP1 loss. Transcriptomic analysis at the early 24 h time point highlighted a general RNA 
expression rescue (Figure 4D). In fact, more than 70% of the significant differentially 
expressed genes identified in our previous transcriptomic analysis (see Figure 3) 
showed a positive correlation when comparing BAP1−/− either to WT or to the 24 h rescue 
organoids (Figure 4D; Table S1). These results confirmed that the transcriptomic changes 
observed in BAP1 KO are specifically driven by BAP1 loss-of-function. In addition, 
given that the acute restoration of BAP1 could rapidly counteract many of the effects of 
sustained BAP1 loss on the transcriptome, our data suggested that most of the affected 
genes could be direct BAP1 targets. Using TMixClust analysis, we clustered these genes 
based on their expression in WT, BAP1−/−, and after BAP1 rescue. This analysis tentatively 
identified 2 different patterns (Figure 4E). Expression of genes downregulated in BAP1−/− 
increased upon BAP1 rescue (including, for instance, the tensins) and, vice versa, genes 
decreasing after BAP1 rescue were upregulated in BAP1 KO (including for instance CA9, 
MT1, and MT2 and the liver-regenerating factor ATF3) (Figure 4E).
A recent study has postulated that, in addition to its roles in the nucleus, BAP1 also 
exerts regulatory functions in the cytoplasm (Bononi et al., 2017). We therefore 
investigated the importance of BAP1 catalytic activity and cellular localization in 
respect to the phenotype we observed. An inducible lentiviral construct similar to the 
one described in Figure 4A, yet expressing a BAP1 mutant carrying an inactivating point 
mutation in its catalytic site (C91A) (Ventii et al., 2008), was generated. We then derived 
organoid lines as described in Figure 4B and induced expression of the catalytically 
dead BAP1. No phenotypic changes occurred upon BAP1 C91A expression: the organoids 
maintained a morphology indistinguishable from BAP1−/− (Figure 5A, top).
 
FIGURE 5 |  BAP1 Catalytic Activity and Nuclear Localization Are Required to Rescue the 
Phenotype Driven by Its Loss
(A) Schematic representation of the constructs used to achieve inducible expression of the catalytically 
dead BAP1 (BAP1 C91A), cytoplasmic BAP1 (BAP1cyt), and nuclear BAP1 (BAP1nuc) (from top to bottom) and 
bright-field and immunofluorescent pictures of the generated corresponding lines without dox, 12 h, 24 
h, 72 h, and 1 week after dox administration (from left to right). Note that only the catalytically active 
nuclear BAP1 is able to rescue the epithelium phenotype (compare with Figure 4). For each construct, 
experiments were reproduced in 3 lines derived from 3 different donors with the same outcome.
(B) Snapshots at different acquisition time points (as indicated) from a live imaging experiment of 
BAP1cyt and a BAP1nuc rescue (see Videos S4 and S5) showing the progressive acquisition of a normal 
epithelium organization with the concomitant expression of GFP (and BAP1) only in BAP1nuc. Dashed 
yellow lines highlight the presence of cellular protrusions. Scale bars, 1,000 μm.
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Similarly, we built inducible lentiviral constructs expressing BAP1 specifically in the 
cytoplasm or in the nucleus. To this end, we either removed the C-terminal localization 
signal (NLS) or added an additional strong C-terminal NLS. Correct localization of 
cytoplasmic (BAP1cyt) and nuclear BAP1 (BAP1nuc) was confirmed in HeLa cells (Figure 
S4A) and in the generated organoid lines (Figure S4B). Only upon restoring BAP1 
expression in the nucleus, we did observe reversion of organoid morphology (Figure 
5A, middle and bottom). 72 h time-lapse imaging of BAP1cyt and BAP1nuc lines upon 
doxycycline administration illustrated that, concomitant with GFP expression, 
BAP1nuc acquired a cystic morphology while the cellular protrusions disappeared 
(Figure 5B; Video S4). Instead, organoid behavior in BAP1cyt did not change upon 
induction (Figure 5B; Video S5). Our previous analyses of transcriptome-proteome 
correlation and RNA-sequencing upon BAP1 rescue already suggested that the effect 
of BAP1 mutation was mainly due to regulation of mRNA expression. Taken together, 
we concluded that the epithelial phenotype upon BAP1 loss was solely due to catalytic 
activity of BAP1 in the nucleus.
BAP1 Regulates Gene Expression by Affecting Chromatin Accessibility 
and Acts as a Repressor or Activator Depending on the Epigenetic 
Landscape
As already anticipated, BAP1 is a mono-deubiquitinase, shown to remove mono-
ubiquitination at Lys119 of histone H2A (Scheuermann et al., 2010). We tested if BAP1 
depletion had an effect on H2AK119Ub by western blotting and by fluorescence-
activated cell sorting (FACS) staining. Indeed, H2AK119Ub levels were increased 
in BAP1−/− organoids (Figure S5A). Because H2AK119Ub modification is believed to 
be critical for regulation of gene expression (Wang et al., 2004), we investigated 
the consequences of BAP1 loss on chromatin accessibility by applying assay for 
transposase accessible chromatin with high-throughput sequencing (ATAC-seq) 
(Buenrostro et al., 2013). As expected, ATAC-peaks were preferentially observed in 
the proximity of transcriptional start sites (TSSs) (Figure 6A). We then compared 
chromatin accessibility in BAP1−/− organoid lines versus the matching parental lines 
(Table S1). Hierarchical clustering and correlation analysis showed a high similarity 
between the BAP1−/− samples, which clustered away from the WT organoids (Figure 
S5B). We focused on the significant, genome-wide ATAC changes and found regions 
of higher (red) and reduced (blue) accessibility upon BAP1 KO (Figure 6B, outer circle). 
When we plotted the distance of each ATAC-peak to its closest neighbor, we noticed 
that the more accessible regions in BAP1−/− organoids clustered in specific “hot-spots” 
along the genome (Figure 6B, inner circle). Between the biological replicates, we 
identified a total of 732 differentially enriched ATAC-peaks (FDR < 0.001), of which 
621 represented significantly more accessible sites in BAP1−/−, while 111 represented 
less accessible sites (Figure 6C). We assigned each peak to the closest gene based on 
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annotated TSSs (it should be noted that more than 1 peak can therefore be assigned to 
the same gene).
To investigate whether the molecular changes observed in BAP1−/− can be linked to a 
direct effect of BAP1 on chromatin accessibility, we performed comparison analyses of 
transcriptomic and ATAC-peaks and found a good correspondence (Figure S5C). When 
we specifically focused on the significantly changed genes, we observed a global, 
positive correlation with ATAC-changes, as highlighted in the heatmap in Figure 
6D. Examples of two genomic regions near two genes with significantly changed 
transcription levels (CLDN1, downregulated in BAP1−/− and GATA5, upregulated in 
BAP1−/−) showed differences in DNA accessibility that reflected the effect on gene 
expression (Figure 6E). Altogether, these data confirmed our previous indications that 
the main effects observed in BAP1−/− were mediated through a direct effect on gene 
expression.
Next, we evaluated whether the changes in chromatin accessibility could be rescued by 
restoring BAP1 expression. We used the previously described organoid lines in which 
BAP1 expression can be acutely induced by doxycycline administration and prepared 
ATAC-seq libraries after 24 h of induced BAP1 expression (rescue). BAP1 re-expression 
in BAP1−/− mutants restored H2AK119Ub to level similar to WT, as assessed by western 
blot (Figure S5A, top).
Comparison between rescue or WT versus BAP1−/− showed a positive correlation of 
ATAC-peak changes (Figure 6F). We found higher similarity of rescue-organoids 
with WT than with BAP1−/− when comparing ATAC-peaks with significantly changed 
accessibility (Figure S5D).
Our ATAC profiling of BAP−/− mutants uncovered increased chromatin opening upon 
BAP1 loss. This result was somehow unexpected, because it is generally believed 
that H2AK119Ub (that we showed as increased upon BAP1 loss) is associated with 
H3K27me3 (Balasubramani et al., 2015; Blackledge et al., 2014; Kalb et al., 2014), a 
repressive histone mark (Gao et al., 2012; Simon and Kingston, 2013). By manually 
inspecting the ATAC-peaks, we noticed a certain correspondence between ATAC-
signal and specific histone marks. Therefore, by focusing specifically on genomic 
regions with significantly changed accessibility (Figures 6G, FDR < 0.001, and S5E, FDR 
< 0.01), we systematically compared ATAC-peaks to the location of different histone 
modifications, defined by publicly available chromatin immunoprecipitation (ChIP) 
data generated from human adult primary liver tissue (Figure 6G) or HepG2 hepatoma 
cells (Figure S5E). Interestingly, opening of chromatin in BAP1−/− organoids occurred in 
regions that are characterized by repressive histone marks (i.e., H3K27me3, H3K9me3, 
and H4K20me1) (Figures 6G and S5G), while decreases of accessibility correlated 
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with histone marks associated with open chromatin (i.e., H3K27ac, H3K4me1, and 
H3K4me3). The ChIP data from publicly available datasets from primary liver are 
mostly representative of histone modification profiles of hepatocytes, the most 
abundant liver cell type. We therefore performed ChIPmentation to identify epigenetic 
marks present in our WT ductal organoids. Comparison of these data with the ATAC-
seq accessibility highlighted that hyperaccessible sites upon BAP1 mutation are 
associated with repressive histone marks (H3K27me3, H3K9me3) and, vice versa, less 
accessible loci with active marks (H3K4me3) (Figures 6G and S5E). Altogether, these 
findings implied that BAP1 regulates gene expression in a context-dependent manner 
and exhibits different effects depending on the epigenetic marks landscape.
FIGURE 6 |  BAP1 Is Necessary to Control Chromatin Accessibility and Impairment of This 
Function Is Linked to Altered Expression of Adhesion and Polarization-Related Genes
(A) Density plot and histogram showing the position of ATAC-peaks relative to transcriptional start 
site (considering peaks both from BAP1−/− and WT samples).
(B) Manhattan plot showing genome wide chromatin accessibility changes upon BAP1 loss. The 
outer circle represents the fold change of significantly different ATAC-peaks in BAP1−/− versus WT (in 
red peaks with higher accessibility and in blue peaks with lower accessibility). The inner circle plots 
the distance for each site to its closest neighbor. Dots approaching the middle of the plot indicate 
“hotspots” of changed DNA accessibility sites.
(C) Heatmap showing the relative changes in ATAC-peak accessibility upon BAP1 loss. Each row is an 
ATAC-peak and significantly changed peaks are plotted (FDR < 0.001).
(D) Heatmaps comparing changes in RNA expression (left) and ATAC-seq changes for the 
corresponding genomic region (right). Only differentially expressed genes are plotted (as in Figure 
3B) and ATAC-seq differences are provided as mean of fold changes of BAP1−/− versus WT for 3 lines 
derived from different donors.
(E) Genomic regions near two differentially expressed genes identified in RNA sequencing analysis. 
The plots show the ATAC-seq signal around these regions in WT (blue) and BAP1−/− (green) organoid 
lines. These are representative examples and similar results have been obtained by comparing 3 
lines derived from different donors.
(F) Scatterplot displaying the positive correlation of fold change in ATAC-peaks signal when 
comparing BAP1−/− versus WT or versus rescue line (24 h). Each dot represents an ATAC-peak. Results 
represent the average fold change from 3 lines derived from different donors for each genotype.
(G) Heatmaps showing significant ATAC-peak signals in BAP1−/− and WT organoid lines (FDR < 0.001) 
(top) and ChIP tracks (relative to the input track) for the corresponding regions (middle and bottom). 
ChIP tracks were obtained for several histone modifications, as indicated, from human primary liver 
tissue from publicly available dataset (middle) and from ChIPmentation of WT human ductal liver 
organoids (bottom).
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BAP1 Function Is Essential to Control Epithelium Organization in a 
Model of Carcinoma Progression In Vivo
We and others have previously shown that consecutive CRISPR/Cas9-induced 
mutations of colorectal cancer genes in human small intestine and colon organoids 
can model human carcinoma progression (Drost et al., 2015; Matano et al., 2015). We 
decided to use a similar strategy to confirm our observations on BAP1 in a human 
cancer model. In order to model CC, we used CRISPR/Cas9 to introduce mutations in 
some additional genes commonly altered in this type of cancer (Nakamura et al., 2015), 
because the presence of BAP1 and TP53 mutations alone in ductal organoids did not 
allow for the organoid growth in vivo upon transplantation (not shown). The genomic 
landscape of liver tumors is extremely heterogeneous. It is therefore not possible 
to identify a combination of mutations that is “typical” for this type of cancer. The 
reported incidence of BAP1 mutation itself is extremely variable, ranging from 1% to 
25% in different studies (Jiao et al., 2013; Wardell et al., 2018). We analyzed publicly 
available sequencing data from human CCs and found that mutations in nearly 400 
different genes co-occurred with BAP1 (Figure S6A), of which the vast majority with 
a low incidence. However, co-mutated genes often belong to certain pathways or 
molecular modules, including the kinase-Ras module, TP53 module, and transforming 
growth factor β (TGF-β) module, in addition to mutations in chromatin remodelers, 
whose function(s) in the context of liver cancer are still only partially characterized. 
Within these, TP53, SMAD4, NF1, and PTEN were among the top BAP1-co-mutated 
tumor suppressor genes (Figure S6B). Moreover, mutations in all these genes were 
never mutually exclusive and all co-existed at least pairwise in human CCs (Figure 
S6C). BAP1 mutant CC cases in which 2, 3, and in one case, even all 4 of these mutations 
co-occur have been reported (cBioportal) (Jiao et al., 2013; Jusakul et al., 2017) (Figure 
7A). We therefore engineered human ductal organoid lines to carry mutations in 
TP53, SMAD4, NF1, and PTEN. Karyotyping of the mutant lines showed an increase of 
aneuploidy in both presence and absence of BAP1 mutation, in contrast to the WT and 
most likely due to loss of TP53 (Figure S7A). In vitro morphological analysis of these 
lines showed that while the quadruple TP53/SMAD4/NF1/PTEN mutants grow as cysts 
and are morphologically indistinguishable from WT organoids (Figures 7B and 1 for 
comparison), additional mutation of BAP1 caused dramatic epithelial disorganization 
and polarity loss (Figure 7B), as previously observed in TP53−/− BAP1−/− mutants.
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In order to assess their tumorigenic capacity in vivo, we subcutaneously transplanted 
the mutant lines into immunocompromised mice and analyzed tumors 10 weeks 
after injection. Histological analysis showed that both types of engineered organoids 
were able to engraft and grow nodules of comparable size in vivo (Figure 7C), with 
comparable level of proliferating Ki67+ cells (Figure S7B). Staining for human-specific 
cytokeratin (hKRT) confirmed the human organoid-origin of the nodules (Figure 
7C). TP53/SMAD4/NF1/PTEN/BAP1WT consisted of cysts growing as an organized 
epithelium that rarely showed cellular stratification, yet overall presented an 
adenoma morphology (Figure 7C, top) and was classified by the pathologist as a biliary 
cyst adenoma, a benign pre-neoplastic lesion. Phalloidin staining showed regular 
cell shape and expression of the apical marker EZRIN restrained to the luminal side 
indicated that proper cell polarity was maintained (Figure 7C, top right). TP53/SMAD4/
NF1/PTEN/BAP1−/− xenografts instead resembled the phenotype observed in the 
organoids and displayed carcinoma features such as loss of proper cell polarity and 
epithelial organization (Figure 7C, bottom), pleiomorphic nuclei, and the presence of 
unpolarized signet ring cells (Figure 7C, bottom left, signet ring cells magnified in the 
inset), regularly found in human cancers including CC (Nakanuma et al., 2010). TP53/
SMAD4/NF1/PTEN/BAP1WT human cells were surrounded and directly in contact with 
abundant, dense mouse stroma, rich in collagen fibers, as stained by Sirius Red and 
Masson trichrome staining (Figure S7C, top). Fibrotic changes in the liver stimulates 
transformation and progression of CC, and collagen deposition is often seen in CC 
(Farazi et al., 2006; Uddin et al., 2015). Some cells produce and secrete Alcian-blue 
positive mucin into the ductal lumen (Figure S7C, top). Abundant collagen deposition 
was also evident in TP53/SMAD4/NF1/PTEN/BAP1−/− tumors (Figure S7B, bottom). 
However, TP53/SMAD4/NF1/PTEN/BAP1−/− grafts were characterized by high secretion 
of Alcian blue-positive extracellular mucin in the surrounding tissue. This resulted 
in stromal tissue displacement and mucinous dissection, and formation of cysts 
containing mucin and clusters of neoplastic transplanted cells within the stroma, 
consistent with invasiveness, again recapitulating human CC (Bosman et al., 2010; 
Nakanuma et al., 2010) (Figures 7C and S7C, bottom).
We decided to evaluate whether the critical progression toward a malignant phenotype 
driven by the presence of BAP1 mutation upon subcutaneous transplantations was 
also seen upon growth in the natural CC environment, the liver. Thus, we performed 
orthotopic transplantation of the TP53/SMAD4/NF1/PTEN/BAP1−/− and TP53/SMAD4/
NF1/PTEN/BAP1WT clones in the liver and sacrificed the animals 10 weeks later. 
Both lines could engraft into small nodules in the liver parenchyma. Similar to the 
subcutaneous grafts, TP53/SMAD4/NF1/PTEN/BAP1−/− tumors displayed malignant 
features such as presence of polymorphic nuclei, irregular cell shape, signet sing 
cells, impairment of cell polarity, and abundant mucin secretion and deposition of 
collagen fibers in the stroma surrounding the grafts (Figures 7D, bottom, and S7D, 
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bottom), in striking contrast to the regular epithelium observed in the TP53/SMAD4/
NF1/PTEN/BAP1WT liver nodules (Figures 7D, bottom and S7D, bottom). In both cases, 
we did not observe metastatic growth. Altogether, these results validated BAP1’s tumor 
suppressor function in vivo both in a subcutaneous transplantation model as well as in 
the natural cholangiocarcinoma environment.
FIGURE 7 |  BAP1 Loss of Function in Human Liver Is Necessary to Develop Tumorigenic 
Features In Vivo
(A) Matrix showing genomics alterations in BAP1, TP53, NF1, SAMD4, and PTEN (rows) in BAP1-
mutated CCs (columns).
(B) Bright-field image (left) and H&E staining (right) showing the distinct morphology of TP53/SMAD4/
NF1/PTEN/BAP1WT (top) or TP53/SMAD4/NF1/PTEN/BAP1−/− (bottom) engineered organoids. Scale 
bars, 2,000 μm and 400 μm.
(C) Representative pictures of H&E staining (left) and human Cam5.2 (hKRT) (middle) staining of 
subcutaneous nodules isolated from TP53/SMAD4/NF1/PTEN/BAP1WT (top) or TP53/SMAD4/NF1/
PTEN/BAP1−/− (bottom) xenotransplanted mice at low and high magnification. The inset in the high 
magnification panel highlights the regular epithelium organization in TP53/SMAD4/NF1/PTEN/
BAP1WT (top) versus the presence of irregular cells with pleomorphic nuclei and signet ring cells 
in TP53/SMAD4/NF1/PTEN/BAP1−/− transplantation (bottom). On the right, staining with phalloidin 
and the apical protein EZRIN (EZR) showed irregular cell shape and loss of proper polarity in TP53/
SMAD4/NF1/PTEN/BAP1−/−  grafts as compared to TP53/SMAD4/NF1/PTEN/BAP1WT. Scale bars, 100 
μm (IHC) and 25 μm (IF).
(D) As in (C), representative pictures of H&E (left) and human hKRT (middle) staining of liver nodules 
growing in the mouse upon orthotopic liver transplantation of TP53/SMAD4/NF1/PTEN/BAP1WT 
(top) or TP53/SMAD4/NF1/PTEN/BAP1−/− (bottom) organoids at low and high magnification. Right: 
staining with phalloidin and the apical protein EZR.
Scale bars, 50 μm (IHC) and 25 μm (IF). The experiments in (C) and (D) were performed in triplicate 
for both organoid lines.
549219-L-bw-Voorthuijsen










BAP1 IN CRISPR-ENGINEERD HUMAN LIVER ORGANOIDS
151
549219-L-bw-Voorthuijsen




In this study, we have applied human-derived organoid culture to understand the 
functions of BAP1, a gene frequently mutated in CC (Jiao et al., 2013; Mosbeh et al., 2018). 
The use of human liver organoids revealed a major effect of BAP1 mutation on ductal 
epithelium organization, cell adhesion, polarity, and motility of organoids in vitro. 
Maintenance of cell polarity and cell-to-cell adhesion are tightly related processes, 
while loss of cell polarity and tissue disorganization are hallmarks of cancers (Royer 
and Lu, 2011). In fact, in a genetic background of common CC mutations, such as TP53, 
SMAD4, NF1, and PTEN, the concomitant loss of BAP1 is required to drive epithelial 
transformation.
Our comparison of transcriptomic and proteomic data highlighted an altered 
expression upon BAP1 mutation for many key components of junction complexes, 
including periplakin, claudins, and tensins. We found a direct correlation of their 
expression with BAP1-mediated regulation of chromatin accessibility, providing a 
possible mechanistic link between BAP1 function and malignant transformation. A 
recent study suggested that reduced BAP1 levels lead to degradation of IP3R3 (Bononi 
et al., 2017), with a concomitant decrease of apoptosis. In our proteomic analysis, 
however, we did not detect a reduction in the cytoplasmic protein IP3R3, and although 
we cannot exclude that BAP1 might exert some function in the cytoplasm, our follow-up 
studies implied that the massive effects on epithelium organization are driven by BAP1 
acting in the nucleus. First, comparison of transcriptome-with proteome profiling 
showed that stability of only a small percentage of proteins is primarily affected, while 
most of the observed proteomic changes are in agreement with alterations in gene 
expression. Second, the rapid response (24 h) upon BAP1 re-expression suggests that 
many of the genes with altered expression are directly regulated by BAP1. Third, the 
phenotype induced by BAP1 can only be rescued when a catalytically active BAP1 is re-
expressed in the nucleus. Finally, profiling and comparison of chromatin accessibility 
in WT organoids, BAP1 mutants, and in BAP1 mutants 24 h after BAP1 re-expression 
showed that BAP1 directly affects expression of specific genes, in agreement with the 
transcriptomic data. We therefore hypothesize that BAP1 regulates a set of genes that 
are essential for epithelium organization, whose dysregulation might be important to 
develop malignant features in the context of CC development.
BAP1 is associated with deubiquitination of histone H2A at Polycomb repressive 
elements (Scheuermann et al., 2010). Later studies in mammalian cells have shown 
that H2AK119Ub and H3K27me3 synergistically maintain gene repression (Margueron 
and Reinberg, 2011), and the presence of H2AK119Ub is important for recruiting 
the protein complex responsible for the repressive epigenetic mark H3K27me3 
(Blackledge et al., 2014; Gao et al., 2012; Kalb et al., 2014). When we assessed chromatin 
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dynamics by ATAC-seq in BAP1−/− human liver organoids, we observed both increases 
and decreases of chromatin accessibility at different genomic loci. Our data suggest 
that BAP1-mediated regulation of DNA accessibility is dependent on the epigenetic 
landscape. Based on these observations, we hypothesize that BAP1 function might vary 
based on cell type as a function of their epigenetic state. This could have important 
implications for the development of tissue-tailored cancer therapies targeting 
epigenetic regulators (e.g., EZH2). For instance, (LaFave et al., 2015) showed that in 
mouse myeloid progenitors and mesothelioma cell lines, BAP1 mutation regulates 
overexpression of EZH2 and sensitivity to EZH2 inhibition. Instead, BAP1 status did 
not influence either EZH2 expression or sensitivity to its inhibition in uveal melanoma 
(Schoumacher et al., 2016), a lesion where BAP1 is often mutated (Harbour et al., 2010). 
This highlights how studying the effect of BAP1 mutation on gene regulation in the 
relevant cell type is essential to uncover its specific regulatory functions. For instance, 
while studies in a BAP1-deficient mouse model postulated that BAP1 acts by stabilizing 
the transcriptional regulators OGT and HCFC-1 (Dey et al., 2012), thus affecting gene 
expression, we did not detect an altered level of these proteins in our quantitative 
proteomic experiments. From this perspective, human organoids may currently 
constitute the experimental model that recapitulates most closely the oncogenic 
process in specific human tissues.
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Contact for Reagent and Resource Sharing
Further information and requests for resources and reagents should be directed to and 
will be fulfilled by the Lead Contact, Hans Clevers (h.clevers@hubrecht.eu)
Experimental Model and Subject Details
Human material for organoid culture
Human liver tissue was obtained from transplanted healthy livers from donors of 
any gender undergoing surgery at Erasmus Medical Centre, Rotterdam. The Medical 
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Ethical Council of the Erasmus Medical Center approved the use of this material for 
research purposes, and informed consent was provided
Mice
Experiments on NSG mice were carried out at the Hubrecht Institute according to 
local and international regulations and ethical guidelines, and were approved by the 
Central Authority for Scientific Procedures on Animals (CCD) and the local animal 
experimental committee at the Hubrecht Institute (IvD-HI-KNAW HI16.1012). Females 
of NOD Scid Gamma (NSG) mice of an age of 12-15 weeks were used.
Method Details
Tissue processing, cell isolation and organoid culture
Liver cells were dissociated from the human biopsy by collagenase digestion, as 
described in (Huch et al., 2015). Cells were washed with cold Advanced DMEM/
F12, filtered with a 70 μm filter and the cell pellet resuspendend in BMER (Amsbio). 
Isolation medium was based on AdDMEM/F12 (Invitrogen) supplemented with: 1X B27 
(both from GIBCO), 1.25 mM N-Acetylcysteine (Sigma), 10 nM gastrin (Sigma), 50 ng/
ml EGF (Peprotech), 10% RSPO1 conditioned media (homemade), 100 ng/ml FGF10 
(Peprotech), 25 ng/ml HGF (Peprotech), 10 mM Nicotinamide (Sigma), 5 μM A83.01 
(Tocris), 10 μM FSK (Tocris), 25 ng/ml Noggin (Peprotech), 30% Wnt conditioned media 
(homemade), and 10 uM Y27632 (Sigma Aldrich). After 3-4 days, the isolation medium 
was changed into a medium without Noggin, Wnt conditioned media, Y27632. 
Organoids could be splitted after ca. 14 days by mechanical shearing and re-plated into 
fresh BMER. Passage was performed in a 1:5 split ratio once every 7–10 days for at least 
6 months.
Generation of Cas9-gRNA plasmid, organoid electroporation and generation of KO 
lines
Sequences of BAP1 gRNA targeting the exon 4 of human BAP1 were designed 
using the online tool http://zlab.bio/guide-design-resources (BAP1#1 5′- 
AGGAAGATAAATCCATATAC-3′ and BAP1#3 5′-GCTCTTCGATCCATTTGAAC-3′). BAP1-
targeting gRNAs were cloned into the pSpCas9(BB)-2A-GFP vector (Addgene plasmid 
#48138), as described in (Ran et al., 2013). For the targeting of TP53 and SMAD4 we 
used the pSpCas9(BB)-TP53-2A-GFP and pSpCas9(BB)-SMAD4-2A-GFP generated 
by (Drost et al., 2015) and for NF1 and PTEN we used 2 different gRNAs cloned in 
pSpCas9(BB)-2A-GFP vector (NF1#1 5′-GTCGTGAAGGAAACCAGCAT-3′; NF1#2 5′- 
GAGATTAGATGAAACGATGC-3′; PTEN#1 5′-GGTTTGATAAGTTCTAGCTG-3′ and PTEN#2 
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5′-GGTGGGTTATGGTCTTCAAA-3′). Plasmid DNA was prepared using the EndoFree 
Plasmid Maxi Kit (Quiagen) and diluted in PBS 1X at a concentration of 2-5 μg/μl. DNA 
was mixed with 0.05% FastGreen dye to be able to visualize the injected DNA in the 
organoid lumen. pCas9-gRNABAP1-GFP and pCas9-gRNATP53-GFP plasmids were co-
injected. To generate the TP53/SMAD4/NF1/PTEN and TP53/SMAD4/NF1/PTEN/BAP1 
mutants the 4 or 5 specific gRNA plasmids were co-injected. Plasmids-dye mixture 
was loaded in a pre-pulled borosilicate glass capillary. Organoids were individually 
injected while embedded into the BMER drop, until their lumen was not filled with 
DNA mixture (ca. 1 μl/organoid). Tweezer-electrods (CUY650P1, Nepagene) were 
used to electroporate the BMER drop containing the injected organoid, using the 
following parameters on the NEPAGENE electroporator: Poring Pulse (Voltage = 50 V, 
Pulse Length = 10 msec, Pulse Interval = 50 msec, Number of Pulse = 4), Transfer Pulse 
(Voltage = 20 V, Pulse Length = 50 msec, Pulse Interval = 50 msec, Number of Pulse 
= 5). 48 hr later, organoids were checked for GFP fluorescence and positive organoids 
were picked using a P20 pipet, dissociated into single cells by accutase digestion, 
washed twice with cold Advanced DMEM/F12 and replated in a BMER drop. To select 
for mutated cells, we supplement the culture medium with Nutlin-3 10 mM (Cayman 
Chemicals), which only allowed TP53 mutant cells to grow. Given the high efficiency 
of co-transfection, TP53 mutant organoids in the vast majority of the cases carried 
mutation in the other targeted genes as well. Organoid lines were derived by picking 
single organoids, and expand them in culture. sgRNA transfections and subsequent 
selections were performed at least in 3 different donors and using 2 different sgRNA. 
We derived at least 2 KO lines for each liver donor. TP53/SMAD4/NF1/PTEN and TP53/
SMAD4/NF1/PTEN/BAP1 KO lines were derived from 1 donor each. Mutant lines were 
splitted at a ratio of 1:3 every 7 days and we cultured them for at least 12 months.
Organoid genotyping
For genotyping of the mutant lines, organoids were lysated using the lysis buffer (0.1 
M Tris-HCl pH 8.5, 0.2 M NaCl, 0.2% SDS, 0.05 M EDTA, 0.4 mg/ml ProteinaseK) and 
DNA isolated by ethanol precipitation. The primers listed in the Key Resources Table 
were used for PCR amplification of the targeted region. PCR products were cloned in 
pGEM-T Vector (Promega). DNA was extracted and sequenced from at least 10 different 
bacteria colonies for gene, to ensure the sequencing of both gene alleles.
Immunohistochemistry, immunofluorescence staining and confocal imaging
For immunohistochemistry, organoids were washed from the BMER using Cell recovery 
solution (Corning), fixed overnight in 4% PFA and embedded in paraffin blocks. 5 μm-
tick sections were processed for H&E staining and immunohistochemistry using 
Ki67 antibody (Abcam). For whole mount immunofluorescence staining, organoids 
549219-L-bw-Voorthuijsen










BAP1 IN CRISPR-ENGINEERD HUMAN LIVER ORGANOIDS
167
were isolated from the BMER using Cell recovery solution (Corning), fixed overnight 
in 4% PFA, permeabilized and blocked by incubation in Triton X-100 0.2% and 5% 
normal donkey serum (Jackson Laboratories) in PBS for 1h at RT. Primary antibodies 
were incubated at 4°C overnight. After washing with PBS 1X, conjugated secondary 
antibodies were added for 1h at RT. DAPI was used to counterstain nuclei. Phalloidin 
(Sigma) was used for Actin staining. Organoids were mounted and imaged on a Sp8 
confocal microscope (Leica). Images were processed using Photoshop CS4 or ImageJ 
software. Imaris software was used for images 3D-reconstruction.
Scanning and transmission electron microscopy
For SEM and TEM, organoids were processed as described in (Heo et al., 2018). Briefly, 
they were collected and incubated in Cell Recovery Solution (Corning) on ice for 20–30 
min to remove the BMER and fixed with 1% (v/v) glutaraldehyde (Sigma) in PBS at 4°C 
overnight and transferred onto 12 mm poly-L-lysine-coated coverslips (Corning). The 
organoids were serially dehydrated by consecutive 10 min incubations in 2 mL of 10% 
(v/v), 25% (v/v) and 50% (v/v) ethanol/PBS; 75% (v/v) and 90% (v/v) ethanol/H2O; and 
100% ethanol (2X), followed by 50% (v/v) ethanol/hexamethyldisilazane (HMDS) and 
100% HMDS (Sigma). Coverslips were removed from the 100% HMDS and air-dried 
overnight at room temperature. Organoids were manipulated with 0.5 mm tungsten 
needles using an Olympus SZX9 light microscope and mounted onto 12 mm specimen 
stubs (Agar Scientific). Following gold coating to 1 nm using a Q150R sputter coater 
(Quorum Technologies) at 20 mA, samples were examined with a Phenom PRO table-
top scanning electron microscope (Phenom-World).
For TEM, organoids were placed in Matrigel on 3 mm diameter and 200 μm depth 
standard flat carriers for high-pressure freezing and immediately cryoimmobilized 
using a Leica EM high-pressure freezer (equivalent to the HPM10), then stored in 
liquid nitrogen until further use. They were freeze substituted in anhydrous acetone 
containing 2% osmium tetroxide and 0.1% uranyl acetate at –90°C for 72 h and 
warmed to room temperature at 5°C for hour (EM AFS-2, Leica). The samples were kept 
for 2 h at 4°C and for 2 h more at room temperature. After several acetone rinses (4 
X~15 min), samples were infiltrated with Epon resin for 2 days (acetone/resin, 3:1 for 
3 h; 2:2 for 3 h; 3:1 overnight; pure resin for 6 h + overnight + 6 h + overnight + 3 h). 
Resin was polymerized at 60°C during 96 h. Ultrathin sections from the resin blocks 
were obtained using a Leica Ultracut UC6 ultramicrotome and mounted on formvar-
coated copper grids. They were stained with 2% uranyl acetate in water and lead 
citrate. Sections were observed in a Tecnai T12 Spirit equipped with an Eagle 4kx4k 
camera (FEI Company) and large electron microscopy overviews were collected using 
the principles and software described previously (Faas et al., 2012).
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For live cell imaging, organoids were plated in BMER in a 24-well plate and mounted 
on an inverted microscope (Leica AF7000), which was continuously held at 37°C 
and equipped with a culture chamber for overflow of 5% CO2. For imaging of BAP1−/− 
organoids growing from small clumps of cells, organoids were digested with accutase 
to reach an average size of about 10-20 cells for tissue fragment, replated and live 
imaging started 2 days after plating. For GFP detection, we used minimal amounts of 
excitation light. Images were taken with a time interval of 15 min over a period of 72 h. 
ImageJ was used for images analysis and Video assemby.
Mass spectrometry
Samples were prepared and mass spectrometry performed as described in (Lindeboom 
et al., 2018). Briefly, organoids were harvested with Cultrex Organoids Harvesting 
Solution (Trevigen) and lysed by using SDS buffer (4% SDS, 1 mM DTT, 100 mM Tris 
pH 7,5) for 3 min at 95°C followed by sonication (Biorupter Pico, 5 cycles 30 s on/off). 
Protein lysates (65 μg / sample) were alkylated with chloroacetamide and digested with 
trypsin using Filter Aided Sample Preparation (FASP) (Wiśniewski et al., 2009). For 
absolute quantification, 1,5 μg of a standard range of proteins (UPS2, Sigma) was added 
to each lysate. The digested peptides were subjected to a Strong Anion eXchange (SAX) 
(Wiśniewski et al., 2009) fractionation, flow through, pH11, 8, 5, and 2 samples were 
collected. The peptides were desalted and stored on StageTips (Rappsilber et al., 2007). 
Samples were applied to on-line Easy-nLC 1000 (Thermo) separation using different 
214-min gradients of acetonitrile (7%–30%, 5%–23%, 8%–27%, 9%–30%, 11%–32%, 
and 14%–32% for unfractionated, flow through, pH 11, 8, 5, and 2, respectively) followed 
by washes at 60% followed by 95% acetonitrile for 240 min of total data collection. 
Mass spectra were collected on an LTQ-Orbitrap Fusion Tribrid mass spectrometer 
(Thermo) in data-dependent top-speed mode with dynamic exclusion set at 60 s.
Raw mass spectra were analyzed in MaxQuant 1.5.1.0 (Cox and Mann, 2008) with 
match-between-runs, iBAQ, and label-free quantification enabled. A human UniProt 
protein sequence database downloaded at 01-12-2015 was used to identify proteins. 
Identified proteins were filtered for reverse hits and potential contaminants. We only 
considered proteins that were identified in at least all of the replicates of the same 
sample, for downstream analyses. Missing values were semi-random imputed using 
Perseus (default settings, MaxQuant software package). Identification of significantly 
changing proteins was done using an adapted t test that is corrected for multiple 
testing by permutation-based estimation of the false discovery rate (default settings, 
Perseus of the MaxQuant software package). For absolute quantification, we applied a 
linear regression between supplied amounts and the iBAQ intensities of the spike-in 
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proteins in the unfractionated sample, followed by a second linear regression between 
the absolute abundances and iBAQ intensities in the fractionated sample.
Lentiviral constructs, virus preparation and generation of inducible rescue lines
Full-length human cDNA for BAP1 and BAP1C91A catalytically dead mutant were 
PCR-amplified from the Addgene plasmids #81024 and #81025 and cloned using 
the NheI and BamHI sites into the doxycycline-inducible lentiviral vector pCW-
Cas9 (Addgene plasmid #50661) after removal of the Cas9 coding sequence, to 
generate the pCW-BAP1 and pCW-BAP1C91A plasmids. In order to generate the 
pCW-BAP1-T2A-GFP and pCW-BAP1C91A-T2A-GFP, first the EGFP sequence was 
cloned in the pCW backbone using NheI and BamHI sites. The BAP1 and BAP1C91A 
were amplified with a forward primer containing the FLAG sequence and a reverse 
primer containing the T2A sequence. FLAG-BAP1-T2A or FLAG-BAP1-T2A were 
cloned in the pCW-EGFP vector using the MluI site. BAP1cyt was generated by 
PCR amplification of BAP1 lacking the C-terminal NLS (using primers: BAP1cyt fw, 
5′-GCTAGCGCCACCATGGACTACAAGGATGACGATGACAAGAATAAGGGCTGGCTGGAGC 
TGGAGAGCGACC-3′ BAP1cyt rev, 5′-CTCCGCTTCCACGCGTCACGGAGATGTTCTGCTCC-3′) 
and BAP1nuc was generated as a gBLOCKR Gene Fragment (Integrated DNA Technology) 
containing BAP1 full length and a C-terminal exogenous NLS. BAP1cyt and BAP1nuc 
were cloned into pCW-EGFP. Localization of BAP1cyt and BAP1nuc was validated in HeLa 
cells. Briefly, cells were transfected using Lipofectamine2000 (Invitrogen) according 
to manufacturer’s protocol. 48 h later, HeLa cells were fixed with 4% PFA for 2 hr and 
stained as described for the organoids using Ab anti-FLAG (Sigma) as primary antibody. 
Samples were imaged using a confocal Sp8 (Leica) and images processed with ImageJ. 
Lentiviruses were produced and organoids lines were infected following a previously 
described protocol (Koo et al., 2013). 3 days after lentiviral infection, puromycin was 
added to the culture media (1 μg/ml) for selection of infected cells and to generate 
the inducible lines. We generated 3 independent BAP1 inducible lines from 3 BAP1−/− 
mutant lines derived from different donors. For expression induction, 2.5 μg/ml of 
Doxycycline were added to the media and media was refreshed every 48 h.
RNA isolation, sequencing and analysis
RNA was extracted from organoids contained in 2 50 μL BMER drop 3-4 days after 
splitting by TRIzol extraction following the manufacturer protocol (Invitrogen). RNA 
was extracted from TP53−/−BAP1−/−, the 24h BAP1 rescue and parental WT lines derived 
from 3 different matching donors. For the TP53−/−BAP1+/+, 1 line was sequenced. Quality 
of RNA samples was checked using a 2100 Bionalyzer Nano 6000 Chip (Agilent) and 
only samples with a RIN number higher than 8.5 were used for library preparation. 
Libraries were prepared as previously described (Artegiani et al., 2017), adapted from 
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(Hashimshony et al., 2016). RNA was first reverse transcribed using the Ambion 
Kit (Thermo Fisher). RT primers contained an 8-mer random molecular barcode 
(UMI), which allows for absolute molecule quantification. 2-5 ng of cDNA from 
each sample was used as a template for overnight linear amplification, and then RT-
PCR amplified into sequencing libraries. Sequencing was performed on an Illumina 
NextSeq500 using 75-bp paired-end sequencing. Paired-end reads were aligned to 
the human transcriptome genome by BWA (Li and Durbin, 2009). For each barcode, 
the number of different UMIs for every transcript was counted, and transcript counts 
were then adjusted to the expected number of molecules based on counts, 16,777,216 
possible UMI’s combinations and poissonian counting statistics (Grün et al., 2014). 
DESeq2 (Love et al., 2014) was used for sample read normalization and for differential 
expression analysis. For normalization, all samples sequenced in the same sequencing 
run or compared to each other were normalized together. Gene-ontology analysis were 
performed using EnrichR and ToppFun and results displayed using GOplot package 
in R environment and reducing redundant terms with more than 50% gene overlap. 
Pearson’s correlation coefficients were calculated pairwise between different samples 
and lead to hierarchical clustering visualized in a correlation plot by using the R 
package Corrplot. Principal component analysis was performed on total normalized 
DESeq2 read counts and visualized using ggplot2. TMixClust was used for clustering 
analyses of the gene expression upon BAP1 rescue. All data analyses were performed 
on Rstudio environment and ggplot2 was used for data visualization unless otherwise 
specified.
Western blot and FACS staining
Organoids contained in 3 50 μL BMER drop were harvested in ice-cold Cell Recovery 
Solution (Corning). Proteins were isolated by incubation of the organoid sample 
in ice-cold RIPA buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.1% SDS, 0.5% Na-
Deoxycholate, 1% NP-40, 1X Complete protease inhibitors (Roche)), snap-freezing and 
mechanical shearing. Protein lysates were loaded on gradient polyacrylamide gels 
12% and subsequently transferred to PVDF membranes (Millipore). Membranes were 
blocked (BSA 5% in T-TBS) and probed with Abs H2AK119Ub, GAPDH, and BAP1.
For FACS staining, same number of cells (100,000) from the different samples was 
isolated from the BMER, digested into single cells with accutase, fixed with 4% PFA, 
permeabilized with 0.1% Triton X-100 in PBS, blocked with 5% normal donkey serum 
and stained with Ab H2AK119Ub for 1.30 h. FACS analysis was performed using a FACS 
Aria (BD) and FloJo software.
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ATAC-sequencing and analysis
ATAC-seq was performed on approximately 75,000 cells from BAP1−/− and parental WT 
lines in triplicate. For the BAP1 expression rescue ATAC-seq experiment, 2 lines with 
BAP1 full-length rescue and 1 line with BAP1nuc rescue were used. Organoids were 
resuspended in Recovery Cell Culture Freezing Medium (GIBCO) and stored at −80°C 
prior to the ATAC-seq procedure. Once thawed, they were washed with PBS and ATAC-
seq was performed as described (Lindeboom et al., 2018), based on a modified protocol 
from (Buenrostro et al., 2015). In short, nuclei were tagmented with in-house made 
Tn5 enzyme followed by DNA purification using 2 × SPRI beads (Ampure). DNA was 
PCR amplified by using KAPA HiFi Hotstart Ready Mix (KAPA Biosystems) and Nextera 
Index Kit (Ilumina) primers followed by reverse phase 0.65 × SPRI beads purification 
and a QIAquick Spin Column (QIAGEN). Amplified DNA libraries were sequenced with 
an Illumina NextSeq 500. Paired-end 50-bp sequencing reads were aligned to hg19 with 
BWA (Li and Durbin, 2009) allowing one mismatch. Reads were filtered for a quality 
score of at least 1, PCR duplicates were removed with Picard, and reads mapping to 
the mitochondrial chromosome were discarded. Peaks were identified with MACS 
2.0 (Zhang et al., 2008) with a false discovery rate of 0.01. Peaks with significantly 
changing DNA accessibility were identified with DESeq2 (Love et al., 2014).
ChIP-sequencing and analysis
ChIP-seq was performed on cells harvested from WT human ductal organoid lines in 
triplicate.
Cell pellets were collected and crosslinked as described in (Lindeboom et al., 2018) and 
ChIPmentation and library preparation was performed as in (Schmidl et al., 2015) with 
the modifications described in (Lindeboom et al., 2018). The chromatin of 250,000 
cells was incubated overnight at 4°C rotating in dilution buffer (1% Triton X-100, 1.2 
mM EDTA, 16.7 mM Tris pH 8, 167 mM NaCl), 1 × Protease Inhibitor Cocktail (Roche), 
and 1 μg of antibody (H3K4me3, H3K27me3, H3K9me3). Sequencing was performed 
using an Illumina HiSeq 2000, and 50-bp paired-end reads were generated. Paired-end 
sequencing reads were aligned to mm9 with BWA (Li and Durbin, 2009) allowing one 
mismatch. Reads were filtered for a quality score of at least 1, and PCR duplicates were 
removed with Picard. Peaks were identified with MACS 2.0 (Zhang et al., 2008) with a 
false discovery rate of 0.01.
Publicly available ChIP tracks for different histone modifications were downloaded 
from Roadmap epigenomics project (from consolidated epigenomes E066 and E118).
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For karyotyping, 3 days after splitting organoids were treated with 0.1 μg ml-1 colcemid 
(GIBCO) overnight. Organoids were collected and dissociated into single cells using 
TrypLE (GIBCO) and processed as described in (Drost et al., 2015). Cells were spread on 
a slide, mounted with DAPI-containing vectashield and imaged on a DM6000 Leica 
microscope. At least 40 metaphase spreads for each line were analyzed.
In vivo xenotransplantation assay and tissue processing
For genomic analysis of human patient cholangiocarcinomas, we used publicly 
available genomic data collections from the cBioportal and previously published 
sequencing data from (Jiao et al., 2013; Jusakul et al., 2017), resulting in a total of 61 
BAP1-mutated CCs. Visualization of co-mutational analyses was performed in Rstudio. 
OncoPrints were generated using the ComplexHeatmap package.
TP53/SMAD4/NF1/PTEN and TP53/SMAD4/NF1/PTEN/BAP1 mutant organoids 
were collected for transplantation 3-4 days after splitting. Organoids were washed 
twice with ice-cold PBS 1X to remove the BMER, an organoid suspension containing 
500,000 cells was prepared in 100 μL of culture media and BMER (1:1) and injected 
subcutaneously into the flank of NSG mice. Small nodules were detectable 4-5 weeks 
after injection. Animals were sacrificed 10 weeks after injection. Nodules were 
immediately collected, fixed overnight in PFA 4% and embedded in paraffin blocks. 5 
μm-tick sections were processed for H&E, Alcian blue, Sirius Red, Trichrome staining, 
and immunohistochemistry using human specific-Cam5.2 antibody (Abcam). 
Immunofluorescence staining was performed using anti-EZRIN, Ki67 antibodies 
and Phalloidin on paraffin sections. Images were acquired using a Leica DM4000 
microscope or a confocal Sp8. Histological slides were examined and classified by 
an experienced gastrointestinal pathologist. For the orthotopic transplantations, 
mutant organoids were collected and processed as described for the subcutaneous 
transplantations. For each mouse transplantation, an organoid suspension of 150,000 
cells was prepared in 50 μL of culture media and BMER (1:1). Before the transplantations, 
NSG mice were anesthetized by isoflurane, abdomen opened by a short longitudinal cut 
and cells injected directly into one liver lobe in multiple injections of small volumes. 
Animals were sacrificed 10 weeks after orthotopic transplantation, the injected liver 
lobe immediately dissected, fixed in PFA 4% and embedded in paraffin blocks. 5 μm-
tick sections were processed and assessed as described for the subcutaneous grafts.
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Quantification and Statistical Analysis
The experiments described in this study are based on the analysis of at least 3 different 
organoid lines derived from 3 independent donors, unless otherwise specified in the 
Method Details. Immunofluorescence imaging results were analyzed based on z stacks 
acquired with confocal microscope. RNA sequencing data, proteomic data and ATAC-
sequencing data were normalized and analyzed in Rstudio using different packages 
as described in the Method Details. Significance is opportunely stated in main text or 
figure legends.
Data and Software Availability
Sequencing, proteomic and chromatin accessibility profiling results are provided in 
Table S1.
RNA sequencing data, ATAC-seq and ChIP-seq are deposited in Gene Expression 
Omnibus (GEO), accession number GEO: GSE129457.
The mass spectrometry proteomics data have been deposited to the ProteomeXchange 
Consortium via the PRIDE partner repository with the dataset identifier PXD013353.
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FIGURE S1 |  TP53 mutation alone does not induce any phenotype in liver organoids (related to 
Figure 1 and 3)
(A) Western-blot showing absence of BAP1 expression upon CRISPR/Cas9-mediated gene mutation.
(B) Pictures of KI67 staining comparing WT and BAP1-/- mutants. Scale bars=100 µm.
(C) Bright-field (left) and H&E pictures low (middle) and high (right) magnification of WT, and 
TP53-/- BAP1+/+ mutants only. Note that the presence of TP53 alone does not induce any architectural 
change in liver organoids. Scale bars=300 µm.
(D) Volcano plot showing the result of the differential gene expression analysis of WT versus 
TP53-/- BAP1+/+ mutant only. The plot represents the fold changes in gene expression versus the 
statistical significance of this change for each gene detected in the dataset. Each dot represents a 
gene. Note that TP53-/- BAP1+/+ and WT transcriptomes are essentially identical since only the 7 genes 
in red are differentially expressed. These genes were not considered
in following comparisons with TP53-/- /BAP1-/-, as their change can be attributed to TP53 mutation.
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FIGURE S2 | Effect of BAP1 on tissue architecture (related to Figure 2)
(A) Confocal immunofluorescent images of WT (left panels) and BAP1-/- (right panels) organoids 
stained for Actin (3D reconstruction is shown on the left and a single z-focal plane on the right), 
showing the complete different morphology upon BAP1 loss. Arrowheads point at some of the several 
internal lumina that are formed in BAP1-/- organoids. Magnification in the inset highlights cells that 
protrude from the organoid body and migrate towards the neighboring organoid and mediate their 
fusion. Scale bars=50 µm. Pictures are representative of 3 different experiments reproduced using 
different lines.
(B) Snapshots at different acquisition time points (as indicated) from a live imaging experiment of 
BAP1-/- organoids growing from small size cell clumps. Black arrows indicate cellular protrusions 
which fuse with surrounding cells. Scale bars=500 µm.
(C) Confocal immunofluorescent images of WT and BAP1-/- organoids stained for plakoglobin. On 
the left, 3D reconstruction and a single focal plane on the z–axis is shown. Arrowheads point at 
the polarized expression which is stronger on the apical side. Note that, while the apical side in 
WT organoids is facing the lumen, polarity is inverted in BAP1-/- organoids. On the right, a single 
focal plane on the y–axis, taken on the apical side, where plakoglobin expression is stronger. The 
localization of plakoglobin at the membrane in BAP1-/- is impaired, and it is instead often found 
perinuclear (white arrows). Scale bars=50 µm.
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FIGURE S3 |  Transcriptomic and proteomic analysis of molecular changes induced by BAP1 
loss (related to Figure 3)
(A) Correlation plot showing Pearson’s correlation coefficient between RNA-seq results from 
biological replicates of BAP1-/- and WT samples (lines derived from 3 different human donors). Color 
intensities and the size of the circles are proportional to the correlation coefficients. Samples are 
ordered based on hierarchical clustering and rectangles in the graph are based on the results of the 
hierarchical clustering.
(B) Heat-maps showing the RNA expression in BAP1-/- and WT organoids of some of the genes found 
downregulated (top) or upregulated (bottom) in human liver HCC carrying mutation in BAP1 from 
the study from Woo et. colleagues. Values are provided as z-scores transformed values.
(C) Heat-maps showing the expression of specific marker genes, as indicated. Values are provided as 
z-scores transformed values.
(D) Volcano plot highlighting the fold change and the significance values of the abundance of 
proteins related to proliferation (top) and involved in the metabolism of lipid and xenobiotics 
(bottom) upon BAP1 loss.
(E) Representation of gene ontology analysis for the list of correlated genes/proteins. Results for 
molecular function (MF, purple), cellular component (CC, pink) and biological process (BP, blue) GO-
categories are shown. Each circle is a GO-term and size of the circle is proportional to the number of 
genes in the dataset belonging to that term. Z-score (on the y-axis) for any given GO-term indicate its 
likelihood to be increased or decreased in the dataset.
(F) Scatter-plot showing the quantitative ratio between protein molecules over mRNA molecules in 
WT versus BAP1-/- organoids. A changed ratio is an indication of altered protein stability. Before doing 
this analysis, we removed the genes/proteins that were significantly changed at RNA level, assuming 
that regulation of their expression happens at transcriptional level. The red dots show proteins that 
have a log2 fold change of protein/mRNA ratio > or < 2 in BAP1-/- versus WT.
(G) Venn-diagram showing the number of detected molecules in transcriptomic and proteomic 
analysis and of the significantly different between BAP1-/- and WT organoids.
(H) Heat-maps showing the relative changes in protein abundance and the respective mRNA 
expression for BAP1-/- versus WT. Only significant proteins are plotted (FDR<0.05).
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FIGURE S4 |  Correct cellular localization of BAP1 cytoplasmic and BAP1 nuclear (related to 
Figure 4 and 5)
(A) Confocal immunofluorescent pictures showing localization in the correct cellular compartment 
after transfection with the relative inducible construct (BAP1, BAP1cyt and BAP1nuc, from top to 
bottom) and 24 h after dox administration. BAP1 was stained by using an antibody against its FLAG 
tag. Note that GFP and BAP1 sequences are linked with a T2A sequence, and they are not translated 
as a fusion protein but as two independent proteins and therefore their localization may differ.
(B) Confocal immunofluorescent pictures showing localization in the correct cellular compartment 
in the generated organoid lines 24 h after dox administration.
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FIGURE S5 | Effect of BAP1 on chromatin accessibility (related to Figure 6)
(A) Levels of H2A K119Ub upon BAP1 loss and expression rescue. Quantification by western blot (top) 
and FACS analysis upon antibody staining (bottom). Isotype IgG has been used as control for the 
staining in the FACS analysis.
(B) Correlation plot showing Pearson’s correlation coefficient between ATAC-seq results from 
biological replicates of BAP1-/- and WT samples (lines derived from 3 different human donors). Color 
intensities and the size of the circles are proportional to the correlation coefficients. Samples are 
ordered based on hierarchical clustering and rectangles in the graph are based on the results of the 
hierarchical clustering.
(C) Scatter-plot showing the positive correlation of chromatin accessibility and transcriptional 
changes. The fold change (log2) of expression for each gene (mRNA) is plotted against the fold 
change (log2) in the relative ATAC-peaks (for all the genes/ATAC peaks with a log2 fold change > or < 
1.5) in BAP1-/- versus WT. Each dot represents a gene/ATAC-peak. Correlated genes/ ATAC-peak are 
shown in red.
(D) Heat-map showing the relative significant changes (FDR<0.05) in ATAC-peak accessibility 
in the rescue lines (after 24h of dox administration) as compared to BAP1-/-. The signal for the 
corresponding peaks in WT lines is shown, and confirm that after BAP1 expression rescue, chromatin 
accessibility is more similar to WT.
(E) As in Figure 6G, heat-maps showing significant ATAC-peak signals in BAP1-/- and WT organoid 
lines at an FDR=0.01 (top heat-map) and the available ChIP tracks of several histone modifications, 
as indicated, for the corresponding regions (from publicly available data set obtained from human 
primary liver tissue as well as from HepG2 (middle), and from ChIPmentation of WT human ductal 
liver organoids (bottom)).
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FIGURE S6 | Co-mutation analysis of BAP1-mutated cholangiocarcinoma (related to Figure 7)
(A) Barplot showing the percentage of co-mutation for all the genes (=380) found mutated in BAP1-
mutated CC. TP53, NF1, SMAD4 and PTEN are highlighted in red.
(B) Matrix showing alterations of different genes (rows) belonging to different pathways, as 
indicated, in BAP1-mutated CC tumours (columns). Different types of mutation are indicated and, in 
this case, structural variations are also included.
(C) Circos plot representing the co-occurrence of mutation in BAP1, TP53, NF1, SMAD4 and PTEN in 
CC. Only tumours in which mutation in at least one of the considered genes is present have been 
represented. Ribbons between genes mean co-occurrence of mutation and the thickness of the 
ribbon indicates number of cases in which co-occurrence have been identified. This plot highlights 
that none of the considered mutation is mutually exclusive in CC patients.
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FIGURE S7 | Characterization of features of xenografts in presence of BAP1 mutation (related 
to Figure 7)
(A) Quantification of ploidy (number of chromosomes) in WT (control), TP53/SMAD4/NF1/PTEN/
BAP1WT (BAP1WT) or TP53/SMAD4/NF1/PTEN/BAP1-/- (BAP1-/-) organoid lines used for transplantation, 
given as percentage of ploidy over the total number of metaphases quantified (>40 metaphases/
line in two independent experiments) (left); on the right, examples of quantified metaphases for the 
different samples.
(B) Proliferation marker Ki67 staining of TP53/SMAD4/NF1/PTEN/BAP1WT (top) or TP53/SMAD4/
NF1/PTEN/BAP1-/- (bottom) grafts showing similar level of proliferation. 
(C) Representative pictures of Alcian Blue (left), Sirius Red (middle) and Masson Trichrome staining 
(right) at low- and high- magnification of subcutaneous nodules isolated from TP53/SMAD4/NF1/
PTEN/BAP1WT (top) or TP53/SMAD4/NF1/PTEN/BAP1-/- (bottom) xenotransplanted mice. Black 
arrows point at the cells that secret mucus in the organoid lumen, and not in the surrounding stroma 
in TP53/SMAD4/NF1/PTEN/BAP1WT nodules (left). Instead, the TP53/SMAD4/NF1/PTEN/BAP1-/- 
organoids (highlighted with the dashed line), are surrounded by abundant mucinous secretion 
(right). Deposition of abundant collagen fibers is characteristic of both type of tumours. Scale bar = 
100 µm in low- and 25 µm in high-magnification.
(D) Representative pictures of Alcian Blue (left), Sirius Red (middle) and Masson Trichrome 
staining (right) at low- and high- magnification of nodules growing in mouse liver upon orthotopic 
transplantation of TP53/SMAD4/NF1/PTEN/BAP1WT (top) or TP53/SMAD4/NF1/PTEN/BAP1-/- 
bottom) organoids, showing similar results as in (B). Scale bar = 100 µm in low- and 25 µm in high-
magnification.
549219-L-bw-Voorthuijsen










BAP1 IN CRISPR-ENGINEERD HUMAN LIVER ORGANOIDS
187
549219-L-bw-Voorthuijsen
Processed on: 6-10-2020 PDF page: 188
188
549219-L-bw-Voorthuijsen
Processed on: 6-10-2020 PDF page: 189
CHAPTER 5
Retinol metabolism and RXR 
mediated gene regulation in 
intestinal organoids and colorectal 
cancer progression
van Voorthuijsen, L.1, Lindeboom, R.G.H.1, Wester, R.A.1, Lamers, L.1, and Vermeulen, M1,2.
1   Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Oncode 
Institute, Radboud University Nijmegen, Nijmegen, The Netherlands
2  Corresponding author (michiel.vermeulen@science.ru.nl)
Manuscript in preparation
549219-L-bw-Voorthuijsen




Mouse small intestinal organoids represent a powerful in vitro model system to study 
adult stem cell maintenance and differentiation in a controlled manner. In previous 
work, we showed a significant up regulation of retinol metabolism in enterocyte-
enriched mouse small intestinal organoids, suggesting that this pathway plays a 
role in regulating cell fate switches in the intestinal epithelium. Here, we show that 
the retinoid X receptor (RXR) and retinol metabolism-associated gene expression 
are involved in enterocyte differentiation in mouse small intestinal organoids. 
Remarkably, this is conserved in human colon cancer since we observed reduced 
differentiation towards the absorptive lineage upon RXR inhibition in human tumor 
progression organoids and an upregulation of retinol metabolism associated genes 
in differentiated human colon cancer cells. Most likely, RXR induces absorptive-cell 
specific gene expression during differentiation as a non-permissive heterodimer. 
This phenotype is apparent in non-metastatic colon cancer organoids, but not in 
metastatic organoids, since these lack absorptive cells to begin with. Thus, RXR 
mediated regulation of gene expression is involved in differentiation in mouse small 
intestinal and human colon cancer organoids. The latter suggests that activation 
of gene expression by non-permissive RXR heterodimers may be therapeutically 
beneficial to inhibit colorectal cancer progression. 
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INTRODUCTION
Vitamin A metabolism is essential in the human body. During digestion of nutrients, 
the intestinal epithelium absorbs vitamin A from the intestinal lumen (Theodosiou et 
al., 2010). Vitamin A, also known as retinol, is further processed via several enzymes 
to the effector molecule retinoic acid (RA), which exists in several stereoisomeric 
forms, such as all-trans retinoic acid (ATRA) and 9-cis retinoic acid (9-cisRA) (Chlapek 
et al., 2018). Retinoic acid interacts with various retinoic acid receptor heterodimers 
in the nucleus. These heterodimers interact with DNA in a sequence specific manner, 
recruiting transcriptional  co-repressor complexes in an unliganded state and co-
activator complexes upon ligand binding to repress or induce gene expression 
respectively. However, in some cases it is reported that RA binding to particular 
nuclear receptor dimers result in the recruitment of repressing complexes and gene 
silencing (Kumar and Duester, 2014). Retinoic acid signaling is well known for its role 
in various biological processes such as differentiation, reproduction, embryogenesis, 
and eye development (Clagett-Dame and DeLuca, 2002; Cunningham and Duester, 
2015; Das et al., 2014; Duester, 2008; Ghyselinck and Duester, 2019). 
Loss of the nuclear receptor RARα leads to aberrant lineage specification in the intestinal 
epithelium and is associated with increased Paneth and goblet cell numbers concomitant 
with a decreased number of enteroendocrine cells (Jijon et al., 2018). Furthermore, 
vitamin A is involved in intestinal immune homeostasis in vivo, which results in altered 
immunological responses upon vitamin A deficiency (Cassani et al., 2012). In previous 
work we showed that retinol metabolism is one of the most prominent upregulated 
metabolic pathways during enterocyte differentiation in mouse small intestinal 
organoids (Lindeboom et al., 2018), suggesting a role for RA signaling in intestinal stem 
cell differentiation towards the absorptive intestinal lineage. Interestingly, aberrant 
regulation of the retinol metabolism is observed in colorectal cancer (Bhattacharya et 
al., 2016). However, the molecular mechanisms underlying the effects of RA signaling on 
lineage specification and tumorigenesis in the intestine requires further investigation.  
Here, we studied the effects of perturbing RA signaling in mouse small intestinal 
organoids and in a human colon tumor progression organoid model (Drost et al., 
2015). In mouse small intestinal organoids we observed a cystic phenotype and smaller 
crypt structures upon RXR inhibition. Using RNA-sequencing, we observed decreased 
absorptive lineage specification upon inhibition of RXR mediated gene expression in 
colon organoids carrying three driver mutations (TPO3: human colon organoids knock-
out for APC and P53, and expressing constitutively active KRAS (G12D)). Inhibition of 
RXR mediated gene expression in TPO3 also results in induction of fetal and repair 
associated gene expression. Strikingly, this effect is absent in human colon organoids 
carrying four driver mutations (TPO4: TPO3 plus an additional SMAD4 knock-out), 
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possibly due to a lack of absorptive cell specific gene expression and an increased 
number of adult stem cells. Finally, in colorectal cancer patients, reduced expression 
of RXR target genes is associated with a poor prognosis, suggesting that these patients 
could possibly benefit from treatment with RXR heterodimer activating drugs. 
RESULTS
Upregulation of retinol metabolism during enterocyte differentiation 
in small intestinal organoids
Since RA signaling is well known for its role in cellular differentiation (Diez Del Corral 
et al., 2003; Janesick et al., 2015; Soprano et al., 2007), we assessed the regulatory role 
of  retinol metabolism in the mouse small intestinal epithelium using small intestinal 
organoids. These organoids are in vitro multicellular 3D ‘mini-gut’ cultures, which 
structurally and functionally resemble the epithelium of the mouse small intestine 
(Sato et al., 2009). Enrichment of differentiated cell types in these organoids can 
be achieved by small-molecule driven perturbations of the culture medium or by 
withdrawal of essential culture medium components (Yin et al., 2014). Previously, 
we have shown that withdrawal of R-spondin1 from the culture medium (EN) results 
in an enrichment of enterocytes compared to regular cultures (ENR) (Lindeboom et 
al., 2018). Comparing the transcriptome between EN and ENR organoids reveals an 
enrichment of retinol metabolism associated gene expression in EN cultures (Figure 
1A). Furthermore, specific genes associated with retinol metabolism are upregulated 
in EN organoids, both at the transcriptome and the proteome level (Figure 1B). 
Altogether, this implies a role for retinol metabolism in regulating differentiation 
towards an absorptive cell fate in mouse small intestinal organoids.
 
FIGURE 1 | Upregulation of retinol metabolism during enterocyte differentiation
(A) Gene Set Enrichment Analysis (GSEA) of gene expression dynamics in enterocyte enriched 
mouse small intestinal organoid cultures (EN) versus wt organoids (ENR). Significantly enriched 
KEGG gene sets (FDR < 0.001) associated with EN gene expression have a positive normalized 
enrichment score (NES), whereas gene sets associated with ENR gene expression have a negative 
NES. Genes associated with retinol metabolism are clearly enriched in EN organoids.  
(B) Expression of retinol metabolism associated genes in ENR and EN organoids. The heatmaps are 
row-matched and all the genes that are shown are dynamically expressed at the protein level. The 
left heatmap shows mRNA dynamics, whereas the right heatmap shows protein dynamics of the 
indicated genes. Relative expression is visualized as log2 fold change over the row mean (RMS). 
Genes associated with the retinol metabolism are upregulated in enterocyte enriched organoids on 
RNA and protein level. 
(C) Light microscopy analyses of small intestinal organoids treated with retinol metabolism perturbing 
drugs for 2 days. No distinct organoid phenotypes are observed in B27-A, R115866 (1 µM), ATRA (5 µM), 
9-cisRA (10 µM), LG100268 (10 µM), and AGN193109 (1µM). In contrast, a cystic lumen is observed 
in organoids treated with DEAB (100 µM), HX531 (1 µM), and AGN193109 + HX531 (both 1 µM). RXR 
inhibition (HX531), with or without RAR inhibition (AGN193109), result in a cystic lumen surrounded by 
small crypt-like structures. Phenotypical changes are not observed upon RAR inhibition or RA treatment 
alone, suggesting RXR-dependent regulation of retinol metabolism in mouse small intestinal organoids.
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RXR mediated regulation of cell fate in mouse small intestinal 
organoids
Enzymes involved in retinol metabolism process vitamin A to retinoic acid, and 
binding of RA to retinoic acid receptors induces gene expression (Kumar and Duester, 
2011). The stereoisomeric form of RA, ATRA, mainly interacts with the nuclear 
retinoic acid receptor (RAR), whereas 9-cisRA is reported as a ligand for RXR (retinoid 
X receptor), but has comparable affinity to RAR as well (Liu et al., 2002). To further 
investigate the role of retinol metabolism in small intestinal organoids, we treated 
them with retinol metabolism regulating drugs (Table 1, Figure S1). To this end, ATRA, 
9-cisRA, LG100268, and R115866 was added to the culture medium to activate retinol 
metabolism and downstream signaling, whereas diethylaminobenzaldehyde (DEAB), 
HX531, AGN193109, and vitamin A withdrawal (B27-A) was used to inhibit retinol 
metabolism. 
TABLE 1 | Overview of retinol metabolism regulating drugs used in this study
As shown in Figure 1C, inhibition of retinoic acid production by DEAB results in a 
cystic phenotype in small intestinal organoids. To uncover which nuclear receptor is 
most affected by the inhibition of retinoic acid production, we treated organoids with 
RAR and RXR inhibitors, AGN193109 and HX531 respectively. Upon RXR inhibition, 
organoids become phenotypically distinct from ENR organoids (Figure 1C). Their 
lumen is enlarged, shows a cystic phenotype and the crypt structures appear smaller. 
In contrast, RAR inhibition alone does not result in a distinct phenotype, only in 
combination with RXR inhibition. This suggests RXR-mediated regulation of cell fate 
in mouse small intestinal organoids, and a regulatory role for retinol metabolism 
during differentiation. 
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Upregulation of retinol metabolism during differentiation in human 
colon and colorectal cancer cells and a decrease of differentiation 
during colorectal cancer progression
The experiments presented thus far indicate a role for RXR mediated and retinol 
metabolism associated gene expression during enterocyte differentiation in mouse 
small intestinal organoids. Previous studies also revealed that RXR expression is 
decreased during colorectal cancer progression (Giardina et al., 2015; Hao et al., 2016). 
Others, however, have reported increased RXR expression in colorectal cancer samples 
(Modarai et al., 2018). To further investigate these contrasting findings, we set out to 
decipher a putative role for retinol metabolism in human colon tumor progression 
organoids (TPOs), which are organoids derived from healthy colon tissue engineered 
using CRISPR-Cas9 technology to carry colorectal cancer driver mutations (Drost et 
al., 2015). In this study we specifically made use of TPO3 (P53 and APC knock-out and 
KRASG12D) and TPO4 (TPO3 plus an additional SMAD4 knock-out). Upon transplantation 
in nude mice, TPO3 organoids generate non-metastatic tumors, whereas TPO4 
organoids cause metastatic disease upon transplantation in mice (Fumagalli et al., 
2017). 
Adult stem cells in human colon organoids can be labeled and sorted using the 
STem cell Ascl2 Reporter (STAR (see Chapter 3 and (Oost et al., 2018)). We generated 
gene sets associated with STAR positive (i.e. adult stem cells) and STAR negative (i.e. 
differentiated cells) cells using gene expression data from STAR containing human 
colon and colorectal cancer organoids (Oost et al., 2018). As shown in Figure 2A, 
retinol metabolism associated genes are enriched in STAR negative cells, indicating 
an upregulation of retinol metabolism during cellular differentiation in human colon 
and colorectal cancer organoids. Next, to compare the differentiation potential of TPO3 
and TPO4, we analyzed transcriptomes from TPO3 and TPO4 using RNA sequencing 
and determined the STAR negative associated gene expression pattern in these 
cultures. We observed an enrichment of STAR negative associated gene expression 
in TPO3 compared to TPO4 (Figure 2B), which suggests a loss of differentiated cells 
during colorectal cancer progression. In summary, retinol metabolism associated 
gene expression is upregulated in differentiated cells of human colon and colorectal 
cancer organoids. Furthermore, metastatic colon tumor progression organoids (TPO4) 
are characterized by reduced differentiation potential compared to non-metastatic 
colon tumor progression organoids (TPO3). 
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FIGURE 2 |  Retinol metabolism is upregulated in differentiated human colon and colorectal 
cancer organoid cells and differentiation is reduced in TPO4 versus TPO3
(A) GSEA of gene expression dynamics in STAR negative versus STAR positive cells of human colon 
and colorectal cancer organoids (Oost et al., 2018). STAR negative cells represent differentiated cells 
and are significantly enriched for retinol metabolism associated gene expression (NES = 1.98, FDR = 
0.001).
(B) GSEA of gene expression dynamics in TPO4 versus TPO3 organoids. TPO3 organoids are 
significantly enriched for STAR negative associated gene expression (NES = -2.69, FDR = 7.3 x 10-6), 
indicating the presence of differentiated cells in TPO3 organoids, and a decrease of gene expression 
associated with differentiation in TPO4 organoids. 
 
Loss of absorptive cell specific gene expression upon RXR inhibition in 
tumor progression organoids
To study the effect of perturbing retinol metabolism during colorectal cancer 
progression, we treated TPO3 and TPO4 with various small molecules (Figure S1). 
Since RXR is possibly involved in cell fate regulation in mouse small intestinal 
organoids (Figure 1C), we treated TPO3 and TPO4 with a specific RXR antagonist and 
agonist, HX531 and LG100268, respectively. In addition, we used molecules to activate 
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or inhibit RA signaling upstream of RXR. Expression of RXRα, and its expressed 
heterodimerization partners, is similar between different treatment conditions and 
organoid background (Figure S2). By using single cell RNA-seq based gene-sets of 
intestinal cell types in mice (Haber et al., 2017) to measure cell type associated gene 
expression in human tumor progression organoids, we determined that TPO4 is 
mainly characterized by a down-regulation of enterocyte associated gene expression 
compared to TPO3, suggesting a decrease of differentiation towards the absorptive 
lineage in TPO4. (Figure 3A). Possibly, as a consequence, RXR inhibition results in a 
decrease of enterocyte associated gene expression in TPO3 but not in TPO4 (Figure 3B). 
Activation of RXR in TPO3 by supplementing the culture medium with the RXR ligand 
agonist LG100268 did not result in increased enterocyte associated gene expression, 
suggesting a RXR ligand independent effect. These findings are supported by the 
expected inhibitory function of HX531 on RXR, which is also ligand independent, 
since it is suggested that this molecule inhibits heterodimerization of RXR with other 
nuclear receptors (Ebisawa et al., 1999; Sato et al., 2010; Yamauchi et al., 2001). 
RXR forms nuclear receptor dimers as a permissive homo- or heterodimer, or as a non-
permissive heterodimer (with RAR, vitamin D receptor (VDR), and thyroid hormone 
receptor (TR)) (Almeida and Conda-Sheridan, 2019; Evans and Mangelsdorf, 2014). 
Permissive dimers can be activated by the ligand of either RXR, or its dimerization 
partner (Almeida and Conda-Sheridan, 2019; Pérez et al., 2012). Activation of non-
permissive heterodimers is dependent on ligand binding to the dimerization partner 
of RXR. RXR ligand binding to a non-permissive heterodimer can lead to synergistic 
activation if the heterodimerization partner is already bound by its ligand, however 
RXR ligand binding solely is insufficient to induce gene expression (Almeida and 
Conda-Sheridan, 2019; Pérez et al., 2012). Gene expression changes observed in TPO3 
are thus predicted to be caused by inhibition of non-permissive RXR heterodimers 
since the RXR agonist (LG100268) does not induce transcriptional activation of genes, 
which are inhibited upon HX531 treatment. 
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FIGURE 3 |  Gene expression dynamics of intestinal cell type associated genes in TPO3 and 
TPO4 upon exposure to retinol metabolism perturbing drugs
Gene sets associated with specific cell types in the mouse small intestinal epithelium as determined 
by single cell RNA sequencing (Haber et al., 2017) are shown. All three heatmaps are row-matched 
with each other. Relative expression is shown as log2 fold change over the row mean within each 
heatmap.
(A) Relative RNA expression dynamics in TPO3 and TPO4 upon addition of retinol metabolism 
perturbing drugs.
(B) Relative RNA expression dynamics within TPO3 (left heatmap) or within TPO4 (right heatmap) 
upon addition of retinol metabolism perturbing drugs. TPO3 shows a decrease in enterocyte 
associated gene expression upon RXR inhibition (HX531).
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Colorectal cancer progression is characterized by loss of differentiation 
capacity and loss of RXR ligand independent gene expression
As described above, we associated retinol metabolism with differentiated human 
colon and colorectal cancer cells (Figure 2A, (Oost et al., 2018)), and we observed a 
decrease of differentiation associated gene expression in TPO4 (Figure 2B and 3A). 
To further characterize TPO4, we performed a gene set enrichment analysis on our 
gene expression data from untreated TPO3 and TPO4 (Figure 4A). Retinol metabolism 
associated gene expression is enriched in TPO3, whereas expression of genes 
associated with TGFβ signaling are enriched in TPO4 cultures, which lack SMAD4 
(Figure 4A). Interestingly, upon RXR inhibition by HX531 in TPO3, the expression level 
of the colonocyte marker ANPEP becomes similar to TPO4 (Figure 4B), suggesting 
that RXR inhibition causes a decrease of differentiation in TPO3. Thus, due to the 
presence of differentiated cells and an active retinol metabolism, TPO3 is sensitive 
to RXR inhibition. TPO4, however, is insensitive to RXR inhibition, possibly due to a 
lack of differentiated cells in these organoids. In addition to a loss of differentiation 
upon RXR inhibition in TPO3, we also observed an increase in fetal associated gene 
expression and expression of genes associated with repair (Figure 4C). Both biological 
processes are induced upon reprogramming of the colonic epithelium (Yui et al., 2018) 
and are thus likely enriched by reduced differentiation upon RXR inhibition in TPO3. 
To investigate a possible clinical relevance of these findings, we analyzed expression 
of the genes that are down regulated upon HX531 treatment, in colorectal cancer 
patients. As shown in Figure 4D, colorectal cancer patients which show low expression 
of these genes have a poor prognosis. This suggests that a decrease of RXR mediated 
differentiation capacity of the tumor contributes to colorectal cancer progression and 
poor prognosis. This also suggests that reactivation of the genes, which are inhibited 
by HX531 treatment, for example by using RXR heterodimer agonists, could be 
therapeutically beneficial for these patients. 
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FIGURE 4 | RXR mediated regulation of differentiation in colorectal cancer
(A) GSEA of gene expression dynamics in DMSO treated TPO4 versus TPO3 cultures. Significantly 
enriched KEGG gene sets (FDR < 0.05) associated with TPO4 gene expression have a positive 
normalized enrichment score (NES), whereas gene sets associated with TPO3 gene expression have 
a negative NES. Genes associated with the retinol metabolism are enriched in TPO3, whereas genes 
associated with TGFβ signaling are enriched in TPO4.  
(B) Normalized read counts (y-axis) of the colonocyte marker ANPEP. ANPEP expression is decreased 
in TPO4 and in TPO3 treated with HX531, indicating decreased differentiation in these organoid 
cultures.
(C) GSEA of gene expression dynamics in TPO3 cultures treated with HX531 versus control cultures 
treated with DMSO. TPO3 cultures treated with HX531 are significantly enriched for a fetal gene 
expression signature (NES = 1.70, FDR = 0.00061) and a repair gene associated signature (NES = 1.35, 
FDR = 0.035) (Yui et al., 2018).  
(D) Survival probability of colorectal cancer patients (n = 283) displaying high (blue) or low (red) 
expression of genes which are downregulated upon HX531 treatment. 
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Here, we showed that retinol metabolism and RXR are linked with differentiation 
associated gene expression in mouse small intestinal and human colon organoids. 
In accordance with our observations, it is well known that retinoic acid induced 
gene expression is associated with differentiation in various cell lineages (Janesick 
et al., 2015; Mezquita and Mezquita, 2019; Theodosiou et al., 2010). Interestingly, it 
has previously been suggested that RXRα interacts with nuclear β-catenin to induce 
its degradation (Han et al., 2008; Ruan et al., 2017; Xiao et al., 2003), which implies 
that RXR can inhibit Wnt signaling and thereby induce differentiation. Contradicting 
this is the identification of the enzyme ALDH, which induces the production of 
retinoic acid, as a cancer stem cell (CSC) marker (Jiang et al., 2009; Landen et al., 2010; 
Nakahata et al., 2015; Rasheed et al., 2010). However, others have argued that ALDH 
enzymes were mainly identified as CSC marker since its increased enzymatic activity 
results in chemotherapy resistance (Dylla et al., 2008; Kozovska et al., 2018; Marcato 
et al., 2011). Furthermore, it was shown that ALDH positive colorectal stem cells are 
characterized by an upregulation of CYP26 enzymes, which results in a decrease of 
retinoic acid induced gene expression (Modarai et al., 2018). Overall, this study shows 
a regulatory role of retinol metabolism and RXR mediated gene expression in mouse 
small intestinal organoids and human colon cancer organoids. However, given the 
likelihood that RXR functions as a non-permissive heterodimer to induce absorptive 
lineage associated gene expression, RXR mediated gene expression and activity of the 
retinol metabolism could act independently in cells of the absorptive lineage. 
Retinol metabolism associated gene expression is regulated on multiple levels; 
ligand binding to the nuclear receptor, hetero- or homodimerization of the receptor, 
and recruitment of co-repressor and co-activator complexes. In this study we show 
that RXR inhibition results in a loss of absorptive lineage specific gene expression 
in non-metastatic tumor progression organoids. However, ligand dependent 
activation of RXR through LG100268 does not induce absorptive lineage associated 
gene expression, which suggests that RXR may form a non-permissive heterodimer, 
for example with RAR, vitamin D receptor (VDR), or (thyroid hormone receptor) TR, 
to regulate absorptive lineage specification. Previously, it was reported that vitamin 
D, the ligand of VDR, induces differentiation in the intestine and in colorectal cancer 
cell lines (Barbáchano et al., 2017; Feldman et al., 2014; Pálmer et al., 2001). More 
recently, similar findings were also reported for human colorectal cancer organoids 
(Fernández-Barral et al., 2020). Thus, VDR induced gene expression seems to reduce 
colorectal cancer progression. For TR, however, contradicting studies have been 
reported. Some studies identified a connection between increased levels of the TR 
ligand T3 (3,5,3’ triiodothyronine) and reduced colorectal cancer risk and increased 
differentiation (Catalano et al., 2016; Dentice et al., 2012), whereas others have reported 
549219-L-bw-Voorthuijsen










RETINOL METABOLISM AND RXR IN INTESTINAL ORGANOIDS
203
that increased TRα1 expression in colorectal cancer cells enhances Wnt activity and 
thereby contribute to the progression of colorectal cancer (Uchuya-Castillo et al., 
2018). Determining the genome-wide binding profile of these nuclear receptors in 
intestinal cells may reveal the RXR dimerization partner(s), that regulates adult stem 
cell differentiation towards absorptive cells, and may help to decipher their putative 
involvement in colorectal cancer progression. 
Remarkably, metastatic colorectal cancer organoids (TPO4) are characterized by 
decreased differentiation towards the absorptive lineage and are insensitive to RXR 
inhibition. The observed reduction of differentiated cells in TPO4 compared to TPO3 
may contribute to the more invasive behavior of TPO4. It would be of great interest to 
study whether activation of the RXR non-permissive heterodimer in colorectal cancer 
organoids would be beneficial to eliminate remaining colorectal cancer stem cells and 
induce differentiation. This is particularly relevant given the fact that we observed a 
more favorable prognosis in colorectal cancer patients showing an upregulation of 
genes, which are downregulated upon RXR inhibition by HX531.
METHODS
Mouse small intestinal organoid culture
Mouse Lgr5GFPDTR/+ small intestinal organoids (Tian et al., 2011) were cultured as 
described earlier (Sato et al., 2009). Briefly, organoids are embedded in RGF BME Type 2 
PathClear (Cultrex, R&D Systems) and cultured in ENR medium (advanced Dulbecco’s 
modified Eagles Medium/F12 (Gibco) (supplemented with 1x Penicillin-Streptomycin 
(Gibco), 10 mM HEPES (Gibco), and 1x GlutaMAX™ Supplement (Gibco)), 1x B27 (Gibco), 
1,25 mM N-acetylcysteine (Sigma Aldrich), 50 ng/mL mEGF (Gibco), 10% final volume 
noggin conditioned medium, 5% final volume R-Spondin1 conditioned medium). 
For maintenance, organoids were split by mechanical shearing every 5 days and the 
culture medium was refreshed every other day.
Human colorectal cancer organoid culture
TPO3APC-/-,P53-/-,KRAS(G12D) and TPO4APC-/-,P53-/-,KRAS(G12D)/SMAD4-/- organoids were cultured as 
described earlier (Drost et al., 2015), with the addition of 10% final volume noggin 
conditioned medium to the culture medium of TPO4, resulting in similar culture medium 
for both TPO3 and TPO4. Briefly, organoids are embedded in RGF BME Type 2 PathClear 
(Cultrex, R&D Systems) and cultured in expansion medium for normal colon organoids 
(Sato et al., 2011) with the withdrawal of several medium components. Resulting in the 
following medium composition: advanced Dulbecco’s modified Eagles Medium/F12 
(Gibco) (supplemented with 1x Penicillin-Streptomycin (Gibco), 10 mM HEPES (Gibco), 
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and 1x GlutaMAX™ Supplement (Gibco)), 1x B27 (Gibco), 1,25 mM N-acetylcysteine (Sigma 
Aldrich), 50 ng/mL mEGF (Gibco), 10% final volume noggin conditioned medium, 10 mM 
nicotinamide (Sigma Aldrich), 500 nM A83-01 (Cayman Chemical), and 10 μM SB202190 
(Cayman Chemical). For maintenance, organoids were split by mechanical shearing every 
5 days and the culture medium was refreshed every other day.
Drugs treatment
Human colorectal cancer and mouse small intestinal organoids were cultured for 
24 hours on maintenance medium (as described in organoid culture section) after 
splitting, followed by an 48 hours drug treatment. The drugs treatment was performed 
under reduced light conditions and refreshed after 24 hours of treatment. Human 
colorectal cancer and mouse small intestinal organoids were treated with: 0.1 % 
final volume DMSO, 1x B27 without vitamin A (withdraw of 1x B-27, addition of 0.1 
% final volume DMSO, Gibco), 100 µM 4-Diethylaminobenzaldehyde (DEAB, Sigma 
Aldrich), 1 µM HX531 (Sigma Aldrich), 10 µM LG100268 (Sigma Aldrich), or 1 µM 
R115866 (Talarozole, Sigma Aldrich). Additionally, mouse small intestinal organoids 
were treated with: 5 µM all-trans-Retinoic acid (ATRA, Cayman Chemical), 10 µM 
9-cis-Retinoic acid (9-cisRA, Cayman Chemical), or 1 µM AGN 193109 (Sigma Aldrich). 
All drugs were dissolved in DMSO and added to the culture medium at working 
concentration in 0.1% final volume DMSO. After treatment, organoids were harvested 
using Organoid Harvesting Solution (Cultrex, R&D Systems) and pelleted. Pellets were 
snap frozen and stored at -80 ⁰C.
RNA sequencing
RNA from snap frozen pellets of TPO3 and TPO4 drugs treated organoids was extracted 
using the RNeasy RNA extraction kit (Qiagen) with DnaseI treatment. A total amount 
of 1 µg RNA per sample was used for the preparation of the RNA sequencing libraries 
using the KAPA RNA HyperPrep Kit with RiboErase (HMR) (KAPA Biosystems). In 
short, oligo hybridization and rRNA depletion, rRNA depletion cleanup, Dnase 
digestion, Dnase digestion cleanup, and RNA elution were performed according 
protocol. Fragmentation and priming were performed at 94 ⁰C for 6:30 min. First 
strand synthesis, second strand synthesis, and A-tailing was performed according 
protocol. For the adapter ligation, a 7 μM stock was used (NextFlex DNA barcodes, Bioo 
Scientific). First, and second post-ligation cleanup was performed according protocol. 
For the library amplification, 6 cycli were used. The library amplification cleanup was 
performed using a 0.8x bead-based cleanup. Library size was determined using the 
High Sensitivity DNA bioanalyzer (Agilent Technologies), library concentration was 
measured using the DeNovix dsDNA High Sensitivity Assay (DeNovix). Sequencing 
was performed using an Illumina NextSeq 500, 50-bp paired-end reads were generated.
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RNA sequencing analysis
Sequencing reads were aligned with Hisat2 version 2.0.4 (Kim et al., 2015) to the 
provided and pre-indexed hg38 transcript assembly from UCSC, with alignment 
tailoring for transcript assemblers enabled. PCR duplicates were identified and 
removed with Picard. Reads per gene were counted with the htseq-count script from 
the Hisat2 software suite using the GTF file corresponding to the transcript assembly, 
with strandness set to ‘reverse’ and identification attribute set to ‘gene_id’. Differential 
gene expression analysis was performed with the DESeq2 package (Love et al., 2014). 
The ‘rlogTransformation’ function in DESeq2 was used to normalize, log2 transform 
and noise-stabilize the expression data for visualization purposes. Heatmaps were 
created with the ComplexHeatmap package (Gu et al., 2016).
Gene Set Enrichment Analysis (GSEA)
Gene Set Enrichment Analysis was performed using the fgsea R-package (Sergushichev, 
2016) on gene expression data that was ranked by fold changes computed with the 
‘lfcShrink’ function in DESeq2. Kyoto Encyclopedia of Genes and Genomes (KEGG) 
pathway gene sets were taken the Molecular Signatures Database (Subramanian et al., 
2005). Human orthologs of consensus cell-type-specific marker genes from (Haber et 
al., 2017) were used for enrichment analysis of intestinal cell types. STAR positive and 
negative gene sets were taken from (Oost et al., 2018). Gene sets for repairing and fetal-
like gene expression in the colon were taken from (Yui et al., 2018) by selecting human 
orthologs of genes significantly upregulated at p<0.01 and with an upregulation of at 
least 1.5 and 3 fold, respectively. 
Survival analysis
Overall survival and expression data from (Marisa et al., 2013) was used for survival 
analysis. We took genes significantly downregulated by HX531 compared to DMSO in 
TPO3 and TPO4 (p<0.05) to define a gene signature containing genes downregulated 
by HX531 treatment. The mean z-score normalized expression of this gene signature 
in each colorectal cancer patient was used to compare the 25% highest expressing 
patients versus the 25% lowest.
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FIGURE S1 | Schematic overview retinol metabolism perturbations
Schematic overview of the retinol metabolism with the perturbations used in Figure 1C and Figure 3 
depicted in purple
 
FIGURE S2 |  RNA expression of RXRα and its expressed heterodimerization partners in TPO3 
and TPO4
Normalized read counts (y-axis) of RXRα, RARα, RARγ, THRα, and VDR in TPO3 and TPO4 retinol 
metabolism perturbed cultures.
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SUMMARY, DISCUSSION AND OUTLOOK
Adult stem cells and organoid models 
The human body contains a large variety of distinct, organ-specific cell types. These 
specialized cells are differentiated and typically not long-lived. Adult stem cells, which 
are multipotent and are characterized by self-renewal capacity, can replenish old or 
damaged differentiated cells in organs. During the last decade, markers for several 
adult stem cells in organs have been discovered, including leucine-rich-repeat-
containing G-protein-coupled receptor 5 (Lgr5). Lgr5 is a membrane bound receptor 
for the Wnt signaling activator R-spondin. In 2007, Lgr5 was discovered as an adult 
stem cell maker for intestinal and colon stem cells (Barker et al., 2007). Later, Lgr5 also 
turned out to be a marker for other epithelial adult stem cells, including those residing 
in the stomach (Barker et al., 2010), hair follicles (Jaks et al., 2008), liver (Huch et al., 
2013a), and pancreas (Huch et al., 2013b). The discovery of Lgr5 as an adult stem cell 
marker eventually led to the development of in vitro 3D epithelial tissue cultures called 
organoids, first for the intestine (Sato et al., 2009), but later also for many other organs 
(Huch et al., 2013a, 2015; Sato et al., 2011). Many adult stems cells residing in different 
organs are dependent on similar signaling pathways, such as Wnt, EGF, BMP, and 
Notch. In most epithelial organoid cultures, these pathways are activated or inhibited 
with a mixture of different small molecules and growth factors in the culture medium 
to balance adult stem cell renewal and differentiation. 
Organoid cultures have great potential since they enable investigating adult stem 
cell maintenance and differentiation and tissue homeostasis in vitro in a controlled 
manner. Importantly, organoid cultures can also be established from diseased 
cells, including cancerous tissue. Cancers are driven by uncontrolled proliferation 
of so-called cancer stem cells. These cancer stem cells show resemblance to non-
transformed adult stem cells. However, an important difference is the fact that they 
become independent of canonical signaling pathways. For example, colorectal cancer 
stem cells are mostly independent of Wnt signaling due to a loss of APC (Fearon, 2011). 
These growth-factor independent characteristics of cancer stem cells can be exploited 
for the culture of cancer organoids (Drost et al., 2015; Matano et al., 2015) and to 
establish cancer organoid biobanks that can be used for ex vivo drug screenings (Van 
De Wetering et al., 2015). The ability to culture both normal and cancer organoids led to 
a rapid increase of various organoids models in biology and medicine. 
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Integrative multi-omics analyses to address gene expression 
regulation in organoids
Organoid cultures are heterogenous and typically contain various cell types. To 
study the molecular signatures of these cell types, single cell technologies such as 
single cell RNA sequencing can be applied (Grün et al., 2015). Furthermore single cell 
transcriptomics data can be combined with trajectory analysis, thus revealing cell 
lineage decisions within the organoid (Camp et al., 2015). However, investigating 
multiple layers of gene expression regulation from the genome down to the proteome 
using multi-omics analyses typically requires more input material and cannot be 
studied (yet) at the single-cell level. In this case, however, perturbing organoid culture 
conditions to enrich for specific cell types can provide a solution (Lindeboom et al., 
2018; Yin et al., 2014). In chapter 2, we used this strategy to perform  differential 
proteome, transcriptome and metabolome analyses between stem cell enriched and 
enterocyte enriched organoids. Furthermore, we studied the differential epigenome 
in these cultures using ATAC-seq and ChIPmentation. These analyses revealed the 
orphan nuclear receptor HNF4g as a major driver of enterocyte differentiation in the 
mouse small intestinal epithelium, which was substantiated with HNF4g perturbation 
experiments.  Knock out of Hnf4g in small intestinal organoids revealed a decrease of 
enterocyte specific gene expression, concomitant with an upregulation of secretory 
cell related gene expression. Furthermore, in mice, Hnf4g knock out results in an 
increase of secretory cells in the small intestine. Collectively, these experiments reveal, 
both in vitro and in vivo, that Hnf4g drives enterocyte differentiation and is necessary 
to maintain a balance between secretory- and absorptive lineage specification. Since 
enterocytes are still produced in Hnf4g knock-out mice (Baraille et al., 2015), we 
cannot exclude that other transcription factors also drive enterocyte differentiation 
or compensate for the loss of Hnf4g. Recently, single cell transcriptome analysis 
of the small intestine reassuringly also identified Hnf4g as an enterocyte specific 
transcription factor (Haber et al., 2017), together with a handful other transcription 
factors which could possibly induce residual enterocyte specific gene expression 
after Hnf4g loss. Another member of the Hnf4 family, Hnf4a, could also be an obvious 
candidate to compensate the loss of Hnf4g. However, we observe a decrease for one of 
the isoforms of Hnf4a in enterocyte enriched organoids (chapter 2), and Hnf4a was 
also identified as a stem cell specific transcription factor in vivo (Haber et al., 2017). 
Furthermore, Hnf4g and Hnf4a knock-out mice show an opposite phenotype, namely 
an increase and a decrease of the enteroendocrine cell lineage, respectively (Baraille et 
al., 2015). Thus, Hnf4a likely has a different or opposite role in regulation of intestinal 
gene expression compared to Hnf4g, suggesting that Hnf4a most likely cannot 
fully compensate for a loss of Hnf4g. However, others have reported a functional 
redundancy between Hnf4a and Hnf4g, also since their genomic localization in the 
intestine is overlapping (Chen et al., 2019). These conflicting results suggest that 
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more research is needed to decipher the molecular mechanisms of gene expression 
regulation by Hnf4a and Hnf4g in the intestinal epithelium. 
Overall, the findings of chapter 2 illustrate the power of multi-omics data integration 
to deduce cell type specific regulation without using single cell approaches. Follow up 
experiments  (unpublished data) revealed that this multi-omics integrative approach 
is powerful to deduce cell type specific transcription factors in perturbed organoid 
cultures. For example, in tuft cell enriched cultures, which only contain 2% tuft 
cells, we identified Pou2f3 as the main tuft cell specific transcription factor, which is 
in agreement with previous studies (Gerbe et al., 2016; Yamashita et al., 2017). These 
confirmatory experiments reveal that even a modest enrichment of a very rare cell 
type, is sufficient to identify important regulators of that cell type using integrative 
multi-omics approaches. In the future, this approach could also be applied to other 
organoid systems to identify drivers of cell fate, although small molecule-driven 
perturbation strategies to enrich for specific cell types are currently not available for 
most organoid cultures. 
Exploring the data presented in chapter 2, we observed an upregulation of retinol 
metabolism-related genes in enterocyte-enriched mouse small intestinal organoids. 
In chapter 5, we show that retinol metabolism is also involved in regulation of 
differentiation in colon tumor progression organoids (Drost et al., 2015). In TPO3, 
which contains three driver mutations (APC and P53 knock-out, and a mutation 
resulting in a constitutively active KRAS (G12D)) we observed a down regulation 
of enterocyte specific genes upon RXR inhibition. TPO4, which contains the three 
TPO3 driver mutations and an additional SMAD4 knock-out, is less sensitive to RXR 
inhibition, possibly since TPO4 does not contain many enterocytes to begin with, 
which is substantiated by integrating the transcriptome data from chapter 5 with 
transcriptome data from chapter 3. Recently, RXRα was reported as an enterocyte 
specific transcription factor in vivo (Haber et al., 2017), which could explain the 
observed effect on enterocyte specific gene expression upon RXR inhibition. 
However, upon addition of the RXR ligand agonist LG100268 we were not able to 
induce enterocyte specific gene expression, suggesting an RXR ligand independent 
regulation of enterocyte gene expression. Based on this we hypothesize that RXR 
regulates enterocyte-specific gene expression as a non-permissive heterodimer. 
Nuclear receptors that can function in an nonpermissive heterodimer with RXR are 
RAR, VDR, and TR (Almeida and Conda-Sheridan, 2019). Activation of gene expression 
by these heterodimers is dependent on ligand binding to the non-permissive partner 
of RXR. Further research is needed to decipher the dimerization partner of RXR in 
intestinal cells, and to determine which ligand may be capable to reverse the effects 
on gene expression caused by RXR inhibition. Since induced expression of genes, 
which are downregulated upon RXR inhibition, may increase the survival probability 
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of colorectal cancer patients, identification of the ligand, which can induce expression 
of these genes, could be therapeutically beneficial (chapter 5). 
In chapter 4, we exploited human organoids for disease modeling by using 
cholangiocyte organoids genetically engineered to carry a cholangiocarcinoma driver 
mutation (BAP1 knock out). In this study we generated proteomics, transcriptomics, 
and epigenomics data to decipher differences between normal and BAP1-/- human 
cholangiocyte organoids. We observed expression alterations in junctional and 
cytoskeleton components, which agreed with the phenotypical characteristics of 
epithelial transformation in these organoids. Collectively, molecular and phenotypic 
analyses directly link a loss of BAP1 to acquisition of oncogenic properties in vitro 
and in vivo, thus emphasizing the potential of organoids for disease modeling. 
Remarkably, loss of BAP1 resulted in increased accessibility of genomic regions 
which contain repressive histone marks in normal cholangiocyte organoids. 
BAP1 is a deubiquitinating enzyme (DUB) and member of the Polycomb repressive 
deubiquitinase (PR-DUB) protein complex (Scheuermann et al., 2010). PR-DUB targets 
the histone mark H2AK119Ub, which is deposited by Polycomb Repressive Complex 
1 (PRC1) and is associated with gene repression. Additionally, H2AK119Ub recruits 
Polycomb repressive Complex 2 (PRC2) (Blackledge et al., 2014; Cooper et al., 2014; 
Kalb et al., 2014), which deposits the repressive histone mark H3K27me3. It was 
recently shown that upon increased activity of BAP1, H2AK119Ub and H3K27me3 levels 
are drastically decreased (Balasubramani et al., 2015), most likely due to the enzymatic 
activity of BAP1, which causes removal of the ubiquitin mark. Upon a loss of BAP1 
in cholangiocyte organoids, which resulted a global increase of H2AK119Ub levels, 
genome wide compaction of chromatin would thus be expected. However, since we 
observe the opposite, it would be of great interest to genome-wide profile H2AK119Ub, 
and H3K27me3, upon a loss of BAP1 in cholangiocyte organoids and to decipher the 
role of BAP1 in epigenetic regulation of gene expression in cholangiocarcinoma. 
In summary, in chapter 2, 4, and 5 we show that the molecular mechanisms of 
differentiation and cancer progression can be studied in organoid culture systems 
using multi-omics approaches. By comparing organoids in different states, for 
example normal versus differentiated, wild-type versus mutant, cell type specific 
regulation can be studied using bulk approaches instead of single cell techniques. 
Single cell techniques, such as single cell RNA sequencing, are very powerful to 
study gene expression regulation and developmental trajectories. However, cell type 
or disease specific regulatory mechanisms can be characterized in heterogeneous 
organoid models in great detail by applying and integrating bulk multi-omics 
techniques.
549219-L-bw-Voorthuijsen












Genetic modification of organoids 
Functional perturbation studies are typically needed to investigate possible regulatory 
mechanisms emerging from multi-omics studies. For example, in chapter 2 we 
validated Hnf4g as a major driver of enterocyte differentiation in Hnf4g knock-out 
organoids generated from Hnf4g knock-out mice. In these organoids, we observed 
a downregulation of enterocyte-specific genes, and an increase of secretory cells 
compared to wild-type organoids, thus confirming a role for Hnf4g as a driver of 
enterocyte differentiation.
Genetic modifications can also be used to visualize and characterize specific cell types 
in organoids. In chapter 3, we developed and used STAR (stem cell Ascl2 reporter) 
to visualize and characterize colorectal cancer stem cells in colon cancer organoids. 
The reporter is integrated in the genome through lentiviral infection, resulting in 
expression of a fluorescent marker in ASCL2 expressing cells, which are the stem cells. 
Therefore, STAR enables studying both stem cells (STAR+) and differentiated cells 
(STAR-) during colorectal cancer progression. Additionally, STAR is also functional in 
mouse small intestinal organoids where it marks intestinal stem cells. Recently, Ascl2 
was identified as a marker for dedifferentiation (Murata et al., 2020), which suggests 
that STAR may also be used as a marker for dedifferentiation.
Genetic manipulation of primary cell culture models, such as organoids, turns out 
to be quite challenging (Haapaniemi et al., 2018; Ihry et al., 2018). The Hnf4g knock-
out organoids described in chapter 2 were not generated by CRISPR/Cas9 mediated 
genome editing in the organoids, but were derived from the small intestine of 
Hnf4g knock out mice (Baraille et al., 2015). This strategy to use primary material 
from knock-out mice to generate genetically manipulated organoids has also been 
used by others (Beumer et al., 2018; Gehart et al., 2019; Simmini et al., 2014). These 
examples illustrate the challenges that have to be overcome to genetically manipulate 
organoids. However, recent studies revealed that genetic manipulation of organoids is 
possible, in particular if that genetic manipulation renders the organoids insensitive 
to essential growth factor withdrawal, which can be used for positive selection. 
Alternatively, genome editing may result in a distinct phenotype compared to the non-
edited organoids (Drost et al., 2015; Geurts et al., 2020; Matano et al., 2015; Schwank et 
al., 2013a). Additional studies reported successful genetic manipulation in organoids 
based on selection with a resistance cassette, such as hygromycin, puromycin, and 
G418 (Fessler et al., 2016; Geurts et al., 2020; Schwank et al., 2013a, 2013b). Recently, 
generation of homology independent knock-in organoid lines combined with FACS-
sorting was reported (Artegiani et al., 2020), obviating the need to select positive 
clones by antibiotics or an adapted culture medium. 
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Early on, most studies used lipofectamine to generate genetically manipulated 
organoids. Nowadays, viral transduction or electroporation are the most common 
methods to deliver plasmids to the organoids. In the coming years, further much 
needed experimental adaptations or technical innovations will hopefully result in 
even more efficient workflows to generate genetically manipulated organoids. 
CRISPR/Cas9 screens and iPSC derived organoids
Although targeting single genes is nowadays feasible in organoids, targeting multiple 
genes using CRISPR screens in organoids is not commonly used. This is most likely 
due to the fact that transfection efficiencies in organoids are not sufficient to target 
a large number of cells simultaneously. Also, in order to screen the effect of gene 
targeting using a CRISPR library, it is essential to continue culturing for some time 
after targeting. In organoid systems, such as small intestinal organoids, differentiated 
cells will die and shed off after several days. Therefore, the effect of gene knock-outs 
in these cells will be difficult to capture. Nevertheless, recently a first CRISPR screen 
targeting 192 genes in mouse biliary epithelial cell (cholangiocytes) organoids was 
reported (Planas-Paz et al., 2019). In this study, Cas9 expressing mice were used to 
generate Cas9 expressing organoids and the gRNA library was delivered using viral 
transduction, which is typically highly efficient. Additionally, the first CRISPR screen 
in human small intestinal organoids was recently reported (Ringel et al., 2020), with 
a library targeting 19.114 genes, which indicates it is now feasible to perform genome-
wide CRISPR screens in organoid models. 
Instead of the above described approaches for gene editing in adult stem cell derived 
organoids, iPSC derived organoids can also be used for genetic editing studies. iPSC 
derived human organoids are an established model, first reported for intestinal 
organoids (Múnera et al., 2017; Spence et al., 2011) and later for other organs such as lung 
(Dye et al., 2015), kidney (Taguchi et al., 2014; Takasato et al., 2015), and brain (Lancaster 
et al., 2013). Genetic editing of iPSC derived organoids can be achieved by single gene 
targeting using CRISPR/Cas9 gene editing at the iPSC or embryoid body state, followed 
by differentiation towards organoids (Bian et al., 2018; Freedman et al., 2015; Nie 
and Hashino, 2017). This system can for example be used to study essential genes 
in lineage specification. To study the effect of perturbing multiple genes on lineage 
specification simultaneously, CRISPR/Cas9 library screens in iPSC derived organoids 
could be performed. To our knowledge, such studies, however, have not been reported 
yet. iPSC based organoid models resemble a fetal stage of development. Maturation 
of the organoids typically only occurs after transplantation in immunocompromised 
mice (Dye et al., 2020; Finkbeiner et al., 2015; Watson et al., 2014). Therefore, studies 
using iPSC derived organoids are mainly limited to the study of organ development 
and lineage specification. In the future, further improvement of iPSC based organoid 
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models, for example by development of scaffolds that can stimulate organoid 
maturation (Dye et al., 2020) may facilitate genome-scale CRISPR library screens to 
study essential genes during cell type specification and differentiation. 
Applying proteomics-based technologies in organoids: future 
perspectives
Single cell RNA sequencing is currently widely used in the research community to 
investigate gene expression at the single cell level in heterogeneous organoid cultures. 
In contrast, due to its limited sensitivity, mass spectrometry-based proteomics 
technologies in organoid studies are typically only applied to bulk cultures and not 
at the single cell level (chapter 1, 2 and 4,(Cristobal et al., 2017)). Recently, a new 
and emerging proteomics technology called mass cytometry was used to investigate 
protein expression for a small number of genes at the single cell level (Qin et al., 2020). 
Efforts are currently also underway to establish mass spectrometry-based proteomics 
workflows that facilitate comprehensive single cell proteome measurements (Budnik 
et al., 2018; Marx, 2019; Slavov, 2020; Specht et al., 2019). In the future, these exciting 
developments will hopefully enable comprehensive proteome quantification at 
single cell level in heterogeneous organoids, which may, for example, result in the 
identification of functionally distinct cell types, which cannot be discriminated at the 
single cell transcriptome level.  
A very important current topic in the organoid community is cell-cell communication 
and development of organoid co-cultures with immune cells or the microbiome 
(Bar-Ephraim et al., 2019; Pleguezuelos-Manzano et al., 2020). A proteomics-based 
technology which potentially can be very useful is this research area is cell-type specific 
stable-isotope labeling using amino acid precursors (CTAP) (Gauthier et al., 2013). With 
CTAP it is possible to label the proteome with stable isotope labeled amino acids by 
expressing enzymes from bacteria and plants, which are able to synthesize essential 
amino acids from precursors. By adding isotopically labeled amino acid precursors to 
the cell culture, a distinction can then be made between proteins produced by cells 
containing, and not containing, this enzyme. In small intestinal organoids, labeled 
amino acid precursor processing enzymes could be expressed from cell-type specific 
promoters, such as Lyz1. In this case, upon addition of an isotopically heavy labeled 
lysine precursor to the culture medium, stable isotope labeled proteins would only be 
synthesized in Paneth cells. This approach would thus enable determining cell-type 
specific proteomes in a heterogeneous cell culture system. CTAP will result in labeling 
of all proteins within a cell, and if combined with a specific stimulus, can also result 
in a readout of specific protein translation after a stimulus. In a similar logic, CTAP 
can also be used to investigate immune cell specific gene expression upon exposure to 
epithelial organoid cells. 
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In the future, cell-fate regulating protein complexes, such as Polycomb Repressive 
Complex 1 and 2 (PRC1 and PRC2), can be studied in organoids using affinity 
purification coupled to mass spectrometry (AP-MS). In previous work, for example, 
we have shown that the composition of PRC1 changes during differentiation from 
mouse embryonic stem cells to neural progenitor cells (Kloet et al., 2016). It would 
be of great interest to study the composition of PRC1, and other chromatin related 
complexes, in organoid based systems to decipher their composition and function 
during disease progression or differentiation. However, to our knowledge, AP-MS has 
not been performed yet in organoid-based studies. This is likely due to the fact that 
AP-MS studies require large amounts (milligrams) of input material. Furthermore, as 
mentioned before, genetic manipulation to generate organoids expressing genes of 
interest with an affinity tag has proven to be quite difficult. Nevertheless, given the fact 
that tools to genetically modify organoids are continuously being improved (Artegiani 
et al., 2020), and downscaling the amount of input material is feasible (Furlan et al., 
2019), we anticipate that AP-MS studies in organoids will become possible in the near 
future. In recent years, proximity biotinylation has emerged as an alternative for AP-MS 
to profile in vivo interactions for proteins of interest. A particularly attractive option is 
TurboID, which is an enzyme that can be conjugated to a protein of interest and which 
will, upon addition of exogenous biotin, biotinylate bait-proximal proteins in vivo 
within minutes (Branon et al., 2018). These biotinylated proteins can subsequently 
be captured from lysates on streptavidin beads and identified by mass spectrometry. 
Fusing RXR to the TurboID enzyme, for example, would enable identification of the 
heterodimerization partner(s) of RXR in colorectal cancer organoids (chapter 5). 
In summary, in the future, CTAP can be used to identify newly synthesized proteins 
upon a stimulus in a cell-type specific manner in heterogeneous organoid cultures, 
whereas AP-MS and TurboID can be used to study protein-protein interactions and the 
spatial interactome, respectively, for proteins of interest in organoid disease models 
or during adult stem cell differentiation. 
The collaborative organoid research field
The organoid field is emerging and fast developing. After publication of the first 
mouse small intestinal organoid model by the Clevers lab in 2009 (Sato et al., 2009), 
many additional organoid models have been developed, ranging from mouse to 
human, ectoderm to endoderm originated organs, and from adult stem cell to iPSC-
based cultures. Many cutting-edge technologies have been adapted for organoid 
cultures, including imaging and (single cell) omics-based approaches. Initially, 
the organoid field was dominated by descriptive studies but in recent years, more 
functional and mechanistic studies, for example making use of genetic perturbations, 
have been reported. An interesting aspect of the organoid research community is 
that fact that many labs are engaged in large collaborative studies. Since the field is 
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quickly developing, many different technologies are required for high-profile and 
comprehensive studies. Typically, one single laboratory does not have all the required 
expertise, for example to perform imaging, (single cell) omics, computational 
biology, and genome editing. As a consequence, many papers are only possible due 
to a coordinated and collaborative effort between multiple laboratories. In the future 
this collaborative spirit will hopefully ensure that the organoid research community 
continues to be powerful force, operating at the forefront of fundamental and 
translational biomedical research.
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The human body contains a wide variety of different organs. These organs, such as the 
small intestine, consist of multiple different cell types which all perform specialized 
functions. For example, absorption of nutrients from the intestinal lumen is carried 
out by the enterocytes, while the Paneth cells protect the lumen of the intestinal crypt 
against pathogens by the secretion of antibacterial peptides. All these different organ-
specific cell types ensure a correct function of the organ. However, mature organ-
specific specialized cells, called differentiated cells, are often not very long-lived. The 
discovery of adult stem cells allows us to understand how these differentiated cells 
are replenished within an organ. Adult stem cells are multipotent; meaning they can 
give rise to multiple specialized cell types within an organ, and have the capacity to 
self-renew. The differentiation capacity and self-renewal rate of these adult stem cells 
is usually tightly regulated, for example via signaling pathways. In cancer however, so 
called cancer stem cells often become independent of these signaling pathways and 
show uncontrolled growth and a lack of differentiation capacity. To study adult stem 
cells, and diseased cells, we used several organoid models in this thesis. Organoids are 
mini-organs, which are self-organizing stem cell based in vitro cultures. These cultures 
resemble the cellular composition of an organ and enable us to study of adult stem cell 
maintenance and differentiation in a controlled manner. Organoid models obtained 
from diseased tissue, for example cancerous tissue, allow the study of cancer stem 
cells in vitro. In this thesis, we use a multi-omics approach to study the (epi)genome, 
transcriptome, proteome, and metabolome of healthy, perturbed, and diseased 
organoid cultures. We have used this approach to increase our knowledge about cell 
fate decisions and cancer progression in organoids.
The introductory chapter of this thesis is Chapter 1. Here, we describe the different 
organoid models which are used throughout this thesis; mouse small intestinal 
organoids, human colon organoids, and human liver organoids. Mouse small intestinal 
organoids are well known for their cellular plasticity. We describe the small molecules 
which can be used for perturbations of the culture media to enrich for specific cell 
types, and we mention the capacity and possible molecular mechanisms of intestinal 
regeneration after stem cell loss or damage. The common signaling pathways that are 
required for the adult stem cell maintenance and cellular differentiation of the above-
mentioned organoid models, are described in this chapter as well. Furthermore, this 
chapter describes the multi-omics techniques that are used in this thesis to study 
the (epi)genome, transcriptome, and proteome of different cell-type enriched and 
diseased organoid models. 
In Chapter 2 we applied an integrative multi-omics approach on cell-type enriched 
small intestinal organoids to investigate cellular differentiation towards enterocytes. 
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We observed a global rewiring of the proteome and transcriptome between stem cell 
enriched and enterocyte enriched organoids. Our epigenetic data showed a large 
number of cell-type specific regulatory elements, which revealed the transcription 
factor Hnf4g as a major driver of enterocyte differentiation. To functionally validate 
the finding of this major driver of enterocyte differentiation in the small intestine, 
we investigated the effect of Hnf4g loss in vivo and in vitro. Here, we observed a 
downregulation of enterocyte related gene expression and an increase of secretory 
cell numbers and associated gene expression. These findings highlight the strength 
of applying an integrative multi-omics approach to study molecular mechanisms of 
lineage specification in the mouse small intestinal epithelium. 
To further characterize the normal and cancer stem cells in human colon organoids, we 
made use of the STem cell Ascl2 Repoter (STAR) in Chapter 3. STAR is a stem cell specific 
reporter which enables the labeling of normal and cancer stem cells in vivo and in vitro. 
We characterized the proteins which bind to the STAR DNA sequence using affinity 
purification coupled to mass spectrometry (AP-MS), in order to gain more insight on 
the molecular mechanism involved in STAR activity. Furthermore, we characterized 
the transcriptome of STAR positive (stem cells) and STAR negative (differentiated cells) 
cells,  which revealed a similar cancer stem cell expression signature at all stages of 
colon cancer progression. STAR positive cells were furthermore found to closely 
associate with the gene expression signature of intestinal stem cells from mice. 
Additionally, this chapter shows the plasticity of human colon cancer organoids, 
since both individual STAR positive and STAR negative cells, from different genetic 
backgrounds, were able to generate colonies and grow out to organoids containing 
a mixed cell population. This chapter provides insight on the mechanism and 
applications of the STAR reporter.
In Chapter 4 we used CRISPR-engineered human liver organoids to study the 
loss of the tumor suppressor and deubiquitinating enzyme BAP1 in the context of 
cholangiocarcinoma. The proteome and transcriptome of organoids with BAP1 loss-
of-function, revealed a decrease in expression of proteins involved in junctional and 
cytoskeleton organization. This was in accordance with the morphological changes 
observed after BAP1 loss. Remarkably, when comparing the chromatin landscape 
of wildtype organoids with BAP1 mutated organoids using ATAC-sequencing, the 
organoids with loss of BAP1 gain chromatin wide accessibility despite a global 
increase of the repressive chromatin mark H2AK119Ub. By using ChIPmentation, 
we observed the repressive mark H3K27me3 in wildtype organoids at regions which 
gained accessibility upon BAP1 loss, which could indicate that fine-tuning the 
amount of H2AK119Ub by BAP1 is required for optimal Polycomb-driven compaction 
of chromatin. Overall, this chapter shows the value of a CRISPR-engineered organoid 
models to study cancer progression in the context of cholangiocarcinoma. 
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We studied the role of the retinol metabolism and RXR mediated gene regulation 
during intestinal differentiation and colon cancer progression in Chapter 5 using 
mouse and human organoid models. We observed an increase of retinol metabolism 
associated gene expression during mouse intestinal enterocyte differentiation and 
in non-metastatic human colon tumor progression organoids. When perturbing the 
retinol metabolism in mouse small intestinal organoids by using retinol metabolism 
regulating drugs, we observed phenotypical changes upon RXR inhibition. 
Additionally, we observed a decrease of enterocyte related gene expression in non-
metastatic human colon cancer organoids upon RXR inhibition. This effect was 
absent in metastatic human colon cancer organoids, most likely due to the lack of 
differentiated cells to begin with. Remarkably, no increase in enterocyte related gene 
expression was observed after treatment with a RXR ligand agonist, which could 
suggest a non-permissive working mechanism of RXR mediated gene regulation. 
Characterization of possible involved RXR dimerization partner(s) will contribute 
to elucidating the role of the retinol metabolism and RXR mediated gene regulation 
during colorectal cancer progression, and possibly identify ligand(s) that induce 
differentiation of colorectal cancer stem cells.
In Chapter 6, we discuss and summarize the findings described in this thesis. We 
discuss how the discovery of adult stem cell markers caused the rapid emergence 
of different organoid models. Furthermore, we discuss the use of integrative multi-
omics analyses throughout this thesis to address gene expression regulation in 
organoids. Additionally, we describe the challenges and opportunities of studies 
based on genetically manipulated organoids. Finally, we conclude with an outlook 
on the future application of several proteomic-based technologies in organoids, and 
with an outlook on the collaborative spirit that is present within the organoid research 
community.
Altogether, the work presented in this thesis contributes to the insights on gene 
expression regulation in organoid models during cellular differentiation and cancer 
progression. By using integrative multi-omics analyses, we obtained a comprehensive 
and unbiased view on different layers of gene expression regulation.
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Het menselijk lichaam bevat veel verschillende soorten organen. Deze organen, zoals 
bijvoorbeeld de dunne darm, bestaan uit verschillende soorten celtypes. Deze celtypes 
hebben allemaal een specifieke functie. Bijvoorbeeld de absorptie van voedingsstoffen 
uit de binnenzijde van de darm (het lumen), dit wordt uitgevoerd door enterocyten. 
Anderzijds zorgen de panethcellen voor bescherming tegen pathogenen door 
uitscheiding van antibacteriële peptiden in het lumen van de intestinale crypten. 
Al deze verschillende soorten celtypes zorgen ervoor dat een orgaan op de juiste 
wijze kan functioneren. Echter, deze volgroeide orgaan-specifieke celtypes (ook 
wel gedifferentieerde cellen genoemd) leven over het algemeen niet heel lang. De 
ontdekking van volwassen stamcellen heeft ervoor gezorgd dat we beter begrijpen hoe 
deze gedifferentieerde cellen vervangen worden in een orgaan. Volwassen stamcellen 
zijn multipotent, wat betekent dat ze kunnen differentiëren in verschillende 
gespecialiseerde celtypes van een orgaan. Ook kunnen volwassen stamcellen zichzelf 
vernieuwen. Normaal gesproken is het vermogen van een volwassen stamcel om 
te differentiëren of zichzelf te vernieuwen strikt gereguleerd, onder andere door 
signaaltransductieroutes. Tijdens een ziekte zoals kanker kunnen de zogenoemde 
kankerstamcellen onafhankelijk worden van deze signaaltransductieroutes, wat 
ervoor kan zorgen dat deze cellen een ongecontroleerde groei laten zien en een 
vermindering van hun differentiatie vermogen. Voor het bestuderen van volwassen 
stamcellen, en zieke cellen (zoals kankerstamcellen), maken we in dit proefschrift 
gebruik van verschillende organoïden kweekmodellen. Organoïden zijn mini 
orgaantjes, ze zijn zelf organiserend en het zijn stamcel gebaseerde in vitro kweken. 
Deze kweken lijken op de cel samenstelling van een orgaan, en zorgen ervoor dat we 
de vernieuwing en de differentiatie van volwassen stamcellen op een gecontroleerde 
manier kunnen bestuderen. Organoïden kweken die verkregen zijn uit ziek weefsel, 
zoals kankerweefsel, maken het mogelijk om kankerstamcellen te bestuderen in 
vitro. In dit proefschrift maken we gebruik van een multi-omics aanpak om het (epi)
genoom, transcriptoom, proteoom, en metaboloom van gezonde, verstoorde, en zieke 
organoïden kweken te bestuderen. We hebben deze aanpak gebruikt om onze kennis te 
vergroten op het gebied van het de beslissingen die leiden tot een specifieke cellulaire 
identiteit en kankerprogressie in organoïden.
Het introducerende hoofdstuk van dit proefschrift is hoofdstuk 1. Hierin beschrijven 
we de verschillende organoïden kweekmodellen die we gebruiken in dit proefschrift: 
muis dunne darm organoïden, humane dikke darm organoïden, en humane lever 
organoïden. Muis dunne darm organoïden staan bekend om hun cellulaire plasticiteit. 
We beschrijven verschillende kleine moleculen die het kweekmedium dusdanig 
kunnen beïnvloeden dat ze ervoor zorgen dat bepaalde celtypes worden verrijkt. Ook 
benoemen we de mogelijke moleculaire mechanisme die een rol kunnen spelen bij 
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intestinale regeneratie na stamcel verlies of schade aan de stamcellen. Eveneens 
beschrijven we de meest voorkomende signaaltransductieroutes die essentieel 
zijn in de organoïden kweken voor de regulatie van de vernieuwing van volwassen 
stamcellen en de cellulaire differentiatie. Tevens beschrijven de verschillende multi-
omics technieken die gebruikt worden in dit proefschrift om het (epi)genoom, 
transcriptoom, en proteoom te bestuderen in verschillende celtype verrijkte- en 
verschillende zieke organoïden kweekmodellen. 
In hoofdstuk 2 hebben we doormiddel van een multi-omics aanpak cellulaire 
differentiatie naar enterocyten bestudeerd in celtype verrijkte muis dunne darm 
organoïden. We hebben een globale herstructurering van het transcriptoom en 
proteoom geobserveerd tussen stamcel verrijkte en enterocyt verrijkte organoïden 
kweken. Uit onze epigenoom data konden we een grote hoeveelheid celtype specifieke 
regelgevende elementen identificeren, wat ons uiteindelijk bracht tot de ontdekking 
van de transcriptiefactor Hnf4g als een belangrijke factor voor de sturing van enterocyt 
differentiatie. Om deze vinding te valideren hebben we het effect bestudeerd van 
het ontbreken van Hnf4g in vivo en in vitro.  Daarbij hebben we geobserveerd dat het 
ontbreken van Hnf4g leidt tot een afname in expressie van enterocyt gerelateerde 
genen, en een toename in expressie van secretoir gerelateerde genen. Tevens zagen 
we een toename in cel aantallen van secretoire cellen. Deze bevindingen benadrukken 
de kracht van het toepassen van een multi-omics aanpak in het bestuderen van 
moleculaire mechanismen die betrokken zijn in het reguleren van specifieke cellulaire 
identiteit in muis dunne darm organoïden.
In hoofdstuk 3 hebben we hebben gebruik gemaakt van de Stem cel Ascl2 Reporter 
(STAR) om normale- en kankerstamcellen  verder te karakteriseren in humane dikke 
darm organoïden. STAR is een stamcel specifieke reporter die ervoor zorgt dat we 
normale- en kankerstamcellen kunnen traceren in vivo en in vitro. Met behulp van massa 
spectrometrie (affinity purification coupled to mass spectrometry (AP-MS)) hebben 
we de eiwitten gekarakteriseerd die binden aan de DNA sequentie van STAR. Hiermee 
hebben we meer inzicht verkregen in de mogelijke moleculaire mechanismen die 
zorgen voor STAR activatie. Daarnaast hebben het transcriptoom van STAR positieve- 
(stamcellen) en STAR negatieve (gedifferentieerde cellen) cellen bestudeerd. Hierin 
zagen we een vergelijkbaar genexpressiepatroon van kankerstamcellen in alle stadia 
van kankerprogressie. Ook zagen we dat de genexpressie van STAR positieve cellen 
vergelijkbaar was met de genexpressie van muis dunne darm stamcellen. Tevens laten 
we de plasticiteit van humane dikke darm organoïden in dit hoofdstuk zien, aangezien 
zowel individuele STAR positieve- als STAR negatieve cellen (ongeacht de genetische 
achtergrond) kunnen uitgroeien tot organoïden kweken met een gevarieerde cellulaire 
compositie. Dit hoofdstuk geeft ons meer inzicht in het werkingsmechanisme en de 
toepassingen van de STAR reporter. 
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In hoofdstuk 4 hebben we gebruik gemaakt van genetisch gemanipuleerde humane 
lever organoïden om het effect van het verlies van BAP1, een tumorsuppressorgen 
en deubiquitinerend enzym, te bestuderen in galwegkanker (cholangiocarcinoom). 
Tijdens het verlies van BAP1 laten het transciptoom en het epigenoom een afname 
in expressie zien van eiwitten die betrokken zijn bij cellulaire verbindingen en de 
organisatie van het cytoskelet van cellen. Dit kwam overeen met het fenotype dat we 
zagen na het verlies van BAP1. Toen we het chromatine landschap bestudeerde, met 
behulp van de techniek ATAC-sequencing, van gezonde organoïden en organoïden 
die geen BAP1 meer hadden, zagen we een opmerkelijke toename van de openheid 
van het chromatine in organoïden die geen BAP1 meer hadden. Ondanks de globale 
toename van het chromatine eiwit H2K119Ub, die geassocieerd is met een gesloten 
chromatine landschap. Door het gebruik van de techniek ChIPmentation, hebben 
we het chromatine eiwit H3K27me3 waargenomen op het chromatine van gezonde 
organoïden in de gebieden waar een toename van de openheid van het chromatine 
geobserveerd is na het verlies van BAP1. Dit zou kunnen betekenen dat een specifieke 
hoeveelheid van het chromatine eiwit H2AK119Ub essentieel is voor het verkrijgen 
van een gesloten chromatine landschap door middel van de polycomb-eiwitten. Dit 
hoofdstuk laat de kracht zien van het gebruik van genetisch gemanipuleerde humane 
lever organoïden om kankerprogressie te bestuderen in galwegkanker. 
We hebben de invloed van het retinol (vitamine A) metabolisme en RXR gemedieerde 
genexpressie regulatie tijdens intestinale differentiatie en darmkankerprogressie 
bestudeerd in hoofdstuk 5. Hierbij hebben we gebruik gemaakt van muis en 
humane organoïden kweekmodellen. Tijdens de differentiatie van muis dunne darm 
enterocyten, en in niet-gemetastaseerd humane dikke darm organoïden, zien we een 
toename in de expressie van genen die geassocieerd zijn met het retinol metabolisme. 
Als we het retinol metabolisme beïnvloeden in muis dunne darm organoïden door 
middel van drugs die het retinol metabolisme reguleren, zien we een verandering in 
fenotype na de toevoeging van drugs die de nucleaire receptor RXR remmen. Tevens 
zien we een afname van de expressie van genen die geassocieerd zijn met enterocyten 
in niet-gemetastaseerd humane dikke darm organoïden. Dit effect was niet te 
observeren in metastaserende humane dikke darm organoïden, waarschijnlijk door 
een verminderde hoeveelheid van gedifferentieerde cellen in deze organoïden. Het 
was opvallend dat na toevoeging van een RXR activerende drug er geen toename in 
expressie van genen geobserveerd werd die geassocieerd zijn met enterocyten. Dit zou 
kunnen betekenen dat de RXR gemedieerde genexpressie gereguleerd wordt op een 
niet-permissieve manier. De identificatie van eiwitten die als dimeer kunnen binden 
aan RXR, zou kunnen bijdragen aan het begrijpen van de invloed van het retinol 
metabolisme en de RXR gemedieerde genexpressie tijdens darmkanker progressie. 
Mogelijk zou dit ook kunnen leiden tot de identificatie van liganden die differentiatie 
kunnen induceren van darmkanker stamcellen. 
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In hoofdstuk 6 bediscussiëren we de bevingen die beschreven zijn in dit proefschrift, 
en vatten we deze samen. We bediscussiëren hoe de ontdekking van volwassen 
stamcellen heeft geleid tot het ontstaan van verschillende organoïden kweekmodellen. 
Tevens bediscussiëren we het gebruik van multi-omics technieken in dit proefschrift, 
wat we gebruiken om genexpressie regulatie te bestuderen in organoïden. Daarnaast 
beschrijven we de uitdagingen en mogelijkheden van het gebruik van genetisch 
gemanipuleerde organoïden in wetenschappelijke studies. Ten slotte sluiten we af 
met een beschrijving van technieken om het proteoom te bestuderen in toekomstige 
organoïden studies, en beschrijven we de kracht van het samenwerken wat momenteel 
sterk aanwezig is in het organoïden onderzoeksgebied. 
De onderzoeken die beschreven zijn in dit proefschrift dragen bij aan de kennis die 
we hebben over hoe de genexpressie, die een rol speelt in cellulaire differentiatie en 
kankerprogressie, gereguleerd wordt in organoïden modellen. Door gebruik te maken 
van multi-omics technieken, hebben we verschillende soorten van biologische 
informatie met elkaar kunnen vergelijken, om zo genexpressie regulatie te kunnen 
bestuderen.
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This thesis research has been carried out under the institute research data management 
policy of the Radboud Institute for Molecular Life Sciences (RIMLS). 
Source (date last access: 07-04-2020): https://www.ru.nl/rdm/vm/policy-documents/
policy-rimls/
Below a list of persistent identifiers for datasets, and corresponding chapters in this thesis
Chapter 1
No data or code has been produced for this chapter
Chapter 2
Next-generation sequencing data is deposited at the Gene Expression Omnibus 
(GEO) with accession code GSE114113. Mass spectrometry data is deposited at the 




RNA-sequencing data is deposited at the GEO with accession code GSE99133. Mass 
spectrometry data is deposited at the ProteomeXchange Consortium via PRIDE partner 
repository with the dataset identifier PXD006575.
DOI: 10.1016/j.celrep.2018.01.033
Chapter 4
Next-generation sequencing data is deposited at the GEO with accession code 
GSE129457. Mass spectrometry data is deposited at the ProteomeXchange Consortium 
via the PRIDE partner repository with the dataset identifier PXD013353.
DOI: 10.1016/j.stem.2019.04.017
Chapter 5
RNA-sequencing data is locally stored for 10 years at university-based servers which 
are maintained by C&CZ (Radboud Universiteit, FNWI).
Chapter 6
No data or code had been produced for this chapter
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